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Cancer chemotherapy with 5-fDu-orouracil is often limited "by
severe gastrointestinal toxicity. The aims of this study were to
dissociate the effects of 5-flnorouracil on the intestine from those
simply due to reduced food intake and to investigate means of
I
reducing the intestinal toxicity of the drug.
Established methods for the estimation of intestinal water
absorption, mucosal DM contents and cytoplasmic peptide hydrolase
activities, with appropriate modifications and improvements where
necessary, were validated. During the estimation of absorption in
vitro peptidase activities were released, from the perfused intestine.
The amounts released were similar to those released from intestines
perfused in vivo provided that the intestine was removed from an
anaesthetized animal; however, they were markedly increased when
the rat was killed prior to establishment of perfusion. The
importance of this observation to the use of intestinal preparations
in vitro and to the physiological site of peptide hydrolysis is
discussed. The release of enzyme activities may be increased by
anoxia but an attempt to use enzyme measurements for the diagnosis
of intestinal ischaemia was unsuccessful.
Intestinal absorption and mucosal DM contents were severely
reduced 3 days after 5-fluorouracil administration. The reduced
food intake alone resulted in a. much smaller reduction. Also, the
Tris and sodium salts of p-fluorouracil have markedly different
systemic toxicities and effects on food intake but similar effects
on the intestine. Hence the intestinal effects of 5-fluorouracil
cannot be attributed only to a reduced food intake.
The plasma pharmacokinetics of the two salt forms of
5-fluorouracil differ after intraperitoneal injection. This is
evidence of a difference in the properties of the two salts and hence
it is a property of the Tris salt per s_e that is responsible for the
mortality associated with administration of this salt of the drug.
Intestinal peptide hydrolase activities are reduced after
5-fluorouracil administration and this might impair the digestion and
absorption of protein. However, 'elemental' diets do not protect the
intestine from the toxic effects of 5--flnorourac.il and may even
increase the toxicity of the drug.
The intestinal toxicity of 5-flnorouraci"i varies with the time
of drug administration. Least toxicity was observed after injection
at 02s00 and maximal toxicity after injection a.t 15:00. These times
coincide with the peak and nadir respectively of the mucosal LNA
content and it is suggested that the intestinal toxicity may be
related to the proliferative activity of the intestine at the time of
injection; this in turn may be related to the feeding pattern of the
animals. The possible application of these observations to the
clinical use of 5-flu.orouracil is discussed.
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Chemotherapy was introduced in the mid 1950's for the treatment
of cancer and, together with radiotherapy, offers great potential for
the non-surgical palliation, or even cure, of some cancers„ Neverthe¬
less, the success rate of treatment is still low and a great deal of
effort is being spent on attempts to improve therapeutic regimes of
existing and of new drugs.
The pyrimidine 5-fluorouracil is an antimetabolite used in the
chemotherapy of certain epithelial tumours. It is a structural
analogue of thymine (see below) and is thought to prevent cell
division by inhibition of thymidilate synthase; an enzyme important
in the production of thymine nucleotides for DNA synthesis
(lieidelberger et al, 1959)* Although 5-fluorouracil is also incorpor¬
ated into ENA in place of uracil this is not thought to be important




While surgery and irradiation can be effective in the treatment
of localised tumours, the introduction of chemotherapy resulted in a
major advance in the treatment of disseminated cancers and by this
method alone a normal life expectancy has been achieved for at les,st
half the patients with ten different types of cancer (Zubrod, 1972).
5~Pluorouracil is most useful in the treatment of carcinoma of the
breast (Ansfield jet al, 19^9) and of the gastrointestinal tra,ct
(Hall, 1979; Haskell, 1980, p. 88; Horton et al, 1974; Ratner et
al, 1972).
The mechanism of action of the majority of cancer chemothera-
peutic agents is either by inhibition of DNA synthesis, e.g. metho¬
trexate, cytosine arabinoside and 5-fluorouracil, or by inhibition of
mitosis, e.g. vincristine and vinblastin (see Haskell, 1980, p. 28).
They are therefore most active against rapidly growing tumours, in
which most of the cells will be dividing at any given time, and have
very little activity against slow growing tumours (Zubrcd, 1972).
However, as is clear from the mechanism of action of these drugs, they
are not specific for tumour cells and their use is accompanied by
toxic side effects. These are especially noticeable in rapidly
proliferating tissues such as the gastrointestinal epithelium and
the bone marrow (Haskell, 1980, p. 29; Calabresi and Parks, 1975)•
Hence, chemotherapeutic agents are only of clinical use if there is a.
quantitative difference in the toxicity against malignant and normal
tissues.
5-Pluorouracil was developed by Heidelberger in 1957 following
the observation that some tumours demonstrate enhanced incorporation
of uracil into nucleic acids as compared with normal tissues (Rutman
et al. 1954). It was hoped that this would provide a basis for the
development of an antimetabolite with a selective toxicity against
tumour cells (Heidelberger et al, 1957). However, 5-fluorouracil, like
most other cancer chemotherapeutic agents, has a low therapeutic
Fig.1.1
Only one in five of those with cancer
respond to a drug called Flouracie,
while four out of three suffer severe
side effects. —The Observer
From Doctor Jekyll,
World Medicine, March 10 (l979)» P»87*
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index (Calabresi and Parks, 1975) i.e. the therapeutic dose is close
to that which produces toxicity in the patient. Indeed, Moertel and
Reitemeier (1967) state that 5-fluorouracil is only of therapeutic
value at a dose greater than that which produces toxicity in non-
malignant tissue.
Gastrointestinal toxicity is the first indication of the
systemic toxicity of 5-Pluorouracil. The symptoms include stomatitis,
diarrhoea, anorexia., nausea and weight loss and these can be so severe
that they limit the dose of 5-fluorouracil that can be used (Calabresi
and Parks, 1975). Leukopenia usually succeeds the symptoms of
gastrointestinal toxicity and also is a major cause of the termination
of treatment (Calabresi and Parks, 1975). Since the low white cell
count results in a reduced capacity of the immune system and hence
an increased susceptibility to infection both of these side effects
of the drug are highly undesirable. Especially so since cancer
itself is associated with anorexia and malnutrition (Costa, 1977)*
The severity of the systemic toxicity of 5-fluorouracil has been
noted (even if misprinted) in the popular press (Eig. l.l)l
It is hard to give an exact figure for the success rate of
treatment with 5~fluorouracil. Moertel and Reitemeier (19^7» P- 930)
show that, in 19 separate trials, claims of objective regression
ranged from 8% to 85%. However, it is generally stated that tumour
regression is achieved in only about 25% of patients selected for
treatment with 5-fliiorouracil (Haskell, 1980, p. 88; Heidelberger,
1973). This low response rate is due, in part, to the resistance of
some tuniours to 5-fluorouracil. 5-Eluorourac.il itself is not toxic
to cells and is only toxic after conversion to 5-fPu-oro--2-deoxyuri-
dilate by a group of enaymes including thymidine kinase, uridine
kinase and phosphoribosyltransferase. Although these enzymes are
present in normal mammalian cells they may "be absent from tumour
cells (or present in a less active form) and this might explain the
resistance of some tumours to 5-fluorouracil (Myers et al, 1976)•
However, the low response rate is probably also due to the systemic
toxicity of the drug which prevents its use at maximal therapeutic
!
doses.
It is clear, therefore, that the potential value of
5-fluorouracil and of other chemotherapeutic agents could be
increased if it were possible to reduce the toxic side effects of
the drug without impairment of the therapeutic activity. This thesi
describes such an approach to enhancing the therapeutic value of
5-fluorouracil. In this thesis the effects of 5-fluorouracil on the
intestine have been studied in detail and attempts have been made
specifically to alleviate the intestinal toxic side effects.
Gardner et al (1978) suggested that the malnutrition and
diarrhoea associated with 5-fluorouracil administration might be due
to impaired intestinal absorption. They showed that although the
absorption of both glucose and water by the small intestine of the
rat were transiently increased by 50?^ on the first day after
administration of 5-fluorouracil they were decreased by 60% on the
third day. There were parallel changes in intestinal peptide hydro¬
lase activities and both enzyme and absorptive activities had
recovered to above normal values 21 days after drug administration.
Since Bounous et al (l971a) reported a marked decrease in the food
intakes-of rats after administration of 5-fluorouracil, Gardner et
al (1978) suggested that the increase in absorptive and enzymic
activities observed 24 hours after 5-fluorouracil administration
6
might be due to starvation, 'but that this was unlikely to be the
cause of the reduction observed on the third day. However, the
literature on the effects of starvation and food restriction on
intestinal absorption is confused and contains reports of both
increased and decreased absorption rates (e.g. Kershaw et al, I96O;
Levin, 1970? Levin et al, 19&5; Newey et al, 1970). Furthermore,
from their results Gardner et al (l978) were unable to determine
whether the impaired absorption which they observed was due to a
change in the number of absorbing cells or a change in the absorptive
capacity of individual absorbing cells. This is an important
question and needs consideration. However, as discussed in Chapter
8, the resolution of this question is much more difficult than
previous authors have implied.
Therefore, before attempts are made to reduce the intestinal
toxicity of 5-fluorouracil, it is essential that the effects of
5-fluorouracil per se on the intestine are characterised, in detail
and that these are dissociated from the effects of the reduced food
intake which follows administration of the drug. Hence, a part of
this work has been concerned with the effects of starvation and semi-
starvation on the intestine; in particular*, attention has been paid
to the choice of a reference basis for expression of absorption
rates since it is apparent that this factor may be responsible for
much of the seemingly conflicting information in the literature.
A major development arose in 1971 when Bounous and his associates
in Sherbrooke, Canada, claimed that an 'elemental' diet could reduce
the systemic toxicity of 5-fluorouracil. 'Elemental' diets are
chemically defined diets composed of relatively simple nutrients
which require little or no digestion prior to absorption. Bounous et
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al (l971a and b) suggested that the impaired intestinal peptide
hydrolase activities observed after 5~fluorouracil administration
prevents digestion of proteins and that an 'elemental* diet is of
benefit to the intestine because it supplies amino acids directly to
the mucosal cells without the need for prior digestion. Since
Hirshfield and Kern (1969) demonstrated that intestinal mucosal cells
can incorporate amino acids supplied via the lumen to a greater-
extent than those supplied systemically, the suggestion of Bounous et
al (1971cl and b) seemed rational. Bounous and associates also
claimed that 'elemental* diets were beneficial in protecting the
intestine against ischaemic damage (Bounoxxs et al. 19&7) and against
irradiation damage (Hugon and Bounous, 1972). These claims, if
proven, would have enormous significance in several areas of medicine
and so it is essential that they be evaluated thoroughly. Therefore
Gardner and Heading (1979) studied the effects of 'elemental' diets
on the intestinal toxicity of 5~fluorouracil. Although they failed
to demonstrate a beneficial effect of 'elemental' diets there were a
number of inconsistencies between their study and that of Bounous et
al (l971a)• 3h view of the benefits to be gained by reduction of the
systemic toxicity of 5~fluoroxrracil this approach clearly merited
further investigation. Furthermore, although 'elemental' diets are
used in the treatment of a number of disorders of the gastrointestinal
tract (Koretz and Meyer, 1980) little is known about the effects of
'elemental' diets on the physiology of the small intestine, and it is
clearly desirable to study these in detail. The aspects which have
received particular attention in this work include the effects on
mucosal peptide hydrolase activities, the relationship between body
weight and food intake for various diets, the possible affect of
dietary flavouring on an ad libiturn regime, and the feeding pattern
(i.e. the hour-to-hour consumption of food).
It has already been claimed that the therapeutic efficiency of
chemotherapeutic agents can depend on the dose schedule used (e.g.
Ansfield and Greenspan, 1979) although this is not often exploited
in clinical practice. Chemotherapeutic agents can be divided into
two groups depending on whether they are toxic only to cells in a
specific phase of the cell division cycle, e.g. cytosine arabinoside
and methotrexate which are specific for cells in S-phase, or whether
they are toxic in all phases of the cell division cycle but may be
more toxic to proliferating cells than to non-proliferating cells,
e.g. 5-flaorouracil (Heidelberger, 1973)- Since most of these
agents are rapidly degraded by the liver (Haskell, 198O) it is clear
that those specific for a single phase of the cell division cycle
will be most effective when administered at a time when most of the
tumour cells are in the necessary phase of the cell cycle. This
rationale has been used as the basis for the development of dose
schedules for a number of chemotherapeutic agents (van Patten, 1974).
Furthermore, Skipper et al (1967) reported that the ability of
cytosine arabinoside to kill mouse leukaemia cells could be greatly
increased if the timing of sequential doses of the drug was such that
they coincided with the S-phase of the cells division cycle.
Al.though this approach has been applied .in attempts to improve
the therapeutic efficiency of these agents, little attention has been
paid to the possibility that a similar approach could be used to
reduce the toxicity to normal tissues of chemotherapeutic agents. A
major part of this work has, therefore, been devoted to such an
approach to minimizing the intestinal toxicity of 5-fluorouracil and
to answering the question "Can the intestinal toxicity of
9'
5-fluorouracil be reduced by selection of a particular time of drug
administration?" Positive results vail be presented which give
grounds for cautious optimism that the therapeutic value of drugs
such as 5-flnorouracil may indeed be increased, perhaps dramatically,
by means as simple as the selection of an optimum time for drug
administration.
Aims of the study
The principle aims of this study can be summarised thus:
(1) To establish the pathophysiology of the effects of 5-flnorouracil
on the small intestine and to dissociate the effects of
5-fluorouracil per se from those of the consequent reduced food
intake.
(2) To determine the effects of 'elemental' diets on the physiology
of the small intestine and to determine whether an 'elemental'
diet is of benefit to the intestine during 5-fluorouracil
administration.
(3) To investigate alternative methods to reduce the intestinal
toxicity of 5-fL&orouracil; in particular the possibility that
alteration of the animals feeding time or of the time of
administration of the drug might be beneficial.
Lav-out of thesis
Each chapter begins with a, self-contained Introduction and
■ therefore details of the rationale behind the various stages of the
work will not be discussed here.
Gardner et al (1978/ had already established a suitable animal
model for the study of the effects of 5-fluorouraci1 on the small
intestine. This model seemed to be well suited to the requirements
of the present study and therefore it has been adopted throughout
this work. A high dose of 5-fluorouracil is used and this induces
sulsfcantial intestinal toxicity.
Gardner et al (l9?8) and Gardner and Heading (1979) estimated
intestinal absorption of glucose and water as indices of the
functional capacity of the small intestine. Furthermore, they showed
that absorption rates of glucose and water were highly correlated.
Since intestinal water absorption rates can be estimated rapidly
and reproducibly by the technique of Fisher and Gardner (l974)5
water absorption is used throughout this work as the principle index
of the functional capacity of the small intestine and the method is
described in Chapter 3-
The rationale behind the claim by Hounous et al (l971a and b)
that 'elemental' diets are of benefit to the intestine during
5-fluorouracil administration was based on the observation that
intestinal peptide hydrolase activities are decreased after
5-fluorouracil administration. A method was therefore required for
the estimation of these activities. Several methods have been
described in the literature. These have been compared and various
modifications tested. It became clear that the thermo-lability of
the peptidases creates special problems in their estimation which can
be minimized by adoption of a rigorously standardised technique.
Also, preliminary trials showed that a highly sensitive assay was
required if peptide hydrolase activities were to be measured in
luminal effluents from perfused intestines. Chapter 4 therefore
describes the development of a satisfactory assay for peptide hydro-
lase activities.
Levin (1968) suggested that an important effect of 5-fluorouraci
was a reduction in the number of cells in the intestine, and this too
was implicit in the histological appearance of intestines from
5-fluorouracil-treated rats mentioned by Gardner et al (l978). In an
attempt to determine whether the impairment of absorptive activity is
due to a decrease in the number of absorbing cells the value of
estimating cell numbers by measuring the mucosal DNA content, as
suggested by Batt and Peters (197^), is considered. Minor modifica¬
tions were made to improve an established method for DMA estimation
and it became clear that simple precautions were necessary if DMA
analyses were to be reliable. Chapter 5 describes the method used
for the estimation of DMA.
Chapter 6 describes the effects of luminal perfusion on the
intestinal mucosal DMA content and peptide hydrolase activities.
This study was designed primarily to test whether a perfused
intestine could be used for the estimation of mucosal DMA content
and peptide hydrolase activities. However, it also gives useful
information about the physiological significance of the release of
peptide hydrolase activities from the small intestine, a matter of
considerable importance to those workers studying peptide transport
or the effects of peptide hormones on the intestine. Since the
results suggested that intestinal hypoxia might promote the release
of peptidases from the mucosal cells, a short investigation (Chapter
7) was carried out to examine whether this might be the basis of a
possible novel method for the clinical diagnosis of intestinal
ischaemia.
The effects of 5-Dluorouracil and of starvation on the small
intestine are described in Chapter 8. Also discussed in this
chapter are the effects of the use of different reference systems
for the expression of absorption rates and the possibility that this
may explain, in part, the confused literature on the effects of
starvation on the small intestine.
During the course of this work a different salt form of
5~fluorourac.il became available and an unexpected finding was that
the two salt forms of 5-flnorouracil have markedly different
systemic toxicities. Chapter 9 describes experiments which show
that the plasma pharmacokinetics of the two salts were different, an
interesting but inexplicable finding.
Chapter 10 describes the effects of 'elemental' diets on the
physiology of the small intestine. The possibility that these diets
might reduce the intestinal toxicity of 5-fluorouracil is considered
in detail, but it is concluded that, on balance, there are more likely
to be adverse effects of 'elemental' diets than benefits.
Chapter 11 describes an attempt to reduce the intestinal
toxicity of 5-fluorouracil by alteration of either the time of drug
administration or the time of feeding. This approach has been
successful and leads to the suggestion that a similar approach in
humans might lead to a significant improvement in clinical chemo¬
therapy.
The final conclusions of this work are presented in Chapter 12.
CHAPTER 2
General Methodss Animals, diets and 5~-fl»-Q£ouracil administration
Animals
Throughout this work male and female rats of a local Wistar
strain, "bred at the Centre for Laboratory Animals, Easter Bush,
Penicuik, Midlothian, were used. The animals, weighing between
140 and 160 g, were kept in the Animal House of the Department of
Biochemistry under conditions of controlled temperature and day
length with a light period of 12 hours from 07:00 to 19:00. Free
access to water was allowed at all times and for the first 7 days
and thereafter unless otherwise stated, all rats had free access to
a standard pelleted diet, Oxoid Diet 86, (Oxcid Ltd., Basingstoke,
Hants), hereafter referred to as 'Oxoid diet* for brevity.
Coprophagy was not prevented.
Animals were kept for at least 7 days before they were used
for experiment in order to minimize possible variability due to
rehousing of the rats.
Caging of animals
When free access to the Oxoid diet was allowed throughout the
experiment up to 8 rats were caged together. However, in some
experiments in which access to food was limited to a short period
each day, or in which rats were fed on an 'elemental' diet, a
maximum of 4 rats were caged together. When 5 more rats were
caged together at least one rat failed to gain weight ox* gained much





Automatic feeding device (elevation)
Fig. 2.1 Automatic feeding device used to restrict access to food
to only a single 3 hour period each day. The device is pre-set each
day in the position shown. At the start of the feeding period Pin A
is withdrawn hy the action of a solenoid and the rats have access to
food through the grille. At the end of the feeding period Pin B is
withdrawn hy a second solenoid and the food drops to a container
below such that the rats no longer have access to food. The
solenoids are actuated hy a Sangamo Weston time-switch. (The
apparatus was designed hy Professor R.B. Fisher and Br. M.L.G. Gardner
for use in a previous study, Fisher and Gardner, 1976)
Diets
In some experiments the standard diet was replaced by an
•elemental' diet. The diets used were either the two commercially
available diets 'Vivonex-HN' (Eaton Laboratories) and 'Elexical1
(Mead-Johnson) or a 'home-made' diet, Diet B, as used by Bounous et
al (1971a.). The compositions of these diets are given in Chapter 10.
Animals had free access to the diet unless otherwise stated and the
'elemental' diets were presented in dry form in a glass bowl in the
cage.
Automatic feeder devices
In some'experiments in which access to food was limited to J
hours each day a pair of automatic feeding devices were used. One
of them had been used previously by Fisher and Gardner (1976) for a
similar purpose and they were built by the work shops of the Depart¬
ment of Biochemistry.
The device is shown in diagramatical form in Fig. 2.1. Two
pins, A and B, hold in position flaps A and B respectively. The
pins are connected to solenoids which are operated by a time switch.
The cage is pre-set in the position shown.in Fig. 2.1. At the start
of the feeding period Pin A is withdrawn by operation of the solenoid
and Flap A drops to release the food as far as Flap B such that the
rats have access to food through the grille. At the end of the
feeding period Pin B is withdrawn by a second solenoid and the food
drops to a container below such that the rats no longer have access
to food.
Only 4 rats could be housed in each cage (see above) and the
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device was suitable for use only with the pelleted Oxoid diet.
Choice of sex of rats
The sex of rats used is stated in all experiments. Fisher
(1955) reported that water absorption rates by the isolated perfused
small intestine from female rats were significantly greater, by 25%,
than those from male rats. As a result of this observation female
rats have been used routinely in this laboratory for the study of
intestinal absorption. However, results are presented in Chapter 8
which demonstrate that there is no significant difference between
absorption rates estimated on intestines from male and female rats
perfused in vitro by the method of Fisher and Gardner (1974). Also,
Crocker (l97'l) demonstrated that water absorption rates estimated on
intestines from female rats vary during the four day oestrus cycle.
Although in retrospect 110 difference was detected in the variability
of absorption rates in intestines from male and female rats during
the present study, the effects of 5-fluorouracil on the oestrus
cycle are not known. Therefore, in order to avoid possible variation
from this source male rats have been used in most of the experiments
which involve 5-fluorouracil administration. Furthermore, the
growth rates and food intakes of male rats are greater than those of
female rats (see Chapter 10) and therefore changes are easier to
measure in males. An added advantage of male rats is that they are
more docile during handling.
5-Fluorouracil administration
Light ether anaesthesia was induced by placing the pre-weighed
rat in a glass dessicator which had a pad of ether soaked cotton
wool in the bottom, covered by a disc of wire gauze. The rat was
removed and injected intraperitoneally with a sterile solution of
5-fluorouracil (Tris or sodium salt, supplied by Roche Products Ltd,
Welwyn Garden City, as sterile aqueous ampules for clinical use) at
a mean dose of 1.44 mmol/kg body weight unless otherwise stated. All
rats were placed in clean cages after injection and daily food
intakes and body weights were recorded at 10:00.
A standard injection time of 10:00 was chosen for convenience;
in some experiments the injection time was varied (Chapter ll) and
all rats were injected within 10 minutes of the specified injection
time.
All times refer to Greenwich Mean Time and precautions were
taken to ensure that the control clocks for the lighting were not
altered to British Summer Time.
Statistical analysis
The significance of the differences between mean values has been
tested by the unpaired Student's t-test unless otherwise stated.
Before use of the test care was taken to confirm that the data were
normally distributed, as far as could be detected by visual
inspection. Formal tests for deviation from normality (e.g. kurtosis,
skewness - see Snedecor and Cochran, 1959» P* 199) were not applied
since large numbers of data would have been required. Nevertheless,
it can be noted that the t-test (unlike variance ratio tests) is
relatively robust towards deviations from normality (Kendall and
Stuart, 1973, p. 483).
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CHAPTER 5
Estimation of water absorption by isolated rat small intestine
Introduction
In this work, intestinal absorption is being used as an index
of the functional capacity of the small intestine and a method for
accurate measurement of absorption rates was required. There are
a number of methods available for the study of intestinal absorption
both in vivo and in vitro and these have been reviewed by Parsons
(1968). However, none of the techniques are ideal and therefore the
choice of method depends upon the requirements of the proposed study.
The study of intestinal absorption in vivo is complicated by
factors unrelated to the actual transfer capacity of the mucosa such
as gastric emptying, intestinal motility, intestinal blood flow and
hormonal action. While these factors are relevant to studies of the
control of intestinal absorption in vivo they can result in
uncontrolled variability in studies of absorption in vivo. Further¬
more, most techniques in vivo measure absorption as a net loss of
solute or fluid from the intestinal lumen and equate this loss.with
transfer from the intestinal lumen to the blood vessels and lymph on
the serosal surface of the intestine. This is not always justifiable
since some.substances are accumulated in the mucosal cells during
transfer from the intestinal lumen to the blood, e.g. iron and
vitamin B^ (Callender, 19&7; Matthews, 1967), and others are
metabolized before entering the blood as in the case of dissacharides,
dipeptides and glycerides, all of which are hydrolysed by the mucosal
cells (see Levin and Smyth, 1965). A great advantage of preparations
in vitro is that the environment of the intestine can he carefully
controlled and, in some, there is access to both mucosal and serosal
fluids.
One of the major problems in the development of intestinal
preparations in vitro was that of supplying sufficient oxygen to the
mucosal cells since the intestinal mucosa has a very high oxygen
requirement (Wilson and Wiseman, 1954 a). Fisher and Parsons (1949)
developed one of the first successful intestinal preparations in
vitro by providing a continuous supply of oxygen to the intestinal
mucosa from an oxygenated Krebs bicarbonate solution circulated
through the lumen of the intestine and from another circulated
around the serosa], surface. They believed that the success of their
preparation was due partly to the fact that luminal perfusion was
established in the anaesthetized rat prior to removal of the
intestine so that it was never deprived of a supply of oxygen. This
precaution cannot be adhered to with some other intestinal preparations
in vitro such as everted sacs (Reid, 1901; Wilson and Wiseman, 1954)?
a!.
tissue rings (Agar et ad, 1956) and tissue slices (Kimbergj. 1961).
Both Fisher and Parsons (1949) and. Fisher and Gardner (1974)
advocated the use of precautions to prevent temporary hypoxia during
studies of intestinal absorption in vitro. Fisher and Gardner (1974)
showed that a delay of 15 minutes between excision of the intestine
arid establishment of luminal perfusion was detrimental to subsequent
absorption of glucose and water although the damage was slowly
reversible. Furthermore, Gardner (1978) demonstrated a 50% reduction
in both glucose and water absorption rates when intestines for
perfusion were removed from freshly killed rats instead of from ether-
anaesthetized rats after establishment of luminal perfusion with a
segmented flow of perfusate and bubbles of oxygen. These observations
demonstrate clearly the value of the precautions to avoid temporary
hypoxia and suggest that absorption might be impaired and experimental
variability increased in preparations in vitro such as everted sacs
and tissue rings where these precautions cannot be applied.
During luminal perfusion the intestine should he maintained at
a distension pressure of about JO cm water in order.to ensure
adequate exposure of the mucosal surface of the intestine to the
oxygenated medium. Distension is achieved in everted sacs by the
pressure of the fluid within the sacs and occurs naturally in
intestinal rings cut from everted intestine due to contraction of
the smooth muscle in the intestinal wall (see Wilson, 1962, p. 35)-
However, Fisher and Gardner (1974) showed that maximal absorptive
activity could not be maintained in isolated small intestine
perfused with a continuous flow of oxygenated perfusate and they
suggested that this effect was due to the slow rate of diffusion of
oxygen in the luminal perfusate. This limitation also applies to
other preparations in vitro such as everted sacs, tissue rings and
tissue slices. Furthermore, Fisher and Gardner (l974) showed that,
when the flow of oxygenated perfusate was broken by bubbles of
oxygen, absorption no longer appeared to be limited by luminal
diffusion. This so-called 'segmented-flow! not only provides
additional oxygen to the mucosal cells in the form of bubbles of 5%
carbon dioxide in oxygen but also results in a rapid mixing of the
luminal perfusate during perfusion. Vinne (l.979) subsequently
confirmed that the segmented-flow, used by Fisher and Gardner (l97.4)>
causes a marked reduction in the calculated thickness of the
unstirred layer adjacent to the mucosal cells which occurs either
with the laminar flow characteristics of a continuous flow of
perfusate or with other in vitro incubation techniques (Wilson and
Dietschy , 1974)• This unstirred layer results in slow diffusion
between the medium and the mucosal cells and hence impairment of
absorption rates, and is a major limitation inherent in many
techniques for the study of absorption. The implication of an
•unstirred layer' is that the concentrations of solutes in contact
with the absorbing surface of the cells are not the same as those
in the bulk fluid within the lumen. Further, as noted above, the
diffusion across this 'unstirred layer' (and not the transport
process) can become rate-limiting for intestinal absorption. A
further advantage of the segmented-flow of luminal perfusate is
that it allows a sufficiently low perfusion rate so that the
concentration difference between the perfusate and luminal effluent
allows the precise measurement of absorption (fisher and Gardner,
1974).
While fisher and Gardner (1974) showed that their preparation
continued to concentrate glucose for more than 5 hours, Levine et
al (1970) demonstrated morphological destruction of everted, sacs
after incubation for only 5 minutes. Also, there is evidence that
eversion of the intestine increases its permeability to some solutes
(Chalfin et al, 1958) and to in ulin and phenol red which are
practically impermeable in vivo (Smyth and Taylor, 1957) and
decreases the potential difference across the rat jejunum (Baker et
al. 1969). furthermore, Silk and Kim (1976) suggested that studie
of peptide absorption in vitro may not be valid due to an unphysio-
logical release of peptide hydrolase activities from these
preparations. As discussed in Chapter 6, this release might be the
result of temporary hypoxia since the release is much less from
intestines perfused in vitro by the method of Fisher and Gardner
(1974) provided that their precautions to avoid temporary hypoxia are
observed.
However, experiments with preparations in vitro such as everted
sacs, tissue rings and tissue slices have made a significant
contribution to the understanding of the mechanisms of intestinal
absorption. These preparations have the advantage of simplicity
since the apparatus requirements are minimal. Furthermore, a large
number of experiments can be carried out on a single intestine
thereby reducing inter-animal variability. In contrast, a large
segment of intestine is required for perfusion in vitro in order to
obtain sufficient secretion from the serosal surface and to obtain a .
large concentration difference between the perfusate and luminal
effluent. Since it is difficult to measure a constant length of the
small intestine in situ the whole jejunum plus ileum are routinely
used in this laboratory; this also avoids the problem of variability
of the absorptive capacity of different regions of the small intestine.
It is, however, possible to carry out more than one experiment cn each
intestine by the method of Fisher and Gardner (1974)• Segmentation
of the luminal perfusate allows the perfusate composition to be
changed with a corresponding rapid change in the composition of the
luminal effluent so that a new steady state is established within
about 5 minutes (Fisher and Gardner, 1974). This permits the use of
at least two perfusate compositions with each intestine, although this
has not been exploited in the present work.
One problem associated with all intestinal preparations in vitro
is that of accumulation of solutes in the tisstie fluid to unphysio-
logical levels due to the absence of the serosal blood flow. Fisher,
and Gardner (1974) showed that tissue accumulation of a solute was
dependent upon the rate of water absorption and that it was only when
absorption rates were high (greater than 150 jil/cm/hr for the proximal
40 cm of the jejunum plus ileum) that the cumulative appearance of a
solute in the serosal fluid was a reliable measure of absorptive
activity. They found that when the glucose concentration in the
luminal perfusate was 28 mmol/l the tissue fluid concentration rose to
about 70 mmol/l. Furthermore, Fisher and Gardner (1974a) demonstrated
that the rate of glucose absorption was increased when the tissue
accumulation was reduced by the introduction of an arterial infusion
technique, and they suggested that maintenance of physiological tissue
fluid glucose concentration may be important for the functioning of
the small intestine. This problem is partly overcome in this and other
preparations in vitro by the use of short experimental periods, although
this may introduce further errors since Fisher and Gardner (1974)
demonstrated that their preparation requires a short period of about
5 minutes to become stable.
The technique of Fisher and Gardner (1974) was therefore chosen
as the most suitable method for the measurement of intestinal
absorption in vitro. Intestines are perfused by a segmented-flow of
bubbles of 3% carbon dioxide in oxygen and slugs of oxygenated perfu¬
sate in a single-pass through the lumen. The mesentery is removed so
that the fluid and solutes which would enter the portal circulation
and the lymphatics can be collected directly. Intestines are removed
from ether-anaesthetized rats only after establishment of luminal
perfusion such that the intestine is never deprived of a supply of
oxygen. This preparation is stable for at least 100 minutes (Fisher
and Gardner, 1974)- Furthermore, the apparatus for this technique
was already available and there existed in the laboratory
considerable knowledge of the properties of the preparation and
expertise in its use.
Since the appearance of a solute in the serosal fluid is
dependent on the water absorption rate and since Gardner et al
(1978) and Gardner and Heading (1979) demonstrated a highly
significant correlation between the rates of glucose and water
absorption, water absorption rates have been used throughout this
work as an index of the functional capacity of the small intestine.
A further advantage of the use of water absorption rates is that
these are estimated directly from the volume of fluid secreted on
to the serosal surface of the intestine. Estimation of the rate of
absorption of glucose or other solutes requires a further analysis
of the contents of the luminal effluent and thus an additional error
in estimations of absorption rates. It must be stressed that
estimation of water absorption rates with most of the alternative
preparations in vitro requires the use of an 'unabsorbable1 marker
substance such as polyethylene glycol which may be adsorbed on to th
mucosal cells and may even decrease absorption rates (Davis .et al.
1980).
This chapter describes the estimation of water absorption ra,tes
by the method of Fisher and Gardner (1974).
Estimation of water absorption rates
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Throughout this work' water absorption rates were estimated on
the whole jejunum plus ileum from either male or female rats. Since
there is a diurnal rhythm in the absorption of glucose and water by
the rat small intestine (Eisher and Gardner, 1976) all absorption
experiments were performed between 10:00 and 16:00.
Perfusate
This was a Krebs and Henseleit (1952) bicarbonate saline solution
modified by halving the concentration of calcium and quartering that
of magnesium. The following stock solutions were prepared with
AnalaR chemicals (B.D.H. Chemicals Ltd) and stored at 4°C:
Stock perfusate 69.25 g NaCl, 20.90 g NaHCO^, 5.53 g KCl, 1.6l g
KH^PO^, 0.73 g MgSO ^H^O in 2 litres of doubly
distilled water.
CaCl 13.9 g CaCl^.611^0 in 500 ml doubly distilled water.
Phenol red 1.0 g phenol red dissolved in 1 litre of doubly
distilled water with 1 pellet of NaOH added and
then filtered.
NaCl 140.2 g NaCl in 1 litre of doubly distilled water.
NaHCO^ 42.0 g NaHCO^ in 1 litre of doubly distilled water.
The•perfusate was prepared freshly from 200 ml of stock perfusate,
50 ml phenol red and 5 g glucose. The volume was made up to about
950 ml with doubly distilled water and 10 ml of the stock CaCl^
solution was added and the volume made up to 1 litre. The final
concentration of glucose and phenol red was 28 mmol/l and 141 nmol/l
respectively and the pH of the perfusate once equilibrated "with 5%
carbon dioxide in oxygen was 7«4« Phenol red was included in the
perfusate to indicate the presence of leaks in the intestine.
The lumen of the intestine was rinsed with a bicarbonate saline
solution (NaCl 120 mmol/l : NaHCO^ 25 mmol/l) prepared from 50 ml of
each of the stock solution made up to a volume of 1 litre with doubly
distilled water and equilibrated with 5% carbon dioxide in oxygen.
Anaesthesia
Anaesthesia was induced by placing the rat in a glass dessicator
which contained a pad of ether soaked cotton wool covered by a disc
of wire gauze. The animal was removed from the dessicator and placed
supine on the operating table on a pad of cellulose wadding B.P.C.
('Cellosene* supplied by Robinsons of Chesterfield). Its feet were
tied down and its nose and mouth placed in an open ended glass tube
which contained a pad of ether soaked cotton wool. The pad of cotton
wool was removed at intervals so that the animal was maintained under
light ether anaesthesia while the intestine was connected to the
perfusion apparatus. Only when perfusion was established was the
intestine removed from the rat and the animal killed. If the animal
died prior to establishment of perfusion the experiment was abandoned.
Setting up the intestine
The abdomen was opened by a midline incision and a black poly¬
ethylene drape laid over the rat. The intestine was exteriorised
through a central slit in the drape and the oral cannula was tied
into the upper end of the jejunum; this was located as the highest
part of the jejunum which could be withdrawn from the abdominal
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cavity without traction-on the ligament of Treitz. Warm oxygenated-
saline was used to wash out the luminal contents and a second




The apparatus is shown diagrammatically in Pig. 3*1*
The perfusate and bicarbonate saline are contained in two glass
reservoirs, either water jacketed or immersed in a water bath at
41°C. They are equilibrated with 5% carbon dioxide in oxygen by
means of gas lifts which carry approximately 100 ml gas per minute
into each reservoir. The perfusate and saline are warmed and equi¬
librated with the gas mixture for at least 1 hour prior to use.
Warm moist gas (5% carbon dioxide in oxygen) is pumped from the
saline reservoir by a peristaltic pump (Watson-Marlow Delta multi¬
channel) into a stream of warm oxygenated perfusate delivered by a
second channel on the pump to form a sequence of slugs of liquid
separated by gas bubbles, the so-called segmented-flow. The pumping
rate was normally 3-5 ml/minute for each of perfusate and gas.
Warm oxygenated saline for washing out the segment of intestine
is pumped by an independent peristaltic pump ('Pericyclic' pump by
Schuco Scientific Ltd, London). A by-pass line with a relief valve
(a modified Starling resistance, Fisher and O'Brien, 1972) allows
saline to return to the saline reservoir if the luminal distension
pressure exceeds 30 cm water.
The segmented-flow of perfusate passes through a flexible water
jacket (37°C) connected to the bung of the organ chamber. The bung is
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Pig. 3.1 Perfusion apparatus. A flow of warm moist gas (3%
carbon dioxide in oxygen) is pumped by a peristaltic pump into a
stream of oxygenated perfusate via an 'h1 piece (Technicon
Instruments Co., Chertsey, Surrey) to form a sequence of slugs of
perfusate and bubbles of gas (the 'segmented-flow'). The segmented-
flow of perfusate passes through a flexible water jacket and is
delivered to the inlet cannula tied into the top end of the jejunum.
The outflow from the segment of intestine passes through a
resistance which maintains the intestine at a distension pressure
of JO cm water and is collected into tared tubes. The intestine is
suspended in a water jacketed organ chamber maintained at 37°0. A
stream of warm moist gas (3% carbon dioxide in oxygen) passes via
the flexible water jacket through the organ chamber. This gas
supplies oxygen to the luminal surface of the intestine and blows
the secretion from the serosal surface of the intestine along the




removed from the organ chamber and placed on the operating table
beside the rat and the segmented flow is delivered to an inlet
cannula of glass tied into the jejunum. The ileal cannula is
connected to the outlet tube which passes through the bung and the
pump speed is increased three fold until luminal perfusion is
established.
A modified Starling resistance is connected to the outflow
tubing to maintain a distension pressure of 30 cm of water so as to
expose uniformly the whole mucosal surface to the perfusate and gas.
Luminal perfusion is established once the segmented-flow passes
through the resistance and the pump rate is then reduced to about
3.5 ml/minute and the intestine is removed from the anaesthetized
rat. The mesentery is clamped adjacent to the caecum and divided
peripherally to the clamp and the remnant is gently torn away from
the segment of small intestine. The intestine is dipped into a bowl
of warm oxygenated saline to remove traces of blood from the serosal
surface and a length of nylon yarn is pulled through the naturally
formed loops of intestine. The organ chamber bung is then replaced
and the intestine is suspended, free from kinks, in the water-
jacketed organ chamber. This procedure is normally completed within
5 minutes of induction of anaesthesia.
Gas (5% carbon dioxide in oxygen) saturated with water vapour at
37°c is carried through the flexible water jacket and passes through
the organ chamber. This gas is passed through two traps, one just
before the water jacket and one at the outlet inside the organ
chamber, to prevent condensed water vapour- passing into the serosal
secretion. The flow of gas serves to oxygenate the serosal surface
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of the intestine and to blow'the transported fluid (the serosal
secretion) along the exit tube at the bottom of the organ chamber to
tared collecting tubes. The outflow .from the intestinal lumen (the
luminal effluent) passes to a second set of tared collecting tubes.
The two sets of tubes are held in a time operated fraction collector
(Central Fraction Collector, supplied by Gallenkamp and Co. Ltd)
modified as described by Gardner (l97l)-
In the original perfusion unit of Fisher and Gardner (1974) "the
perfusate and saline reservoirs are immersed in a water bath at 41°G
and this water is circulated through the water jackets by a pump
(1Circotherm' supplied by Shandon Southern Ltd, Camberley, Surrey).
An alternative design employs a flow heater (Model FEU5 Grant
Instruments Cambridge Ltd) to circulate warm water through the water
jackets and in this design the reservoirs are also water jacketed.
Estimation of intestinal length and dry weight
After completion of perfusion the intestine was removed from the
perfusion apparatus. The length was estimated with the intestine
laid along the length of a metre rule and held straight between the
cannulas but not under tension. The cannulas were removed and the
intestine placed 011 a piece of tared aluminium foil and dried to
constant weight at 75°C in an oven.
Absorption rates
Because the water content of the intestine remains constant
throughout the experiment (Fisher and Gardner, 1974) it is assumed
that the total volume of liquid pumped into the lumen during any
collection period is equal to the sum of the volume of effluent
issuing from the lumen plus the volume of secretion. Water absorption
rates are therefore calculatedrttxrectly from the volume (ie. weight)
of secretion on to the serosal surface of the intestine in a given
time.
The serosal secretion was collected over sequential 5 minute
!
periods commencing immediately after setting up the intestine.
Absorption rates became stable within 5 minutes and remained so over
the next hour (fig. 3-2). These rates agree closely with the values
observed by Fisher and Gardner (1976) under the same conditions.
Normally four 5 minute collections were made of the serosal
secretion from each intestine and the absorption rate was calculated
from the last three collections.
Absorption rates are normally expressed in terms of pl/cm/hr.
However, in Chapter 8, they are also expressed with reference to
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Fig. 3.2 Stability of the preparation. Rates of water absorption
from the lumen were measured over successive 5 minute periods (mean
of 4 experiments)
CHAPTER 4
Estimation o.f peptide hydrolase activities
Introduction
As described in the General Introduction it was desired to measure
peptide hydrolase activities in the mucosal cytoplasm since impair¬
ment of these activities had already been shown by Bounous et al
(l971a), Gardner et al (1978) and Gardner and Heading (l979),
furthermore, this observation was central to the rationale behind
the suggestion by Bounous et al (l971a and b) that 'elemental' diets
were beneficial to the intestine during 5-fluorouracil administration.
An existing method was investigated and modified for use in
these studies. Gardner et al (1978) and Gardner" and Heading (1979)
used a method modified from that of Pujita et al ("1972) for the
estimation of cytoplasmic peptide hydrolase activities in the
intestinal mucosa. Their method involves two steps: in the first
the material to be assayed is incubated in the presence of a
dipeptide substrate and "then, after termination of this reaction,
the released amino acids undergo oxidative deamination by the
action of L-amino acid oxidase from snake venom and the hydrogen
peroxide so produced oxidises the chromogen, O-dianisidine, in the
presence of peroxidase.
However, Gardner et al (1978) noted high variability in the
activities estimated and they stressed the technical difficulties
involved. These were mainly due to (a) loss or leakage of enzymes
from tissues in vitro. (Josefsson and Sj8str8m, 1966; Lindbex'g et
al, 1975; Silk and Kim, 197&) (b) loss of activity during
handling of the tissue' at room temperature since many peptidases are
thermolabile. Furthermore, in order to be able to estimate absorptive
and enzymic activities on the same intestine, Gardner et al (1978)
used only 1 cm segments of proximal jejunum and distal ileum for the
estimation of enzymic activities and expressed the activities found
relative to protein.
Since peptide hydrolase activities are known to vary in
different regions of the small intestine (Lindberg et al, 1975>
p. 226; Robinson and Shaw, i960), activities estimated on 1 cm
segments might not be representative of the activity of the whole
small intestine. Also, the use of short segments of intestine
necessitates the use of a reference system such as unit length of
intestine, unit weight of intestine or protein, all of which might be
affected by the treatment under study thereby influencing the changes
observed in enzyme activities. In order to avoid the use of such
reference systems in this work enzyme activities are expressed as
the total activity of the whole jejunum plus ileum. The advantages
of this, and the consequences of the use of different reference
systems, are discussed elsewhere in the specific context of the
effects of starvation on absorption by the rat small intestine
(Chapter 8).
The method used by Gardner et al (1978) was therefore modified
for application to the whole jejunum plus ileum. Furthermore,
strict control of temperature during preparation of the mucosal
homogenate and preparation of the assay has been introduced in order
to minimize thermal inactivation of the enzymes.
This method was used in the preliminary study, described in
Chapter 6, of the release of peptide hydrolase activities from the
small intestine during perfusion in vitro and in vivo. The study had
two purposes: (l) to test the application of the peptide hydrolase
assay to the estimation of peptide hydrolase activities in the
intestinal mucosa and (2) to determine whether an intestine which
had already teen perfused for measurement of absorptive activity
could be used for the estimations. If the latter were possible, it
would enable the estimation of water absorption and of peptide
hydrolase activities on the same intestine and the advantages of
this are discussed in Chapter 6. The method was found to have a
number of shortcomings (see below) and therefore other published
methods were explored.
The method of Fujita et al (1972) involves two consecutive
incubations of 30 minutes and 60 minutes, for the peptide hydrolysis
and the amino acid oxidase reactions respectively. Nicholson and
one of which
Kim (1975) reported methods, /\ combines the two steps into a
single incubation of 20 minutes. This method was investigated and
compared with a similar one in which two 20 minute incubations are
used (Nicholson and Kim, 1975)- The latter method gave consistently
higher activities than the former and it was concluded that the
L-amino acid oxidase inhibits the peptide hydrolase activities
estimated. Therefore, since the two step assay, described by
Nicholson and Kim (1975)? Nad several advantages over that of
Gardner et al (1978) in terms of speed and sensitivity, it was
chosen with minor modifications for use in this work.
peptidase
Dipeptide + H^O » L-amino acids
L-amino acid
oxidase
L-amino acid + 0^ } keto acid + NH + H Od J d d
peroxidase
H O + O-dianisidine > oxidised dianisidine
(brown)
Fig. 4-1 The sequence of reactions involved in the estimation
of peptide hydrolase activities.
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Method '1': The method of Pu.jita et al (1972) as modified by Gardner
et al (1978)
Principle of the method
Samples containing peptide hydrolase activity are incubated with
dipeptide substrates. The liberated L~amino acids are oxidised by
ophidian (snake) L-amino acid oxidase to the corresponding imino
acids which spontaneously decompose to the keto acids, releasing
ammonia. The reduced flavin moiety of the oxidase enzyme is
reoxidised by molecular oxygen, and the resulting hydrogen peroxMe
is coupled by peroxidase to the oxidation of colourless O-dianisidine
to a brown dye (see Pig. 4«l).
Snake venom L-amino acid oxidase does not oxidise dipeptides or
larger peptides and only acts on some L-amino acids. Of the
dipeptides chosen as substrates for the assay in this work, Gly-L-Met,
L-Leu-Gly and L-Val-L-Leu, only one of each pair of amino acids
(leucine or methionine) reacts with the L-amino acid oxidase and
therefore the amount of L-amino acid determined is equivalent to the
amount of dipeptide substrate hydrolysed.
Preparation of ,a cytoplasmic fraction from intestinal mucosa
As will be shown in Chapter 6, cytoplasmic peptide hydrolase
activities are slightly, though not significantly, decreased if the
intestine is removed from a freshly killed rat when compared with
those of an intestine removed from an ether-anaesthetized rat.
Therefore, intestines were removed from living, but anaesthetized, •
rats, except during the initial investigation of the assay when
intestines were removed from ether killed rats.
The procedure for .the preparation of an intestine for perfusion,
described in Chapter 3» was followed and P.Y.C. gloves were worn
throughout to prevent contamination of the intestine during handling.
Once the luminal contents had been washed out with warm (37°C)
bicarbonate saline equilibrated with O^/CO^ (95s5)s "the whole jejunum
plus ileum was torn away from the mesentery and excised just proximal
to the ileo-caecal valve. Immediately, the intestine was placed on
a piece of aluminium foil, pressed into a beaker of crushed ice to
form a depression to hold the intestine, and taken to a cold room
(4°C). Blood was removed from the serosal surface by rinsing the
intestine in chilled NaCl solution (0.9 g NaCl in 100 ml distilled
water). For ease of handling the intestine was divided into two;
each piece was slit open with sharp scissors and laid flat, mucosal
side uppermost, on a pre-chilled glass sheet resting on a tray of
crushed ice. Two chilled glass microscope slides were used to scrape
off the mucosa which was then transferred to a glass homogenizer
vessel previously calibrated at a volume of 10 ml. The total volume
of the mucosa was made up to 10 ml with chilled NaCl solution (0.9%
w/v) and the sample was homogenised with a loose fitting 'Teflon'
pestle. The pestle was rotated by a GaTlenkamp 'Handilab Stirrer'
operated at maximum speed (about 1200 rev/min). Homogenization was
standardized to 30 strokes where 1 stroke represents movement of the
pestle down through the homogenate and back up again. This took
about 3 minutes to complete.
Finally, the homogenate was divided into portions. If required,
two 2 ml portions were transferred to capped plastic tubes and
stored at -40°C prior to estimation of the DNA content of the
mucosa - details given in Chapter 5- A portion of the homogenate
(1 ml) was used for estimation of the total water content and the rest
was transferred to a pre-chilled^,capped plastic centrifuge tube and
centrifuged immediately in a pre-cooled centrifuge (M.S.E.) at
20 000 g at 4°G for 1 hour. The supernatant fraction was decanted
into chilled plastic tubes on ice and was used immediately for the
peptide hydrolase assay.
Feutide hydrolase assay
The following solutions were prepared freshly:
Tris-HCl buffer, 50 mmol/l
(pH 8.4)
6.057 S Tris (hydroxymethyl) amino
methane (Sigma London Chemical Co.)
in 900 ml distilled water. The pH
was adjusted to 8.4 with HC1 (5 mol/l)
and the volume was made up to 1 litre.
Tris-HCl buffer, 250 mmol/l
(pH 7.8)
Gly-L-Met, 30 mmol/l
30.285 g Tris (hydroxymethyl) amino
methane in 900 ml distilled water.
The pH was adjusted to 7«8 with EC1
(5 mol/l), and the volume was made
up to 1 litre.
61.6 mg Gly-L-Met (Sigma London
Chemical Co.) in 10 ml distilled water.
L-Leu-Gly, 30 mmol/l 56.5 mg L-Leu-Gly (Sigma) in 10 ml
distilled water.
L-Val-L-Leu, 30 mmol/l 69.I mg L-Val-L-Leu (Sigma) in 10 ml
distilled water.
L-amino acid oxidase reagent 6 mg L-amino acid oxidase (Protalus
adamanteus venom, Sigma London
Chemical Co. Type LV, purified),
1 mg peroxidase (Boehringer,
purified) and 10 mg 0-dianisidine
(Sigma, water soluble) made up to a
total volume of 100 ml with Tris-HCl
buffer (250 mmol/l, pH J.8).
Procedure:
Peptide hydrolase activities against three dipeptide substrates,
Gly-L-Leu, L-Leu-Gly and L-Val-L-Leu, were estimated in duplicate at
two suitable dilutions of the supernatant fraction to be assayed.
The supernatant fraction was diluted in the range 1:320 to
1:1280 in Tris-HCl buffer (50mmol/l) pH 8.4. To tubes containing
0.4 ml dipeptide substrate, 0.1 ml of a supernatant dilution was
added. Blanks were prepared containing either 0.4 ml dipeptide
substrate and 0.1 ml Tris-HCl buffer (50mmol/l)pH 8.4» 0.4 ml
(50 mmol/l) Tris-HCl buffer pH 8.4 and 0.1 ml of the supernatant
dilution, or 0.5 ml Tris-HCl buffer (50mmol/l.) pH 8.4. All tubes
were mixed rapidly with a vortex mixer and then incubated in a water
bath at 37°C for 30 minutes. After incubation the tubes were
transferred to a boiling water bath for 3 minutes to terminate the
reaction and then removed and allowed to cool to room temperature.
1 ml of the L-amino acid oxidase reagent was then added to the
sample tubes which were mixed and incubated for 1 hour at room
temperature.
Sample absorbance was measured within 2 hours in a Pye Unicam
Pig. 4.2 Calibration curves for the assay of L-Leucine and
L-Methionine with L-amino acid oxidase from snake venom by the method
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SP1750 spectrophotometer at 440 nm. All samples wex^e measured
against the Tris-HCl buffer blank, The absorbance measurements
were corrected for the absorbance, if any, of the supernatant and
dipeptide blanks.
Calibration curve
A calibration curve was prepared for each set of estimations.
Standard amino acid solutions, 500 nmol/l (26.24 nig L-Leucine or
29.84 mg L-Ivlethionine in 200 ml distilled water, stored at -40°C
in 2 ml portions) were diluted in the range 100 - 300 nmol/l in
Tris-HCl buffer (50mmol/l, pH 8.4). 1 ml of the amino acid oxidase
reagent was added and the samples were incubated as above.
The calibration curve was almost linear over this range (Fig.
4.2) and the amino acid content of the test samples was determined
from the first order regression line of the calibration curve for
the relevant amino acid.
Estimation of the total water content of the homogenate
The total water content of the supernatant was calculated from
the difference between the wet and dry weight of the homogenate. A
1 ml portion of the homogenate was pipetted into a pre-weighed
plastic dish and the wet weight was recorded. The sample was dried
to constant weight at 37°C in an incubator and the water content was
calculated from the weight loss. The cytoplasmic enzyme activities
were assumed to be evenly distributed throughout the water volume of
the homogenate. A-ctivities estimated per ml of supernatant were
multiplied by the total supernatant volume to give the total
activity in the supernatant.
The effect of storage of the supernatant on peptide hydrolase
activities
It was important to determine whether the supernatant fraction
could be stored frozen and used subsequently for the estimation of
peptide hydrolase activities. Segments (about 1 cm) of proximal
jejunum and distal ileum were removed from an anaesthetised rat
after the jejunum plus ileum had been removed for perfusion measure¬
ments. Hie intestinal mucosa was scraped off as described
previously, and homogenized in 2 ml of NaCl solution (O.J% w/v).
The homogenates were transferred to pre-chilled centrifuge tubes
and centrifuged at 20 000 g for 1 hour at /\°C. A portion of the
supernatant was taken for immediate estimation of peptide hydrolase
activities and the rest was stored frozen at -26°C (the estimated
temperature of the deep freeze) in 0.1 ml portions in capped plastic
tubes. Peptide hydrolase activities against Gly-L-Met, L-Leu-Gly
and L-Val-L-Leu were estimated on each of the next 4 days and on the
twelfth day after preparation of the supernatant. A single 0.1 ml
portion was thawed for use each day. Activities were expressed with
reference to protein (estimated by the method of Lowry et al, 1951)•
The results are shown in Pig. 4-3*
There was a dramatic decrease (P-<0.00l) in all three
activities after storage for 12 days at -26°C and the decrease was
greatest for activities against Gly-L-Met (84%). Furthermore, all
activities were decreased after storage at -26°C for only 1 day
although the decrease was only significant for activities against
Gly-L-Met (27% for the jejunum, 33% For the ileum P-^O.OOl) and
L-Val-L-Leu (18% for the jejunum, 3&% For the ileum P-=^0.00l).
Pig. 4-3 Cytoplasmic peptide hydrolase activities against (©)
Gly-L-Leu, (A) L-Leu-Gly, and (H) L-Val-L-Leu estimated on the mucosa
from (a) jejunum and (b) ileum on the day of preparation of the
supernatant fraction and after storage at -26°C for various times.
Activities are expressed per mg protein. Values are the mean i S.E.M.
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The changes were similar for activities in the jejunum and ileum.
Thus it is clear that cytoplasmic peptide hydrolase activities
are decreased if the supernatant is stored frozen overnight prior to
estimation of the activities: hence activities should be estimated
immediately after preparation of the supernatant.
Auulication of the assay to the estimation of peptide hydrolase
activities in mucosal cytoplasm, serosal secretions and luminal
effluents
This method was used in the study of the release of peptide
hydrolase activities from the rat small intestine during perfusion,
described in Chapter 6. However, activities could not be estimated
with any degree of accuracy in the luminal effluents and serosal
secretions since these activities were at the lower limit of the
sensitivity of the assay (0.02 pmol/min/ml). Furthermore, estimates
of cytoplasmic peptide hydrolase activities in the intestinal mucosa
varied to an unsatisfactory extent between duplicate samples
(coefficient of variation of an estimate = 12.3%, n = 10).
Peptide hydrolase activities estimated on different dilutions of the
supernatant fraction
Fig. 4«4 shows the time course of the hydrolase activity against
L-Leu-Gly estimated at three different dilutions of the supernatant
fraction, 1:160, 1:320 and 1:640. The assay was performed as
described previously except that the first incubation time was varied
from 5 "to 60 minutes. The amount of L-Leucine released is expressed
per ml of supernatant.










































Fig. 4*4 The amount of L-Leucine released after incubation of the
supernatant fraction of a mucosal homogenate in the presence of
15 mmol/l L-Leu-Gly. The supernatant was used at three dilutions;
1:160 (A)» 1:320 (o) and 1:640 (©). The amount of L-Leucine
released is expressed per ml of undiluted supernatant. Each point
is the mean of 3 estimations.
for all three dilutions used; there is, however, a trend towards
linearity with increasing dilution of the activities. This effect
was found to be due partly to the low solubility of O-dianisidine in
the pH 7.8 Tris buffer and partly to the non-linearity of the assay
at amino acid concentrations greater than 150 nmol/0.9 ml (Fig. 4-2).
However, provided that the O-disnisidine was completely dissolved in
1 ml of distilled water prior to addition of the Tris buffer (as
recommended by Fujita et al, 1972), this effect was reduced.
DISCUSSION OF METHOD '1'
The method of Gardner et al (1978) lacked sufficient sensitivity
to enable the estimation of peptide hydrolase activities in the
luminal effluents and serosal secretions from perfused intestines.
Furthermore, the method was found to have several shortcomings which
were introduced when the method was modified from that of Fujita et
al (1972). The calibration curves were non-linear over the range
used by Gardner et al (1978) and this resulted in low estimates of
peptide hydrolase activities at low dilutions of the supernatant
fraction. This effect was emphasised by the insolubility of the
chromogen, O-dianisidine, in the Tris buffer; the extent of
solubility also varied between batches of the L-amino acid oxidase
reagent.
Although the latter shortcomings of the method could be easily
overcome, its lack of sensitivity made it unsuitable for use in this
work. Furthermore, Lindberg et al (1975) have rightly criticised
the technique of boiling the sample in order to inactivate the
peptide hydrolase activities since this may temporarily speed up the
reaction. Therefore other methods were investigated.
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Method '2': Hie method of Nicholson and Kim (l975)
The method of Nicholson and Kim (l975) is based on the same
principle as that of Fujita et al (1972). However, Nicholson and Kim
have combined the two incubations into a single incubation and the
whole process is terminated by the addition of sulphuric acid. This
produces a purple complex which is stable overnight as opposed to
the brown colour resulting from the oxidation of O-dianisidine which
is stable for only about 2 hours (Fujita et al, 1972). This method
was therefore investigated and the results were compared with those
obtained by a similar method, also reported by Nicholson and Kim
(1975), in which the two incubations were performed separately in
order to deteimine whether the L-amino acid oxidase inhibits the
peptide hydrolase activities. These are referred to below as the
'one-step' and 'two-step' assays.
The 'one-sted peptide hydrolase assay of Nicholson and Kim (1975)
This method was investigated and was found to give consistently
lower activities than were observed with the 'two-step' assay even
with the dipeptide substrates used by Nicholson and Kim (1975)
(i.e. L-Leu-L-Ala, L-Phe-Gly and Gly-L-Phe, results not shown). Add¬
ition of L-amino acid oxidase to the first of the two incubations of
the 'two-step' assay resulted in a similar reduction in the activity
to that observed when activities were estimated by the 'one-step'
method. Addition of peroxidase or O-dianisidine to the first of the
two incubations had no effect on the activities estimated by the
'two-step' assay.
It was therefore concluded that the peptide hydrolase activities
were inhibited by the L-amino acid oxidase and that the combination
-VV
VhoV
of the two incubations is not possible for these activities. However,
the second method reported by Nicholson and Kim (1975) involves two
incubations, each of 20 minutes, and is therefore quicker to perform
than that of Fujita et al (1972). The method is also more sensitive
since the lower limit of sensitivity is about 6 nmol/min/ml. This
second 'two-step' method was therefore modified for use in this work.
The 'two-step' peptide hydrolase assay of Nicholson and Kim (1979)
The following solutions were prepared freshly:
Tris-HCl buffer, 50 mmol/l
(pH 8.0)
Gly-L-Met, 20 mmol/l
6.057 g Tris (hydroxymethyl) amino
methane in 900 ml distilled water.
The pH was adjusted to 8.0 with HC1
(5 mol/l), and the volume was made
up to 1 litre.
41.26 mg Gly-L-Met in 10 ml Tris-HCl
buffer.
L-Leu-Gly, 15 mmol/l 28.25 mg L-Leu-Gly in 10 ml Tris-HCl
buffer.
L-Val-L-Leu, 15 mmol/l 54-55 mg L-Val-L-Leu in 10 ml Tris-
HCl buffer.
L-amino acid oxidase reagent 20 mg L-amino acid oxidase, 2 mg
peroxidase and 10 mg 0-dianisidine
(dissolved in 1 ml distilled water)
were dissolved in 100 ml Tris-HCl .
buffer.
(The source of the chemicals was as stated previously).
53
Procedure:
A supernatant fraction was prepared as described previously.
In order to minimise thermal inactivation of the enzyme activities
they were estimated immediately after centrifugation of the homo-
genate.
Samples were diluted in the range 1:320 to 1:2560 by serial
dilution on ice (4°0) in pre-chilled Tris-HCl buffer (50mmol/l, pH
8.0). Although Nicholson and Kim (l975) used 14% glycerol for the
dilution of their homogenate this was omitted since glycerol was
found to inhibit all three activities estimated.
Activities against three dipeptide substrates, Gly-L-Met,
L-Leu-Gly and L-Val-L-Leu, were estimated in duplicate at each of
two dilutions. Tubes containing 0.5 ml dipeptide substrate were
placed in a water bath at 37°C and 0.04 ml of a suitable dilution
of the supernatant, luminal effluent or serosal secretion was added.
Samples were mixed rapidly with a vortex mixer and incubated for 20
minutes at 37°0. The samples were removed from the water bath and
placed in a boiling water bath for 6 minutes to terminate the
peptide hydrolysis reaction. After cooling to room temperature the
tubes were returned to the 37°0 water bath and 1 ml of the L-amino
acid oxidase reagent was added. The samples were shaken and
incubated for 20 minutes at 37°0 after which 0.74 ml of 50% ^2*^4
(H^SO^ : H^0 l:l) was added and the tubes were removed from the
water bath and allowed to cool to room temperature.
The absorbance was measured at 530 nm in a Pye Unicam SP1750
spectrophotometer read against a blank consisting of 0:54 ml Tris-HCl
buffer (50mmol/l, pH 8.0).l ml L-amino acid oxidase reagent and
Pig. 4.5 Calibration curve for the assay of L-Leucine and
L-Methionine with L-amino acid oxidase from snake venom by the 'two-
step' method of Nicholson and Kim (l975). Each point is the mean of
2 estimations.
Amino acid concentration (nmol/0-5ml)
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0.74 ml 50% HgSO .
Calibration curve
A calibration curve was prepared for each set of estimations in
the range 20 - 100 nmol L-Leucine or L-Methionine in 0.5 ml Tris-HCl
buffer (50mmol/l,pH 8.0).The samples were incubated for 20 minutes at
37°0 with 1 ml L-amino acid oxidase reagent and then 0.74 ml of 50%
H SO„ was added. The absorbance was read as above.2 4
The calibration curve was linear over this range (Fig. 4- 5 ) •
The amount of dipeptide substrate hydrolysed was equivalent to the
amount of free amino acid estimated and this was determined for the
test samples from the first order regression line of the calibration
curve.
Sample blanks
Blanks were included in all estimations, consisting of 0.5 ml of
Tris buffer and 0.04 ml of each supernatant dilution. The absorbance
of the test samples was corrected for the absorbance of the blank,
although this was normally negligible.
The optimal substrate concentrations
Peptide hydrolase activities were estimated on a suitable
dilution of a supernatant fraction with a range of dipeptide
substrate concentrations (5 - 30 nmol/l). The results are shown in
Pig. 4-6. All three activities estimated, Gly-L-Leu, L-Leu-Gly and
L-Val-L-Leu, were inhibited by high concentrations of the dipeptide
substrate. The optimal substrate concentration was therefore deter¬
mined as the substrate concentration which gave the highest estimate
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Fig. /[.6 Cytoplasmic peptide hydrolase activities against Gly-L-Leu,
L-Leu-Gly and L-Val-L-Leu estimated at various dipeptide substrate
concentrations. Activities are expressed as total tinits per ml of
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Fig. 4.7 The amount of free amino acid estimated with L-amino acid
oxidase after incubation for various times of a suitable dilution of
a supernatant fraction from a mucosal homogenate in the presence of
either Gly-L-Met (20 mmol/l) (©), L-Leu-Gly (15 mmol/l) (H), or
L-Val-L-Leu (15 mmol/l) (A). The absorbance of the samples are





























of peptide hydrolase activities: these were Gly-L-Met ~ 20 nmol/l,
L-Leu-Gly - 15 nmol/l and L-Val-L-Leu - 15 nmol/l.
Progress curve of the reaction
The amount of free amino acid released was estimated with the
L-amino acid oxidase reagent after incubation for various times at
37°C of* a suitable dilution of a supernatant fraction in the presence
of either Gly-L-Met (20 nmol/l), L-Leu-Gly (15 nmol/l) or L-Val-L-Leu
(15 nmol/l). The results are shown in Pig. 4-7-
The reaction is linear with time for at least the first 30
minutes for all three activities estimated. It is therefore
justifiable to use a single point estimate at 20 minutes to measure
peptide hydrolase activities.
Thermolability of the peptide hydrolase activities
A supernatant fraction prepared from a mucosal homogenate was
divided into four portions. Peptide hydrolase activities against
Gly-L-Met, L-Leu-Gly and L-Yal-L-Leu. were estimated immediately on
one portion and then at various times either after storage on ice
in a refrigerator at 4°C or after incubation at 21°C or 37°8 in a
water bath. The results are shown in Pig. 4-8.
Activities against all three dipeptide substrates decreased
with time. However the decrease was greatest, by 66%, 49% 37%
for activities against Gly-L-Leu, L-Leu-Gly and L-Yal-L-Leu
respectively, when the enzymes were incubated for 1 hour at 37°C
and least (l9%» 18% and 11% respectively) when the supernatant
fractions were stored at 4°C for 1 hour. Furthermore, incubation
Pig. 4.8 Cytoplasmic peptide hydrolase activities against (a)
Gly-L-Met, (h) L-Leu-Gly, and (c) L-Val-L-Leu estimated at various
times after incubation of the supernatant fraction at (A) 4°8,
(fl) 21°C, and (©) 37°8. Activities estimated immediately after
preparation of the supernatant fraction are also shown (o). Each
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for only 5 minutes at 21°C (room temperature) resulted in a decrease
by 12%, 5% and 10% of activities against Gly-L-Met, L-Leu-Gly and
L-Val-L-Leu respectively.
These results show clearly that it is essential to maintain
strict control of temperature at 4°C during preparation of samples
containing peptide hydrolase activities and, furthermore, that
these activities should be estimated immediately after preparation
of the supernatant fraction (or after collection of the luminal
effluent and serosal secretion from a perfused intestine).
DISCUSSION
The two methods of Nicholson and Kim (1975) have, been investi¬
gated. Although the combination of the two reactions, hydrolysis of
the dipeptide substrate and determination of the released amino acid
with L-amino acid oxidase, was found to be unsatisfactory the
separation of the reactions into two 20 minute incubations proved to
be a highly sensitive and satisfactory method for the estimation of
peptide hydrolase activities. This method has been used to estimate
these activities in the mucosal cytoplasm of the small intestine and
in the luminal effluents and serosal secretions from a perfused small
intestine.
Lindberg at al (1975) criticised the use of the amino acid
oxidase reaction for the estimation of peptide hydrolase activities
since the enzyme preparation itself may contain amino acids and since
termination of the peptide hydrolase activity against the dipeptide
substrate by boiling the samples might increase the reaction rate for
a short period. The first criticism was found to be unjustified
since enzyme blanks were included in estimations and these were,
without exception, found to contain very little amino acid relative
to the amounts released during the assay. The second point is a
justified criticism of the method. However, it is stressed that the
assay was used only in comparative studies and therefore this source
of error should not affect the overall conclusions.
It is clear that all three enzymic activities estimated in this
work are unstable and that the instability is increased with
increased storage temperature. In order to minimise the thermol-
ability of the enzymes strict control of temperature during
preparation of the samples has been introduced and the activities
were always estimated immediately after preparation of the samples.
It is not known whether the three activities assayed in this
work represent three individual enzymes or three activities of a
single enzyme. Although hydrolase activities against a large number
of dipeptide substrates have been demonstrated to be present in the
intestinal mucosa (see Lindberg et al, 1975? Table 6.1) it is not
known whether there are a large number of dipeptidases with a narrow
specificity or a small number of dipeptidases with a broad
specificity. There have been several reports of multiple forms of
dipeptide hydrolase activities which can be separated by starch gel
electrophoresis (Dolly et al, 1971; Fottrell et al, 1972; Kim et al,
1971)- However, Das and Radhakrishnan (1973) reported an electro-
phoretically homogenous dipeptidase activity, purified from the
soluble extracts of monkey small intestine, which was shown to
hydrolyse at least 65 dipeptide substrates. They suggested that
there is a 'master' dipeptidase in the small intestine and possibly
only four or five other dipeptidases.
The 'master' dipeptidase of Das and Radhakrishnan (1973) can
hydrolyse all three substrates used in this work and it is possible,
therefore, that only one enzyme has been studied. However, there is
some evidence from the results presented in Chapters 6 and 10 and
here which suggests tentatively that at least two enzymes have been
studied:
(l) In Chapter 6 it is shown that the activities against all three,
dipeptide substrates (Gly-L-Met, L-Leu-Gly and L-Val-L-Leu)
appearing in the luminal effluent during perfusion in vitro are
greater when the intestine is removed from a freshly killed rat than
when the intestine is removed from an ether-anaesthetized rat.
However, there was a much greater increase in activities against
Gly-L-Met and L-Val-L-Leu (8 fold) than in activities against
L-Leu-Gly (4 fold).
(2) There was a slight increase (11%) in peptide hydrolase
activities against Gly-L-Met when rats were fed for 1 week on an
'elemental' diet, 'Flexical', whereas activities against L-Leu-Gly
and L-Val-L-Leu were decreased by a similar amount (Chapter 10,
Fig. 10.1). Gardner and Heading (1979) made a similar observation on
rats fed on casein-based diets, although, in their work, the
decreases in activity against L-Val-L-Leu and L-Leu-Gly were not
significant. 1
(j) Furthermore, all three activities are thermolabile (Fig. 4-7)
but this is much more marked for activities against Gly-L-Met than
against L-Leu-Gly and L-Val-L-Leu.
These three observations suggest that Gly-L-Met might be a
separate enzymic activity but there is very little evidence to
suggest that the activities against L-Leu-Gly and L-Val-L-Leu are
due to more than one enzyme.
Although this question is of interest, its solution was not
central to the intended use of the peptidase assays in the present
project, and therefore it was not pursued.
In view of the satisfactory outcome of the investigation of the
'two-step' method of Nicholson and Kim (1975) "the method as detailed




Estimation of DNA~Tm Intestinal mucosa
Introduction
Many methods for determination of nucleic acids in biological
materials that involve colorimetry or ultraviolet spectrophotometry
require separation of the nucleic acids from free nucleotides and
other interfering substances; they also lack sensitivity (Monro and
Fleck, 1966). LePecq and Paoletti (1966) developed a fluorometric
method for the determination of purified nucleic acid based on the
enhancement of the fluorescence of the dye 2,7-diamino-9-phenylphen-
anthridine 10-ethyl bromide (ethidium bromide) due to complex
formation with native nucleic acid. Prasad et al (l9?2) have modified
the method to permit the measurement of nucleic acids in tissue
homogenates. Batt and Peters (1976) have already applied this method
successfully to the estimation of cell numbers in intestinal homo¬
genates, and the simplicity of the method made it an obvious choice
for use in the estimation of the DNA content of the intestinal mucosa.
Principle of the assay
Ethidium bromide is added to a buffered sample of tissue homo-
genate containing 5 pg or less of DMA. The buffer is added to
maintain the pH and salt concentration such as to minimise nucleic
acid-protein interactions. The fluorescence of this solution is due
to the presence of both DNA and RNA. The RNA is removed by
incubation with RNAase and the fluorescence due to DNA alone is
measured. The fluorescence due to RNA can be derived from the
difference between the first and second fluorescence readings.
Preparation of an homogenate of intestinal mucosa
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The method of preparation of a mucosal homogenate was as
described in Chapter 4 except that the samples were stored for up to
5 hours at 4°C prior to estimation of the DM content. P.V.C. gloves
were worn throughout in order to minimize contamination of the sample
with exogenous nuclease activities.
DM estimation - Preliminary trials
The following solutions were prepared just before use:
Tris buffer, 0.1 mmol/l 12.11 g Tris (hydroxymethyl ) amino
methane and 5-84 g NaCl (both from
Sigma London Chemical Co.) in 900 ml
distilled water and adjusted to pH 8.0 with
HC1 (5 mol/l), and the volume made
up to 1 litre.
Ethidium bromide 2 mg ethidium bromide (Sigma London
Chemical Co.) in 100 ml distilled water.
DM A stock solution of DM (Calf thymus,
sodium salt, Type I, Sigma London
Chemical Co.) was prepared by addition
of 100 ml of 0.9% NaCl solution (o^g
NaCl in 100 ml distilled water) to 5 mg
of DM. This was stirred by a magnetic
stirrer for 4 hours at 4°C (in a cold
room).
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A stock solution of REA (Calf liver,
Type IV, Sigma London Chemical Co.) was
prepared by addition of 100 ml 0.9% EaCl
solution to 10 mg REA.
20 mg REAase (Ribonuclease A type 111A
from bovine pancreas, Sigma London
Chemical Co.) dissolved in 1 ml
distilled water.
The mucosal homogenate was mixed well with a vortex mixer. A
portion (0.1 ml) was diluted at room temperature in the range 1:80
to 1:640 by serial dilution in the Tris buffer (O.lmol/l). Sample
tubes were prepared containing 0.2 ml diluted homogenate, 1.8 ml
Tris buffer and 2 ml ethidium bromide solution. These were mixed
with a vortex mixer and the fluorescence was read in a Perkin-Elmer
203 Fluorescence Spectrophotometer at an excitation wavelength of
365 nm and an emission wavelength of 590 nm. Zero emission intensity-
was set with a blank containing 2 ml Tris buffer and 2 ml ethidium
bromide solution and 100% emission intensity was calibrated with a
standard sample containing 10 pg DMA. REAase (0.04 ml) was then
added to all tubes and they were mixed well and incubated in a water
bath at 50°C for 1 hour. After removal from the water bath the
samples were cooled to room temperature prior to measurement of the




A calibration curve was prepared in the range 10 - 50 pg DEA/ml
and 10 - 60 pg REA/ml.
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Estimation of the DM. content of a mucosal homogenate
Three major problems were encountered when the assay was applied
to a mucosal homogenate:
(1) Fluorescence readings were very unstable especially at low
dilutions of the homogenate.
(2) The results obtained with different dilutions of the
homogenate did not agree.
(3) The RMase digestion was very unreliable; frequently the
first and second fluorescence measurements were similar.
The first two problems were both due to the particulate nature
of the homogenate. Addition of the detergent 'Triton X100' (Sigma)
had no effect on the stability of the readings. When the homogenate
was boiled for J minutes to denature the proteins present and then
rehomogenised the sample fluorescence readings were stable but the
technique resulted in a reduction, by about of the estimated
mucosal DM content. Both problems were eventually solved by
alteration of the technique used for serial dilution of the homogenate.
Initially, samples were mixed with a vortex mixer prior to pipetting.
However, when samples were mixed by repeated uptake and release from
a 1 ml automatic pipette fluorescence measurements were very stable
and good agreement was obtained between different dilutions.
UNA digestion
When test samples, prepared from a mucosal homogenate, were
incubated for 1 hour at 50°C in the absence of RMase the decrease
in sample fluorescence was frequently similar to that observed in
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Fig. 5*1 Calibration curve for the estimation of RNA with ethidiun
bromide (e). Also shown is the emission intensity of the samples
after incubation for 1 hour at 21°C (A), 37°C (fj) or ^iO°C (o).
Each point is a single observation.
effect of incubation for 1 hour at 21°C, 37°0 or 50°0 on '^e
fluorescence of RNA calibration standards. Sample fluorescence was
decreased, by 3 - 8%) after incubation and the decrease was greatest
for samples incubated at 50°C. Furthermore, incubation of DNA at
50°C for 1 hour in the presence of RNAase resulted in a 5% decrease
in the fluorescence of the DNA sample (results not shown). Thus both
RNA and DNA contents are decreased after incubation for 1 hour at
50°C.
An incubation temperature of 50°C for RNAase was recommended by
Van Dyke and Szuslkiewicz (1968) to ensure the total removal of KNA
from mixtures of RNA and DNA. Since at this temperature a small loss
of DNA occurs the incubation temperature was decreased to 37°C. At
this temperature DNA was stable for at least 1 hour in the presence
of RNAase. The fluorescence enhancement of ethidium bromide by the
most concentrated RNA standard (60 pg/ml) was reduced to less than
2%, and that of the other solutions to less than 1%, by incubation
for 1 hour at 37°C in the presence of RNAase. This was acceptable
since the RNA content of the mucosal homogenate dilutions was always
less than 40 jig/ml.
DNA content of .the intestinal mucosa
The assay was used to estimate the DNA content of the mucosa
from the whole jejunum plus ileum. The mean value from 5 rats was
19.42 - 1.53 mg/intestine. This is much lower, by about 41%> than
the values quoted in the literature (see Table 5«1» P^O),
In view of the fact that the incubation temperature had been
reduced and the fact that the estimates of the mucosal DNA content
appeared to be lower than those reported elsewhere alternative methods
were investigated.
The method of Karsten and Wollenberger (1972)
Karsten and Wollenberger (1972) have also developed the method
of LePecq and Paoletti (1966) for application to the measurement of
nucleic acids in tissue homogenates. The method of Prasad et al
(1972) relies on the pH and salt concentration of the buffer to
reduce nucleic acid - protein interactions and does not attempt to
inhibit endogenous nuclease activity apart from stressing that the
assay should be carried out rapidly to prevent this activity. In
contrast, Karsten and Wollenberger (1972) include a protease during
tissue homogenization and during the DNA assay. The activity of the
protease, extracted from Strentomyces griseus, has two functions.
It inactivates endogenous nucleases although it does not inhibit the
activity of RNAase from bovine pancreas, and it reduces the protein -
nucleic acid interactions thereby producing greater fluorescence
enhancement of ethidium bromide by the nucleic acids in the homo-
genate.
Since the estimates of the DNA content of the intestinal mucosa
obtained by the method of Prasad et al (1972) were low and since the
method of Karsten and Wollenberger (1972) gave a 2^>% increase in the
estimated DNA content the latter method was adapted for use in this
work.
Principle of the assay
The tissue is homogenized in the presence of a protease which
inactivates endogenous nuclease activity. A sample of the homogenate
containing 5 Jig or less DNA, is incubated with a buffer in the
presence of the protease. During this incubation the protease
reduces the protein - nudeic acid interactions and maximum
fluorescence enhancement is obtained subsequently upon addition of
ethidium bromide. The sample is then incubated in the presence of
KNAase and the fluorescence enhancement due to DNA alone is obtained.
The fluorescence enhancement due to RITA is obtained from the
difference between the two readings.
Preparation of an intestinal mucosa homoannate
The mucosal homogenate was prepared as described in Chapter 4
and samples were frozen at -40°C prior to estimation of the DNA
content. Since the mucosal homogenate was also required for the
estimation of peptide hydrolase activities, the protease was omitted
from the homogenate at this stage since it inactivates peptide
hydrolase activities (results not presented).
DNA estimation - Method finally adopted
The following solutions were prepared just before use:
Phosphate buffered saline 0.1 g CaCl^, 0.2 g KCl, 0.2 g KH^PO^,
0.1 g MgCl2,6H20, 8.0 g NaCl, l.lp g
Na„HP0. dissolved in 1 litre of2 4
distilled water and the pH was adjusted
to 7.5 with NaOH (2mol/l)just before
the final volume was reached. (All
salts were AnalaR chemicals from
B.D.H. Chemicals Ltd)
Ethidium bromide 2.5 g ethidium bromide (Sigma London
Chemical Co.) in 200 ml phosphate
buffered saline.
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DNA and ENA As described previously.
'Pronase1 10 mg 'Pronase' (Pronase P, Type VI,
bacterial, purified, Sigma London
Chemical Co. ) in 100 ml phosphate
buffered saline.
ENAase As described previously.
The homogenate was thawed for 15 minutes at room temperature
and then mixed well with a vortex mixer. A portion (0.1 ml) was
diluted in the range 1:80 to 1:640 by serial dilution on ice with
an automatic pipette as described previously. Tubes were prepared
containing 0.2 ml sample, 0.8 ml 'Pronase' solution and 1 mi phosphate
buffered saline. The quantities used by Karsten and Wollenberger
(1972) have been doubled to give a convenient volume for fluores¬
cence measurement. The samples were incubated for 20 minutes at
37°C in a water bath. After removal from the water bath 2 ml of
ethidium bromide solution was added to each of the tubes which were
then mixed and the fluorescence was read in a Perkin-Elmer 203
Fluorescence Spectrophotometer at an excitation wavelength of 360 nm
and an emission wavelength of 580 nm. Zero emission intensity was
set with a blank containing 1.2 ml buffer, 0.8 ml 'Pronase' and 2 ml
ethidium bromide and the emission intensity was calibrated at 100%
with a sample containing 10 yig LEA.
Stable readings were obtained without the use of surface
fluorometry as recommended by Karsten and Wollenberger (1972).
ENAase (0.04 ml) was then added to the set of sample tubes
which were mixed and incubated at 37°C in a water bath for 1 hour.
Karsten and Wollehberger (1972) used an incubation time of 20
minutes at 37° C and a lower concentration of ENAase (50 pg/ml).
Under these conditions very little ENAase activity was observed and
this was probably due to the different RNAase preparation used. The
concentration used previously was therefore used in the assay.
After removal of the samples from the water bath 2 ml of ethidium
bromide was added and the fluorescence was read as above.
Calibration curves
A calibration curve in the range 10 - 50 pg DNA/ml was prepared
for each set of estimations. The curve -was linear over the whole
range (Pig. 5.2) and the DMA concentration of the test samples was
calculated from the first order regression line of the calibration
curve.
During investigation of the assay a calibration curve for KNA
in the range 10 - 60 pg RNA/ml was also prepared. However, since
RNA was not estimated in the mucosal homogenates only the 60 pg
RNA/ml sample was routinely used as an index of the activity of the
EMase.
DNA stability
Karsten and Wollenberger (1972) stated that stock solutions of
DNA may be stored at 4°C for 3 months without a decrease in
fluorescence. However, as shown in Pig. 5- 3» the fluorescence of a
stock solution of DNA had decreased by 16% after storage at 4°C for
5 weeks and by 37% after storage at -40°C for 5 weeks (a stock
solution of 50 pg/ml DNA was divided into 1 ml portions; half were
stored at 4°C and half at -40°C. The DNA content was assayed at
DNA concentration (pg/ml)
Fig. 5-2 Calibration curve for the estimation of DNA with
ethidium bromide by the method of Karsten and Vollenberger (1972).
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Fig. 5.5 Fluorescence enhancement of ethidium bromide by DNA
estimated after storage of the DNA solution at 4°C (&) or -40°C (O)
for various times. The fluorimeter was calibrated with a quinine
sulphate fluorescence standard. Each point is the mean of 3
estimations.
1 week intervals and the fluorimeter was calibrated with a-quinine
sulphate fluorescence standard of 10 mg/l of 0.1 mol/l HCl).
A stock solution of BHA was therefore prepared freshly for each
set of estimations.
Estimation of BEA jn a mucosal homogenate
Estimations were made in duplicate at each of two dilutions
unless otherwise stated. Initial estimations on 4 rats gave a mean
mucosal BEA content of 29-4 - 2.5 mg BEA/intestine and this compares
well with estimates reported elsewhere (see Table 5-l)»
Table 5.1 Values quoted in the literature for the DMA content of






Altman and Enesco (1967) 100 26.7
11 500 47-7
Gardner and Plumb (1979') 180 26.5
Gardner and Plumb (l98l) 180 32.5
McManus and Isselbacher (1970) 200 40.4
Steiner et al (1968) 370 22.2
Williamson and Malt (l980) 210 1.7 mg/5 cm
The estimates were reproducible; the coefficient of variation
of an estimate was 2.7% (n = 10).
UNA and RNA recoveries
Portions (0.2 ml) of solutions of BEA in the range 10 - 40 pg./ml
were added to 0.2 ml portions of a suitable dilution of a mucosal
homogenate. Hie MA content of the test samples was then estimated
as described except that only 0.8 ml of phosphate buffered saline
was used. Fig. 5-4a shows the MA content of the test samples
plotted against the amount of MA added.
The recovery was very good; the slope of the regression line
was l.'Ol - 0.02 (i standard error of the slope). The calculated
intercept on the ordinate gives the MA content of the mucosal
homogenate (26.1 mg/intestine) which compares well with the
estimated MA content of the sample (25-7 mg/intestine).
The results for RNA recoveries are shown in Fig. 5-4b.
Similarly the recovery was good; the slope of the regression line
was 0.9:3 - 0.03 (- standard error of the slope). The RNA content
of the mucosal homogenate calculated from the intercept on the
ordinate (102.4 mg/intestine) compares well with the estimated
mucosal RNA content (98-7 mg/intestine).
Thus the recoveries were 101 - 2% and 98 - 3% for MA and RNA
respectively.
Fig. 5.4 The recovery of RNA and DNA added to a suitable dilution
of a mucosal homogenate. The total DNA (a) or RNA (b) content of
the sample is plotted against the amount added. Each point is the
mean of 2 estimations.
Concentration of DNA added ((jg/ml)
DISCUSSION
The method of Karsten and Wolleriberger (1972) with the modific¬
ations described in this chapter proved to be a suitable method for
the estimation of the DNA content of a mucosal homogenate prepared
from the small intestine of the rat. The results were reproducible
and the recovery of added DNA was very good.
The introduction of a protease by Karsten and Wollenberger (1972)
was beneficial to the measurement of DNA in an homogenate. Two
further modifications have been introduced:
(a) A fresh preparation of DNA is used for the calibration curve
since a solution cannot be stored without loss of DNA.
(b) The concentration of RNAase used has been increased and the
incubation time at 37°C has been extended to 1 hour; this is
probably a reflection on the activity of the enzyme obtained
from a different source.
One problem associated with the assay was the variability in the
activity of the RNAase. This variation was observed between
different batches of RNAase and the activity of a batch of RNAase
decreased with the time of storage. It was therefore essential to
include the RNA standard solution in the assay in order to ensure
that RNA digestion was complete after incubation for 1 hour with
RNAase.
The action of both endogenous and exogenous nuclease activities
presents a major problem during the measurement of the nucleic acid
content of a mucosal homogenate. This activity was minimized by the
inclusion of a protease in the assay and also by the precaution of
wearing P.Y.C. gloves during handling of the intestine. If the DNA
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content of a mucosal homogenate could not be estimated immediately,
as in the experiments described in Chapter 6, the homogenate was
stored frozen at -40°C for up to 5 hours. V/hen samples were stored
at 4°C for 5 hours the mucosal DNA content of intestines removed from
anaesthetized animals was decreased by about 25% (see Pigs. 6.5 and
6.8) and it is possible that this decrease was due to nuclease
activity even at 4°C.
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CHAPTER 6
Release of dipeptide hydrolase activities from rat small intestine
perfused in vitro and in vivo
Introduction
Although it has been known since the turn of the century that
animals fed on protein that has been completely hydrolysed to amino
acids can maintain a positive nitrogen balance (Henderson and Dean,
1903)5 "the form in which protein is normally absorbed from the
intestinal lumen is not known and is the subject of much debate.
Originally it was assumed that proteins were absorbed as polypeptides
(see review by Matthews, 1975)- However, in 1901 Cohnheim demonst¬
rated that the fluid in the intestinal lumen (the 1succus entericus')
contained peptide hydrolase activity ('erepsin') (Cohnheim, 1901,
cited by Matthews, 1975)« Prom this observation developed the belief
that all protein entering the intestine was completely hydrolysed to
amino acid prior to absorption (e.g. Evans, 1949; Verzar and
McDougall, 1936). This belief was held so rigorously that a number
of studies which demonstrated that peptides were absorbed, more
rapidly than amino acids in the human were ignored (e.g. Heath and
Pullerton, 1935; Messerli, 1913)* It was not -until 1959 when Newey
and Smyth shoved that the dipeptide glycylglycine was taken up in
intact form from the intestinal lumen that this theory was seriously
questioned. It is now known that there is a significant hydrolysis
of small peptides on the brush border and in the cytoplasm of
intestinal mucosal cells (Smyth, 1972). However, the relative
importance of transport of amino acids and peptides is unknown
(Crampton et al, 1971); nor is it known whether or not a significant
amount of these transported-peptides enter the "blood stream without
hydrolysis (Matthews, "1975)- These observations have attracted
attention to the existence of peptide hydrolase enzymes, in the small
intestinal mucosa.
Peptide hydrolase enzymes are present in the intestinal lumen
as well as on the brush border and in the cytoplasm of the intestinal
mucosal cells. The physiological significance of the luminal activity,
thought to originate predominantly from the mucosal cytoplasm (Silk
and Kim, 1975), is not known but some workers argue that it is
insufficient to account for the total hydrolysis to amino acids of a
protein meal (Cajori, 1933; Fisher, 1954)* On the other hand, it has
been suggested that the release of dipeptida.se enzymes from the small
intestine in vivo may be a physiological process and that it responds
to various specific stimuli such as the hormones gastrin, caerulein
and glucagon (Eloy et al, 1978) and cholecystokinin - pancreozymin
(Gfltze et al, 1972).
Alternatively, since some intestinal preparations in vitro
release considerably greater amounts of peptidases into the
incubation medium, other workers have suggested that the release
is simply an artifact associated with a dying tissue (Lindberg, 1972;
Silk and Kim, 1978).
If peptide hydrolase enzymes are secreted into the intestinal
lumen, then this might be an important site of terminal digestion of
protein. However, if the release is abnormal and is associated only
with intestinal preparations in vitro then the results of studies of
the physiological relationship between peptide transport and
hydrolysis made with such preparations may not be valid; a point
stressed by Silk and Kim (l9?6)-.
As discussed in Chapters 4 and 5 the procedures chosen in this
work for the estimation of both mucosal DNA content and cytoplasmic
peptide hydrolase activities involve estimating these in the mucosa
from the entire jejunum plus ileum in order to avoid the use of an
alternative reference basis. Although Gardner and Heading (1979)
!
estimated peptide hydrolase activities on 1 cm segments of jejunum
and ileum these activities need not be representative of activities
in the whole small intestine since these activities are known to vary
in different regions of the small intestine (Josefsson and Lindberg,
1965; Robinson and Shaw, i960). Thus the whole small intestine was
chosen as a reference system since this also overcomes the need to
use a reference system such as protein, unit length or weight of
intestine, all of which are variable with respect to the whole small
intestine , and which are themselves subject to variation during,
e. g.} 5-fluorouracil treatment or food restriction It was therefore
important to determine whether mucosal DNA contents and cytoplasmic
peptide hydrolase activities could be determined 011 an intestine
which had already been used for a perfusion experiment or whether
additional unperfused intestines were necessary for these
estimations. If the former were possible then water absorption
rates, mucosal DNA contents and cytoplasmic peptide hydrolase
activities could all be estimated on the same intestine. Not only
would this reduce the number of animals required, it would also
provide information on the inter-relationship of the three para¬
meters. In particular, in Chapter 8, the mucosal DNA content is
used as an index of the number of mucosal cells in an attempt to
determine whether the changes in the intestinal water absorption
rates following 5-Dluorouracil injection are caused by (a) a change
in the number of absorbing cells, (b) a change in the absorptive
capacity of individual absorbing cells or (c) a combination of these
two. Obviously it would be preferable in such a study to be able to
estimate absorption rates and mucosal DNA contents on the same
intestine.
Thus, in view of the previous observations that peptide hydro¬
lase activities are released from preparations in vitro, a study was
designed to determine whether intestines, after perfusion, could be
used for the estimation of mucosal UNA contents and cytoplasmic
peptide hydrolase activities. This study was extended to intestines
perfused in vivo in an attempt to give information on the physio¬
logical significance of the release of peptide hydrolase activities
from the small intestine. The technique of Fisher and Gardner (1974)
described in Chapter 3 has the advantage that intestines can be
perfused on the same apparatus either an vitro or in vivo and thus,
unlike any of the previous studies of enzyme release (G£5tze et al,
1972; Josefsson and Sj8stri3m, 1966; Silk and Kim, 1975 197&;
Silk et al, 197&) a direct comparison can be made between the
enzyme release in vitro and in vivo. Mien intestines are perfused
in vitro by the technique of Fisher and Gardner (1974) specific care
is taken to ensure that the intestine is never deprived of a supply
of oxygen; the rat is maintained under ether anaesthesia until
establishment of luminal perfusion and removal of the intestine from
the rat have been completed (see Chapter a precaution recommended
by Fisher and Parsons (1949) and Fisher and Gardner (1974)- Since
failure to abide by these precautions results in a. 50% decrease in
and
the glucose^water absorption rates by the rat small intestine
perfused in vitro (Gardner, 1.978), a second preparation in vitro in
which the intestine for perfusion is rapidly removed from a freshly
killed rat has been includedjijn-the study of enzyme release. Thus
three intestinal preparations were used with a view to determining
whether the release of peptidase enzymes from perfused intestines
differs in vitro and in vivo and also whether the release from a
preparation in vitro depends to an appreciable extent on whether the
intestine is deprived of oxygen at any point during preparation for
perfusion.
Peptide hydrolase activities were estimated in the mucosal
cytoplasm from unperfused and in perfused intestines and in the
luminal effluents and serosal secretions from perfused intestines.
Since the luminal activity might originate from cells sloughed off
the intestinal mucosa during perfusion, the mucosal MA content has
been estimated in unperfused and in perfused intestines in order to
determine the extent of cell sloughing during perfusion.
A preliminary study was designed to test the suitability of' the
peptidase assay and the DNA assay chosen for use in this work and
also to give an indication of the extent of the release of enzyme
activities. This study revealed a number of problems, discussed
below, which lead to the introduction of a different method for
the estimation of peptide hydrolase activities. The results of the
preliminary study are therefore included in this chapter since they
are pertinent to the choice of peptide hydrolase assay used in this
work and since the information gained from this study was then used
as the basis of the study of the physiological significance of the
release of peptide hydrolase activities from the perfused small
intestine.
The principal results from this investigation have been
presented to the European Intestinal Transport Group (Plumb and
Gardner, 1979) and have been published in full (Gardner and Plumb,
1979).
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Part I; Preliminary observations
METHODS
Animals
Female rats, weighing 160 - 200 g, were used throughout this
study.
Intestinal -perfusion
Perfusion in vitro: Whole jejunum plus ileum from the ligament
of Treitz to the ileo-caecal valve was perfused in vitro by the
method of Fisher and Gardner (1974)> described in Chapter 3» For 0,
20, 40 or 60 minutes. Intestines perfused for 0 minutes were
removed from the rat immediately after the lumen had been washed
through with the oxygenated bicarbonate-saline (see p. 27). The
luminal effluent and serosal secretion were collected over the entire
perfusion period at room temperature. Experiments were performed on
4 separate days: on each day 4 rats were used, one for each duration
of perfusion. The order of these experiments on each day was varied
according to a pseudo-random Latin Square design.
The precautions of Fisher and Gardner (1974) to avoid temporary
anoxia were strictly observed: if any animal died then the experi¬
ment was abandoned.
Perfusion in vitro of intestines from freshly killed rats:
Whole jejunum plus ileum from the ligament of Treitz to the ileo-
caecal valve was perfused by the method of Fisher and Gardner (l974)
except that the ether-anaesthetized rats were killed by stunning and
cervical dislocation immediately before the intestine was removed in
the usual way for perfusion. Intestines were perfused for 0 or 60 .
minutes and those perfused 0 minutes were removed from the rat
immediately after the lumen had been washed through with oxygenated
bicarbonate-saline.
Perfusion in vivos Animals were anaesthetized 1 hour before
use with urethane (l ml of 0.8 mg'/ml solution injected subcutan-
eously) while under temporary light ether anaesthesia. Phe technique
and apparatus of Fisher and Gardner (l974) were used except that the
small intestine (jejunum plus ileum) was left in situ partly outside
the abdominal cavity with the vasculature intact. Phe intestine was
covered with moist cotton wool and a polyethylene sheet and was
maintained at approximately 38°C by an overhead lamp. As with the
experiments in vitro the intraluminal distension pressure was about
30 cm water and the perfusion rate was about 3-5 ml/minute. Phe
luminal effluent was collected at room temperature over the entire
60 minute perfusion period; there was no serosal secretion from
this preparation. Intestines perfused for 0 minutes were removed
from the rat immediately after the lumen had been rinsed through with
oxygenated bicarbonate-saline.
Peptide hydrolase assay
Hydrolase activities against Gly-L-Met, L-Leu-Gly and
L-Val-L-Leu were estimated by the method of Gardner et al (1978),
described in Chapter 4> in the supernatant of the mucosal homogenate
of the whole jejunum plus ileum, in the serosal secretions and the
luminal effluents. Supernatant samples were diluted within the
range 1:320 to 1:1280 and the serosal secretions and luminal
effluents were used undiluted. All assays were carried out in
duplicate and enzyme activities were expressed in terms of total
enzyme units in the mucosa, luminal effluent or serosal secretion
where 1 unit is defined as the amount catalysing the hydrolysis of
1 pmol of substrate/minute under the conditions of temperature and
pH given in Chapter 4-
Estimations were carried out on the same day as, but not until
completion of, all the perfusion experiments. The mucosal homogenates
were prepared immediately after perfusion and all samples were stored
at 4°C until the assays were carried out on them.
Mucosal DNA estimation
DNA in the mucosal homogenate of the whole small intestine was
estimated by the method of Le Pecq and Paoletti (1966) as modified
by Karsten and Wollenberger (1972) with further modifications as
described in Chapter 5• Samples were estimated in duplicate at each
of three dilutions, 1:80, 1:160 and 1:320, and the assays were carried
out after completion of the perfusion experiments. The homogenates
were stored at 4°C vrntil the assay was carried out on them.
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RESULTS
Peptide hydrolase activities in the luminal effluents and serosal
secretions
Pig. 6.1 shows the dipeptidase activities determined in the
luminal effluents and secretions on to the serosal surfa.ee
of the intestine pooled over the perfusion period of 1 hour.
Activities estimated in the luminal effluent from perfused intestines
that had been rapidly removed from freshly killed rats were two to
four times greater than those estimated in the luminal effluents
either from intestines perfused in vitro and removed from anaesthet¬
ized rats or from intestine perfused in vivo. Similarly activities
estimated in the serosal secretions were greater by a factor of 2
when intestines, perfused in vitro, had been removed from freshly
killed rats.
The release of activities into the luminal effluent appears to
be a continuous process throughout the perfusion period (Pig. 6.2).
Activities estimated in the luminal effluents and serosal
secretions were all very low and close to the lower limit of
sensitivity of the assay except in the experiments on intestines
from freshly killed rats.
Cytoplasmic peptide hydrolase activities of intestines before and
after perfusion
Pig. 6.3 shows the hydrolase activities against Gly-L-Met,
L-Leu-Gly and L-Val-L-Leu in the mucosal cytoplasm from whole
jejunum plus ileum of unperfused intestines and of intestines after















































Fig. 6.1 Peptide hydrolase activities recovered in (a) secretion
on to the serosal surface of the intestine, and (b) luminal effluent
during perfusion for 1 hour in vitro of intestines prepared from
ether-anaesthetized rats (open bars), in vitro of intestines prepared
from freshly killed rats (hatched bars) and in vivo (stippled bars).
"f*
Values are means - S.E.M. and the number of intestines is shown within
the bars in (b). Results are shown for the dipeptidase activities




































Duration of perfusion (min)
Fig. 6.2 Peptide hydrolase activities in luminal effluent from
intestings prepared from ether-anaesthetized rats and perfused in
vitro for 20, 40 and 60 minutes. Values are the mean - S.E.M. of
observations on 4> 4 and 7 intestines respectively. Substrates were
(©) Gly-L-Met, (A) L-Leu-Gly, and (s) L-Val-L-Leu.
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Fig. 6.3 Cytoplasmic peptide hydrolase activities in the mucosa of
unperfused small intestines (open bars) and of small intestines
perfused for 1 hour in vitro or in vivo (hatched bars). Intestines
for perfusion in vitro were prepared both from ether-anaesthetized
rats and from freshly killed rats. Substrates were (a) Gly-L-Met,
(b) L-Leu-Gly, and (c) L-Val-L-Leu. Values are the mean - S.E.M.
and the number of animals is shown within the bars in (c). The
significance levels of the differences between the values in




















































































In all cases cytoplasmic peptide hydrolase activities were
decreased after perfusion but the decrease was not always
significant. Activities against Gly-L-Met and L-Val-L-Leu were
slightly, but not significantly, less in unperfused intestines
removed from freshly killed rats than those of intestines removed
from ether-anaesthetized rats; in contrast, activities against
Gly-L-Met and L-Val-L-Leu were significantly greater (P < O.Ol) in
■unperfused intestines removed from urethane anaesthetized animals.
The loss of cytoplasmic peptide hydrolase activities from
intestines perfused in vitro appears to be a continuous process
throughout the period of perfusion for activities against L-Leu-Gly
but appears to increase after 40 minutes of perfusion for activities
against Gly-L-Met and L-Val-L-Leu (Pig. 6.4). However, in most
instances, activities estimated in the supernatant fraction of the
mucosal cytoplasm were inaccurate due to low reproducibility of
estimates.
Mucosal DMA content of unperfused and, of perfused intestines
.Pig. 6.5 shows the mucosal DMA content of unperfused intestines
and of intestines after perfusion for 1 hour. The mucosal DNA
content (relative to that in unperfused intestines) was less after
perfusion in vitro of intestines removed from ether-anaesthetized
rats or from freshly killed rats although the decrease was not
significant (P > 0.1). In contrast, perfusion in vivo for 1 hour
had no effect on the mucosal DNA content (Fig. 6.5).
However, it is of note that these estimates of the mucosal DNA
content of intestines removed from ether-anaesthetized rats were
about 20% lower than those estimated previously (see Chapter 5)«
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Fig. 6.4 Cytoplasmic peptide hydrolase activities in mucosal
supernatant after perfusion in. vitro of intestines, prepared from
ether-anaesthetized rats, for 20, 40 or 60 minutes. Substrates
were (a) Gly-L-Met, (b) L-Leu-Gly, and L-Val-L-Leu. Values are
•j"




































































Fig. 6.5 DMA. content of whole small intestinal mucosa of
unperfused intestines (open bars) and of intestines after perfusion
for 1 hour in vitro or in vivo (hatched bars). Intestines for
perfusion in vitro were prepared both from ether-anaesthetized rats
"t*
and from freshly killed rats. Values are the mean - S.E.M. and the
number of intestines is shown within the bars.
\
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Total recovery of -peptj.de hydrola.se activities after psr.fus.lon
The total peptidase activity recovered in the luminal effluent
serosal secretion and mucosal cytoplasm after perfusion for 1 hour
amounted to only 60,3% (mean of all experiments) of the activity in
the mucosal cytoplasm of unperfused intestines.
DISCUSSION
Hie results of the preliminary study show that peptide hydrolase
activities are released from the intestine during perfusion in vitro
IS. vivo • Hie amount of activity released into the luminal
effluent and serosal secretion during perfusion in vitro appears to
be ■ influenced by the technique used during preparation of the
intestine for perfusion; activities were two to three times greater
when the intestine had been removed from a freshly killed animal than
the activities found in the luminal effluent and serosal secretion
from intestines removed from anaesthetized animals (fig. 6.l). Also,
there is a small loss of DNA from the mucosa during perfusion in
vitro but not during perfusion in vivo (Dig. 6.5). Although all
three peptide hydrolase activities estimated in the mucosal cyto¬
plasm were decreased by perfusion in vitro or in vivo for 1 hour the
decrease was only significant for activities against Gly-L-Met (Dig.
6.3).
However, the study also revealed a number of problems associated
both with the peptide hydrolase and DNA assays and with the design
of the study.
Hie peptide hydrolase assay
Hie problems associated with the use of this assay are described
in detail in Chapter 4« It became apparent that the assay, as used
by Gardner et al (l978)> was not sufficiently sensitive to estimate
reliably peptide hydrolase activities in the luminal effluent and
serosal secretion. Furthermore, peptide hydrolase activities
estimated at different dilutions of the mucosal cytoplasm did not
agree and often duplicate samples at the same dilution differed.
106
The results of the preliminary study are therefore probably inaccurate
and are not discussed in detail. However, it appears probable that
the release of peptide hydrolase activity during perfusion is a gradual
process throughout the period of perfusion rather than one which
commences after a period of perfusion (Figs. 6.2 and 6.4). If this is
so then it is not necessary to estimate the release after various
durations of perfusion; a single estimate will be representative of
the amount of activity released from the preparation during perfusion.
It was noted that the intestinal cytoplasmic peptide hydrolase
activities varied between animals and that activities against Gly-L-
Met and L-Yal-L-Leu estimated in the intestines removed from urethane
anaesthetized animals were significantly greater (P > O.Ol) than those
estimated in intestines removed from ether-anaesthetized animals.
These differences were not observed subsequently (see Fig. 6.7) and
were probably due to the inaccuracy of the method used to assay the
activities.
The PITA assay
'The mucosal DNA contents of intestines removed from ether-
anaesthetized animals were consistently about 20% less than those
estimated previously (Chapter $)• Hie reason for this discrepancy is
not known but it is possible that the delay of up to 5 hours between
preparation of the mucosal homogenate and estimation of the DNA
content might have been responsible. Samples were stored at 4°C but
it is possible that some nuclease activity remains at this temperature.
Stability of -peptide hydrolase activities
Peptide hydrolase activities are known to be thermolabile
(Heizer et al, 1972) and a subsequent study of the effects of
temperature on peptidase activities in the mucosal cytoplasm has
confirmed this (see Chapter 4)- Since the luminal effluents and
serosal secretions were collected at room temperature over a period
of 1 hour* and furthermore, since all samples were stored for up to
5 hours at 4°C prior to estimation of peptidase activities, it is
probable that the activities estimated in these samples were much
lower than the true activities due to the heat inactivation of the
enzyme activities during the experiment. This could well explain
the very low recovery (60%) of activities after perfusion.
* an experimental approach similar, in effect, to that used by
Silk and Kim (1976)
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Part lis The release of peptide hydrolase activities from the small
intestine perfused In vitro and in vivo
The preliminary observations provided substantial information
upon which was based the following study of the release of peptide
hydrolase activities during perfusion in vitro and in vivo.
In order to overcome (a) the insensitivity of the peptide
hydrolase assay and (b) thermal lability of the hydrolase enzymes
the study wan redesigned to allow estimation of peptide hydrolase
activities in the luminal effluents and serosal secretions as soon
as possible after completion of perfusion and a new assay was
developed for the estimation of these activities.
METHODS
Intestinal -perfusion
The three preparations described in the preliminary study
were used and intestines were perfused for 0 and 60 minutes only.
Peptide hydrolase assays
Hydrolase activities against Gly-L-Leu, L-Leu-Gly and
L-Val-L-Leu were estimated by the modified method of Nicholson and
Kim (1975)5 described in Chapter 4s in the supernatant of the
mucosal homogenate of whole jejunum plus ileum, in the serosal
secretion and in the luminal effluent. Samples were diluted on ice
in the range 1:320 to 1:2560 for supernatants, 1:4 to 1:10 for
secretions and 0 to 1:2 for luminal effluents. All assays were
carried out in triplicate and enzyme activities were expressed in
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terms of total enzyme units'in the mucosa, luminal effluent or
serosal secretion, where 1 unit is defined as the amount of enzyme
catalysing the hydrolysis of 1 pmol of substrate/minute, under the
conditions described in Chapter 4-
Mucosal LNA estimation
No changes were made in the method described in Part I except
that samples were stored at -40°C prior to assay the same day.
Experimental design
The modifications were concerned mainly with ensuring that all
material for enzyme assay was processed as rapidly as possible.
Luminal effluents and serosal secretions were collected into
glass measuring cylinders surrounded, by ice. Ten minutes before the
completion of a 60 minute perfusion experiment a mucosal homogenate
was prepared from an unperfused intestine (t = 0). After preparation
of a mucosal homogenate from the perfused intestine a portion of each
homogenate was frozen at -40°C for subsequent estimation of DNA and
a se'cond portion was centrifuged immediately at 20 000 g at 4°C for
1 hour. Luring this hour peptide hydrolase activities were assayed
in the luminal effluent and serosal secretion. Peptide hydrolase
activities were assayed in the supernatant of the mucosal homogenates
immediately upon completion of centrifugation.
This procedure was repeated for a second pair of intestines
(perfused and unperfused) and upon completion the mucosal LNA contents
of the homogenates from all four intestines were assayed.
110
•RESULTS '
Appearance of -peptide .hydrolase activities in luminal effluents and
serosal secretions
Peptide hydrolase activities against Gly-L-Leu, L-Leu~Gly and
L-Yal-L-Leu were estimated in the luminal effluents and the
secretions on to the serosal surface of the intestine pooled over the
perfusion period of 1 hour.
The results are shown in Pig. 6.6 which also shows in parentheses'
these activities expressed as a percentage of the activities in the
mucosal cytoplasm of the unperfused intestines. Significant amounts
of dipeptidase activities were found in the luminal effluents during
perfusion in_ vitro and in vivo. Only small amounts were found in the
luminal effluents during perfusion in XiX2. or perfusion in vitro of
intestines prepared from anaesthetized rats. In contrast, when
intestines for perfusion in vitro were prepared from freshly killed
rats (hatched "bars in Pig. 6.6), the amounts of dipeptidase activity
found in the luminal effluents were dramatically greater by factors
of from 3-8 (against L-Leu-Gly) to 7-8 (against Gly-L-Met).
Similarly, small amounts of activity were found in the secretion
on to the serosal surface of the intestine. A corresponding increase
(approximately three-fold) was seen in the activities found in the
serosal secretion from intestines prepared from freshly killed rats.
However, the total activity found in the serosal secretions was
invariably much less than that in the luminal effluents. When
intestines from anaesthetized rats are perfused in vitro less than
1.9% of the initial cytoplasmic activity is recovered in the luminal





































Fig. 6.6 Peptide hydrolase activities in (a) secretion on to the
serosal surface of the intestine, and (b) luminal effluent during
perfusion for 1 hour in vitro (lO intestines prepared from ether-
anaesthetized rats) (open bars), in vitro (7 intestines prepared
from freshly killed rats) (hatched bars) and in vivo (stippled bars,
4 rats). Values are means - S.E.M. Values in parentheses show
mean values expressed as percentages of activities found in mucosal
cytoplasm of unperfused intestines.
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Cytoplasmic peptide hydrolase activities of unperfused and "of
perfused intestines
Pig-. 6.7 shows the dipeptidase activities against Gly~L~Met,
L-Leu-Gly and L-Val-L-Leu in the mucosal cytoplasm of unperfused
intestines and of intestines after perfusion for 1 hour.
In all cases there was less cytoplasmic dipeptidase activity
(8-32% less) after perfusion than in the unperfused intestines,
although this difference was not always significant (see Fig. 6.7).
The peptidase activities in the unperfused, but saline-rinsed,
intestines were slightly but not significantly (P > 0.2) lower in
the killed animals and those anaesthetized by urethane (i.e. the
controls for those perfused in vivo) than in the ether-anaesthetized
ones.
Mucosal DM content of unperfused and of perfused intestines
Fig. 6.8 shows the DNA content of the mucosa of unperfused
intestines and of intestines after perfusion for 1 hour.
In all cases the mucosal- DNA content was slightly less (by 6-
14%) after perfusion than in the unperfused intestines, although
this difference was never significant (P > 0.05). However, the
difference between the DNA content of the perfused intestines
prepared from dead animals and the unperfused ones prepared from
ether-anaesthetized rats was significant (P < 0.05).
Fig. 6.9 shows the cytoplasmic peptide hydrolase activities
expressed as units/mg DNA in unperfused intestines and in intestines
after perfusion for 1 hour. Although in all cases there are losses
Fig. 6.7 Cytoplasmic peptide hydrolase activities in mucosa of
unperfused small intestine (open bars) and of small intestines
perfused for 1 hour in vitro or in vivo (hatched bars). Intestines
for perfusion in vitro were prepared both from ether-anaesthetized
rats and from freshly killed rats. Substrates were (a) Gly-L-Met,
(b) L-Leu-Gly, and L-Val-L-Leu. Values are means - S.E.M. and the
number of animals is shown within the bars in (c). Values in
parentheses show the activities in perfused intestines expressed as
percentages of the activities in unperfused intestines. The signif¬
icance levels of the differences from values in unperfused intestine




























































































Fig. 6.8 KNA content of whole small intestinal mucosa of unperfused
intestines (open bars) and of intestines after perfusion for 1 hour
in vitro or in vivo (hatched bars). Intestines for perfusion in
vitro were prepared both from ether-anaesthetized rats and from
freshly killed rats. Values are the mean - S.E.M. and the number of
intestines is shown within the bars.
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Fig. 6.9 Cytoplasmic peptide hydrolase activities per mg MA in
unperfused small intestine (open bars) and after perfusion for 1 hour
in vitro or in vivo (hatched bars). Intestines for perfusion in
vitro were prepared both from ether-anaesthetized rats and from
freshly killed rats. Substrates were (a) Gly-L-Met, (b) L-Leu-Gly,
and (c) L-Val-L-Leu. Values are means - S.E.M. and the number of
intestines is shown within the bars in (c). Values in parentheses
show the activities after perfusion for 1 hour expressed as a































































































of enzymic activity, relative to MA content, during perfusion they
are not significant (P > O.l) except for L-Ieu-Gly peptidases from
the killed animals (P < 0.05).
Total recovery of peptide hydrolase activities after perfusion
The total peptidase activities recovered in luminal effluents,
serosal secretions and mucosal cytoplasm after perfusion for 1 hour
are shown in Table 6.1 as a percentage of the activities in mucosal
cytoplasm of unperfused intestines.
Table 6.1 Total peptidase activities recovered in luminal
effluents, serosal secretions and mucosal cytoplasm after perfusion
in vitro and in vivo fore 1 hour
% of activity in unperfused
Number of intestines
Preparation intestines Gly-Met Leu-Gly Val-Leu
In vitro from
anaesthetized 10 72.4 70*9 69.4
rats
In vitro from
freshly killed 7 84.1 81.4 84.0
rats'
In vivo 4 90.3 95*8 76.2
The amount of activity recovered after perfusion was least when
intestines removed from anaesthetized rats were perfused in vitro.
However, as shown in Pig. 6.7, this is due partly to the fact that
the peptide hydrolase activities found in unperfused intestines
removed from ether-anaesthetized rats were greater by 6-25% than
those found in unperfused intestines removed from freshly killed rats
or from urethane-anaesthetized rats.
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Discussion
These results extend earlier studies (Silk and Kim, 1975;
Lindberg, 1972) which demonstrated that intestines in vitro can
release peptide hydrolase enzymes into perfusion and incubation
media, but, since different activities have been measured, direct
comparisons between studies cannot be made. However, the results
indicate that the amounts appearing in the luminal effluent of the
preparation used in this work are normally very small, amounting
over 1 hour to only 0.6 - 1.9% of the initial cytoplasmic content
(Pig. 6.6). The enzyme activities recovered in the luminal
effluent during perfusion in vitro and in vivo were closely similar
provided that the preparation in vitro was set up from anaesthetized
animals - a practice which is rigorously adopted in this laboratory.
However, when the segments for perfusion were excised from freshly
killed animals, the enzyme activities found in the luminal effluents
were four to eight times greater than when the animals were maintained
under ether anaesthesia while the intestines were being connected to
the perfusion apparatus (Pig. 6.6). Similarly, the activities found
in the secretion on to the serosal surface of the intestine were
small (0.3 - 0.5% of the initial cytoplasmic activity) when intestines
were set up from anaesthetized rats. These values also increased
substantially (three-fold) when animals were killed before removal of
the intestine (Pig. 6.6). The results from the preliminary study
(Pig. 6.2) indicate that the release of enzymes into the luminal
effluent was a continual process at an approximately constant rate
throughout the hour of perfusion rather than one which commenced •
after a certain time.
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Thus, these results indicate that the release of hydrolases from
the perfused intestine is normally small although it can be increased
experimentally. Although this might suggest that the release of
peptidases is not a normal physiological process, it must be noted
that the amount of peptidase activity within the mucosa is so large
that the release of 1% cannot necessarily be dismissed as functionally
insignificant, especially in. view of the likelihood that hormones
stimulate this process. Cholecystokinin-pancreozymin has been shown
to stimulate a five to nine fold increase in the release of brush
border enzymes from the rat small intestine perfused in vivo (Gfltze
et al, 1972). Eloy et al (1978) reported that pentagastrin, caerulein
and glucagon stimulate a four to eight fold increase in the release of
aminopeptidase activity from rat small intestine perfused ex vivo.
A five to nine fold stimulation of the release observed with the
preparation in_ vivo might result in significant luminal activity.
The high rates of peptidase release in vitro, which Lindberg
(1972) and Silk and Kim (l976) reported, probably had been influenced
by the method of preparation. It must be emphasised that the
intestines removed from freshly killed rats in the experiments
described in this chapter were deprived of an oxygen supply for only
about 4 minutes. This is the time between the death of the rat and
the establishment of luminal perfusion with the segmented flow of
oxygenated perfusate and includes the period during which the lumen
is washed out with oxygenated saline. Silk and Kim (1976) studied
the release of peptidase activities from intestinal segments incubated
in vitro in saline with no additional oxygen supply apart from that
dissolved in the saline throughout the 90 minute incubation period.
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Although it is not known that results similar to those obtained,
in this study would be obtained^-from all other types of intestinal
preparation in vitro, or whether temporary anoxia specifically causes
the enzyme release, the results indicate the merit of using
anaesthesia and the precautions of Fisher and Parsons (1949) and
Fisher and Gardner (1974) for the preparation of isolated intestines
for perfusion, especially during studies on peptide absorption* and
hydrolysis or on peptide hormones. Furthermore, the similarity
observed between the peptidase release from intestines perfused in
vitro by the method of Fisher and Gardner (1974) from intestines
perfused in vivo lends further support to the value of these
precautions. Also, the absorptive activity of isolated perfused
intestine prepared from anaesthetized rats is substantially greater
than if the animals are killed before removal of the intestine
(Gardner, 1978)*
The relatively large amount of activity against Gly-L-Met found
in the luminal effluent and serosal secretion (Fig. 6.6) reflects the
large amount of Gly-L-M&t activity in the cytoplasm (Fig. 6.7); this
is probably not due to differences in the stability of the three
activities studied since Gly-L-Met hydrolase activity is the most
labile (see Chapter 4» Fig. 4.8).
Silk and Kim (l97^) concluded that the peptidase release in
vitro by their preparation was not affected by the incubation
* Wiggans and Johnston (1959) observed that the serosal fluid, of
everted sacs of rat intestine contained peptidase activity and
stressed that this made it impossible to interpret whether intact
peptides had. crossed the intestine.
temperature. However, both of -the enzyme activities studied by
Silk and Kim (l97^) are thermolabile; cytoplasmic activities against
Gly-L-Phe and L-Phe-Gly are decreased to less than 20% following
incubation at 25°C and 37°C respectively (Heizer et al, 1972). It is
therefore probable that during incubation of intestinal tissue at
37°C the estimated release of peptidase activity will be much lower
than the true value.due to heat inactivation of the enzymes during
the course of the experimental period, a point which escaped Silk and
Kim's attention. Thus, in view of the thermolability of the activi¬
ties estimated by these authors, they were not justified to conclude
that peptidase release in vitro is not affected by the incubation
temperature.
The total recovery of peptidase activities after perfusion is
fairly low and depends upon the preparation used (Table 6.1); lowest
recoveries were observed when intestines, removed from anaesthetized
rats, were perfused in vitro and the highest recoveries were obtained
with intestines perfused in vivo - However, these results do not
indicate an increased loss of peptidase activities from intestines
removed from anaesthetized rats and perfused in vitro since the
activities in the unperfused intestines were greater than those from
the other two preparations studied (Fig. 6.7). Furthermore, there
was a substantial increase in the activities recovered when care was
taken to minimize heat inactivation of the peptide hydrolase
activities. The discrepancy between the activities in unperfused
intestines and those recovered after perfusion cannot be explained,
but it might be due to heat inactivation of the peptide hydrolase
activities during perfusion. If so then the activities released
into the luminal effluents and serosal secretions might have been
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underestimated.
It is not known whether^the enzymes released into the lumen are
of cytoplasmic or brush border origin: however, the work of Silk and
Kim (].976) and Silk et al (1976) suggests that they may be
predominantly cytoplasmic with some contribution by ileal brush
border.
DNA is also lost (6 - 14% in 1 hour) from the pa?fused intestines
(Pig. 6.8). The small DNA loss from intestines perfused in vitro
accords with the good absorptive stability of the preparation
reported by Pisher and Gardner (l974) (see also Chapter 5)* However,
in the experiments in vitro at least, the losses of enzyme activity
from the cytoplasm during perfusion were proportionately slightly
greater than the losses of DNA (Pig. 6.9). Although this difference
is not quite significant it was consistently observed in all three
groups of experiments; hence it is probable that enzymes are lost
from the mucosa by a combination of sloughing of whole (but not
necessarily intact) cells (leading also to the slight DNA loss) and
a moke specific process. This is consistent with Lindberg's (1972)
observation that di saccharida'se activities were not released in vitro
along with the dipeptidase activities and with the substantially
larger amounts of Gly-L-Leu hydrolase activities, expressed per mg
nitrogen, found in saline in the intestinal lumen after incubation
in vitro than in vivo (lindberg et al, 19755 p. 228).
Although the results of this study demonstrate the stability of
intestines perfused in vitro by the technique of Pisher and Gardner
(1974) it must be noted that there is a small but consistent loss of
both peptide hydrolase activities and mucosal DNA during perfusion.
Thus, it roust 'be concluded that intestines, after perfusion, cannot
be used for accurate estimations of mucosal peptide hydrolase
activities and MA contents and consequently, that these two measure¬
ments and that of absorption cannot be made on the same intestine.
This is a great disadvantage since the use of two sets of animals
introduces greater variability into the results and also prevents
direct comparisons between the three measurements. Furthermore,
these results indicate that intestines used for the estimation of
peptide hydrolase activities and mucosal MA contents should,
ideally, be removed from anaesthetized rats since there is a slight,
though not significant, loss of both peptidase activities and MA
when animals are killed immediately before removal of the intestine.
However, there is also a slight loss of peptidase activities and of
MA when animals are anaesthetized with urethane as opposed to ether
prior to removal of the intestine. This difference cannot be
explained but it is of note that the induction of anaesthesia with
urethane is complete after about an hour whereas ether anaesthesia
is induced within minutes.
These results stress that the characteristics of the preparation
are strongly dependent upon the method of preparation of the intestine
for perfusion. They raise the possibility that preparations in which
the precautions advocated by Fisher and Parsons (l949) and by Fisher
and Gardner (1974) cannot be observed (e.g. everted sacs and
intestinal rings) may give misleading results, or at any rate,
different results, due to the presence of peptide hydrolase activities
in the incubation medium. This may be especially relevant in studi.es
on absorption of peptides and on the effects of peptide hormones.
125
Peptide hydrolase activities against Gly-L-Met and L-Val-L~Leu
estimated in the mucosal cytoplasm by the method of Nicholson and Kim
(1975) were much greater than those estimated in the preliminary study
by the method of. Fujita et al (1972) as modified by Gardner _et al
(1978) (Figs. 6.3 and 6.7). This demonstrates clearly the benefits
of the final choice of peptide hydrolase assay and of the experimental
design adopted in Part II of this study. Furthermore, it was shown
in Chapter 4 that peptide hydrolase activity against Gly-L-Met is the
most themiolabile of the three enzyme activities estimated and it is
the estimates of this activity which show the greatest increase upon
introduction of the precautions to minimize heat inactivation of
peptide hydrolase activities (compare Figs. 6.1 and 6.6, and Figs.
6.3 and 6.7). However, the converse is true for the hydrolase
activity against L-Leu-Gly; these were less when estimated in the
mucosal cytoplasm by the method of Nicholson and Kim (1975) than those
estimated by the method of Fujita et al (1972) as modified by Gardner
et al (1978) (Pigs. 6.3 and 6.7). Also,cytoplasmic peptide hydrolase
activities against Gly-L-Met and L-Yal~L-Leu, estimated by the method
of Fujita at al (1972), were greater when intestines were removed
from urethane-anaesthetized rats than when intestines were removed
from ether-anaesthetized animals (Fig. 6.3) but were less when
estimated by the method of Nicholson and Kim (1975) (Pig* 6.7).
These are weak points in this study and the differences cannot be
explained.
■ CHAPTER 7
Does intestinal ischaemla affect plasma peptide hydrolg.se activities?
Introduction
Although acute mesenteric vascular occlusion with intestinal
ischaemia is a relatively uncommon clinical occurrence, the result¬
ing mortality is very high (Harper and Buist, 1978; Watt et al,
1967). This is largely due to the difficulty in diagnosis of the
condition because of the lack of specific symptoms in its early
stages. Early diagnosis is essential since successful treatment can
only be accomplished by surgery before the recognisable specific
symptoms become apparent (Koehler and Kressel, 1978; Morris et al,
1962).
The intestine is supplied with blood from the splanchnic
circulation via three great vessels, the coeliac axis and the
superior and inferior mesenteric arteries. An extensive network of
collateral vessels ensures an adequate blood supply to the intestine,
most regions being supplied by more than one of the great vessels.
Intestinal ischaemia is therefore a rare event (Boley et al, 1978,
p. rj). However, since the superior mesenteric artery accounts for a
major part of the splanchnic blood flow, occlusion of this vessel is
one of the two most common causes of intestinal ischaemia (Jacobson,
1970; Marston, 1977)* A reduced mesenteric blood flow due to
cardiac failure is the other common cause (Marston, 1977)-
Mortality from acute occlusion of the superior mesenteric artery
remains at over 90% (Mavor, 1972), not only because of the difficulty
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in diagnosis (Harper and' Buist, 1978; Mavor, 1972) "but also, since ■
the condition is uncommon, because of failure to suspect intestinal
ischaemia (Watt et al, 1967). In 1967 there were 653 deaths from
mesenteric infarction in the U.K. (Marston, 1970)• Jacobson and
Lanciault (1979) suggest that in the U.S.A. the death rate from
abnormalities of the gastrointestinal circulation may be greater
than that from cancer of the same organs.
During the early stages of intestinal ischaemia the symptoms
are non-specific, consisting of abdominal pain usually accompanied
by vomiting and diarrhoea (Harper and Buist, 1978). The interval
between the onset of ischaemia and the development of peritonitis
can be of the order of days or wreelcs, but it is more commonly about
six hours and it is during this period that diagnosis must be made
(Mavor, 1972).
Both clinical studies and animal experiments have so far failed
to find any structural or functional abnormality in the intestine
that can be used as the basis of a clinical test to aid the diagnosis
of a reduced mesenteric blood flow (Marston, 1977). Elevated serum
lactate dehydrogenase has been reported in only 50% of patients with
infarction cf the small intestine (Zimmerman and West, 1964). In another
study all patients with intestinal ischaemia demonstrated elevated
serum lactate dehydrogenase, but a consistent elevation was not
observed in dogs after ligation of the superior mesenteric artery
(Braun et al, 1959)- Similarly in dogs and cats serum alkaline
phosphatase and glutamic oxalacetic transaminase have been reported
to increase (Bonakdarpour et al, 1976; Dagher et al, 1987; Larson
et ad. 1959; Rudolph erfc al, 1957) or remain unchanged (Marston e_t
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al, 1969; Rosato et a1, 1971) during intestinal ischaemia. These,
enzyme activities are not specific to intestinal cells and would,
therefore have limited value in the diagnosis of intestinal ischaemia.
Similarly, the raised white cell counts, elevated haematocrit and.
metabolic acidosis observed in acute mesenteric ischaemia are
extremely non-specific (Boley et al, 19785 P* 19)*
Angiography has been used with great success in confirming
diagnosis of mesenteric ischaemia (Watt et al, 1967). However, this
is an expensive and time consuming diagnostic aid and is therefore
generally used only after a provisional diagnosis has been made
(Boley, 1978, p. 27).
Thus a specific biochemical test that would provide an early
and reasonably specific index of intestinal ischaemia would have
great potential value. A possible diagnostic test was suggested by
the results of the peptidase release study described in Chapter 6.
When intestines were removed from freshly killed rats, the dipeptide
hydrolase activities appearing in the serosal secretion during
perfusion were three to four times greater than when intestines were
removed from anaesthetised rats. The intestines removed from the
freshly killed rats were deprived of oxygen for less than 4 minutes.
The enzyme release was a very rapid response and it is possible that
the release was stimulated by this short period of anoxia. In the
intact animal enzymes released from the serosal surface of the
intestine should enter the mesenteric blood vessels and lymph.
Peptide hydrolase activities in the blood are normally very low
(Krzysik and Adibi, 1977)* If intestinal ischaemia stimulates the
release of peptide hydrolase activities into the blood, then the
estimation of peptide hydrolase activities in the blood could
possibly be used as a simple and rapid method of diagnosis.
Intestinal ischaemia can be induced experimentally in animals
by ligation of the mesenteric blood supply. The severity of
ischaemia induced can be pre-determined by the position and number
of ligatures. The pathological changes that result from ischaemia
induced experimentally in this way are similar to those seen in
clinical ischaemia (Boley et al, 1978> P- !!)•
Therefore intestinal ischaemia has been induced in ra/ts and
subsequently peptide hydrolase activities were estimated in the
plasma at various times after ligation; they were compared with
values from unligated controls.
METHODS
Ligation of arcadian vessels and the superior mesenteric artery
Female rats weighing 180 - 200 g were anaesthetised throughout
the experiment with urethane (l.5 ml of 0.8g/ml solution) injected
subcutaneously whilst under temporary light ether anaesthesia.
Anaesthesia wan complete after 60 - 90 minutes. The abdomen was
then opened by a mid-line incision and the small intestine and
caecum gently exteriorised. 'Mild' ischaemia was induced by
■ligation, with silk thread, of a group of arcadian vessels supplying
about 10 cm of small intestine commencing approximately 15 cm distal
to the ligament of Treitz. The abdominal contents were then
replaced and the skin incision closed by three stitches. As a
control for this preparation, the same procedure was followed in one
animal but the vessels were not ligated.
'Severe' intestinal ischaemia was induced by ligation of the
superior mesenteric artery. This vessel was located by blunt
dissection at the root o-f the mesentery adjacent to the colon. The
artery was isolated from the superior mesenteric vein and ligated
with silk thread. The abdominal contents were replaced and the skin
incision closed as before. In one animal the artery was isolated
by blunt dissection but not ligated. This animal served as the
control for this preparation.
All the animals were kept warm by an overhead lamp during the
period of ischaemia.
Estimation of plasma peptide hydrolase activities
Approximately 4 nil of blood was taken by cardiac puncture after
20, 60, 120 or 240 minutes from the time of ligation, and after 240
minutes, from the controls. Samples were taken up into 10 ml syringes
fitted with a 21 g needle and with the dead space of the syringe and
needle filled with heparinised saline (0.1 g sodium heparin, Sigma/
10 ml 0.9% w/v NaCl). Some rats died during the experiment and the
blood sample was taken immediately after death. Blood samples were
centrifuged immediately at approximately 4000 g at room temperature
in an M.S.E. bench centrifuge. Peptide hydrolase activities against
Gly-L-Met, L-Leu-Gly and L-Val-L-Leu were estimated immediately in
plasma at a dilution of 1:5 by the modified method of Nicholson and
Kim (l975)j described in Chapter /[. The experiments were timed such
that all the blood samples were taken within a 50 minute period to
reduce the possibility of loss of activity in the plasma due to
storage.
As a further control, plasma peptide hydrolase activities were
estimated in rats that had not been subjected to any surgical
treatment; blood, samples were taken by cardiac puncture from two
ether anaesthetised rats-
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Table 7-1 Plasma dipeptide hydrolase activities measured at various
times after the induction of intestinal ischaemia
Duration of Peptide hydrolase activity
Position of ligature ischaemia (units/ml)
(mins) Gly-Met Leu-Gly Val-Leu
Control 0 0.16 0.18 0.10
Control 0 0.17 0.20 0.12
Control (a.v.) 0 0.17 0.16 0.10
Control (s.m.a.) 0 0.19 0.21 0.12
a.v. 10 (died) 0.14 0.09 0.12
a.v. 20 0.16 0.20 0.11
a.v. 60 0.14 0.15 0.06
a.v. 82 (died) 0.19 0.19 0.11
s • in . a « 20 0.14 0.19 0.09
s.m.a. 60 0.18 0.19 0.09
s. m. a. 100 (died) 0.18 0.17 0.13
s.m.a. 240 0.18 0.17 0.11
Each line refers to an individual rat
a.v. - arcadian vessel
s.m.a. = superior mesenteric artery
RESULTS
Effect of .ischaemia on the Intestine
The gross appearance of the intestines of the two preparation
controls was normal. In all experimental animals the gross
appearance of the intestine at the time of cardiac puncture was
similar. In one or two places a region of the intestine of about
3 - 4 cm length was heavily braised and there were extensive
haemorrhagic lesions in the adjacent mesenteric vessels. In most
cases there was blood in the intestinal lumen. The general
appearance of the intestines agreed closely with that described by
Whitehead (l97^)«
Effect of intestinal ischaemia on plasma peptidase activities
Dipeptide hydrolase activities against Gly-L-Met, L-Leu-Gly and
L-Val-L-Leu were estimated in plasma at various times after ligation;
the results are shown in Table 7»1«
Small, but significant, peptide hydrolase activities were found
in the plasma from control rats. However, it is clear that there was
no effect of intestinal ischaemia on plasma peptide hydrolase
activities even after 4 hours duration of ischaemia.
DISCUSSION
The results of the study described in Chapter 6 suggested that
the release of peptide hydrolase activities from the small intestine
is normally very small and that it may possibly be stimulated by
anoxia. If the release is stimulated by anoxia, then it seems
possible that occlusion of the mesenteric blood supply in the intact
animal will result in an increased release of intestinal peptidase
activity into the mesenteric blood.
This possibility has now been investigated as the basis of a
method for the diagnosis of mesenteric infarction. However, as the
results presented in Table 7-1 demonstrate, there is no effect either
of duration or severity of intestinal ischaemia on plasma peptide
hydrolase activity. It is also of note that the operative
techniques did not affect plasma peptidase activities since those of
the preparation controls do not differ from the a.ctivities observed
in the plasma taken from ether anaesthetised rats.
The gross appearance of the intestines at the time of cardiac
puncture confirmed that intestinal ischaemia had been induced, since
damage appeared as early as 10 minutes after ligation. Since the
animals were maintained under anaesthesia throughout the period of
ischaemia, the deaths cannot be attributed solely to intestinal
infarction - since anaesthesia may make the animals more sensitive
to surgery and the results of ligation.
Although this study failed to demonstrate an increase in plasma
dipeptide hydrolase activities associated with intestinal ischaemia,
it is of note that total occlusion of the superior mesenteric artery
or of a group of arcadian vessels will severely impair the mesenteric
blood supply and also the venous and l^mph drainage of the intestine.
Therefore it is possible that the release of dipeptide hydrolase
activities from the serosal surface of the intestine was stimulated
in this study but due to absolute obstruction of the mesenteric
circulation the enzymes did not enter the general circulation.
Severe intestinal ischaemia was apparent in all animals and
most had blood in the intestinal lumen. In the human, the
appearance of blood in the intestinal lumen is associated with the
later stages of the acute disease (Mavor, 1972) and diagnosis must
be made before this stage of the disease is reached. Thus it is
possible that the method of induction of ischaemia in this study
was too severe. Perhaps a less severe induction of ischaemia in the
rat would be associated with raised plasma peptide hydrolase
activities.
Thus the negative outcome of this experiment should not be
regarded as the final verdict as to the potential use of peptidase
activities in clinical diagnosis: further studies are justified,
especially in view of the benefits at stake.
Very low peptide hydrolase activities (about0-15 umol/min/ml)
were found in plasma from control rats. Similarly, Krzysik and
Adibi (1977) found no activity against Gly-Gly and activities against
Gly-L-Leu amounted to less than 100 pnol/min in the total blood
volume of the rat. Although these activities are very low, their
presence might explain the absence of dipeptides from blood.
CHAPTER 6
The differential effects of 5-fluorouracil and starvation on the rat
small intestine.
Introduction
In view of the clinical evidence that 5-fluorouracil administra¬
tion can be associated with major gastrointestinal disturbances, it
is desirable to investigate the pathogenesis of these in animals
before attempts are made to minimize these disturbances. Although
there is clear evidence of severe impairment of intestinal digestive,
and absorptive functions following administration of 5-fluorouracil,
previous studies have not included all the necessary control experi¬
ments. Detailed information on several aspects, as discussed below,
is therefore essential.
Decreased intestinal absorption following 5-fluorouracil
injection has already been demonstrated in the rat (Gardner et al«
1978; Levin, 1968; Roche et al, 1970); histological changes and
impairment of enzyme activities in the intestine have been reported
both in rat and man (Bounous et al, 1971a au<l L; Hartwich et al.
1974s Roche et al, 1970). Although it is possible that these
effects can be, directly ascribed to the 5-fluorouracil, it must be
noted that administration of 5-Tluorourac.il to rats is followed by a
severe reduction in food intake (Bounous et al, 1971a; Gardner et
al, 1973) and that food restriction or starvation per se are both
known to,cause changes in the absorptive and enzymic activities of
the small intestine (Debnam and Levin, 1975; Kershaw et al, i960;
Kim et al, 1973; Lis et al, 1972; McManus and Isselbacher, 1970;
Newey et al, 1970). Hence it is important to dissociate the primary
effects of the drug from the secondary ones, i.e. those merely due
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to the reduced food intake. 'Furthermore, the nature of the-changes
due to the effects of starvation and food restriction is unclear,
since the literature contains much apparently conflicting information.
There is an extensive literature on this subject but the various
studies have used a number of different methods and regions of the
intestine for the estimation of both intestinal absorption and
enzyme activities. Also, and in particular, absorption 1ms been
expressed with reference to many different reference systems such as
unit dry or wet weight of small intestine or mucosa, unit length of
intestine, whole everted sac, mucosal DMA content, etc. Therefore
comparisons between the various results are difficult and the
conflicting results may be due, at least in part, to this use of
different reference systems.
Therefore the differential effects of 5-fTuorourac.il and.
starvation on absorption from the small intestine have been studied
with a view to dissociating the effects of 5-fTuorouracil on the small
intestine from those of the consequent reduced food intake.
Intestinal water absorption rates were measured at various times
following 5-fTuorouracil injection; absorption rates were also
measured in uninjected rats subjected to a food restriction regime
designed to mimic the food intakes of 5-fTuorouracil-injected rats.
It must be stressed that such a food restriction regime cannot mimic
exactly the feeding pattern of rats following 5-fTuorouracil adminis¬
tration. Although the total daily food intake was determined, the
feeding pattern during each 24 hour period was not known. Thus the
daily food intake was the same as that of 5-fTuorouracil-injected
rats, but the time at which the food was consumed was probably not
the same.
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In order to clarify the effects of starvation and food
restriction on intestinal, absorption and to determine the effect of
the use of different reference systems, four different reference
systems have been used: whole small intestine, unit length of
intestine, intestinal dry weight and mucosal DMA content.
The changes in absorption rate following administration of
5-fluorouracil may result from either (a) a change in the number of
absorbing cells, (b) a change in the absorptive capacity of
individual absorbing cells, or (c) a combination of these. In this
respect Batt and Peters (1976) suggested that absorption rates
should be expressed per enterocyte as an indication of the absorptive
capacity of each enterocyte. The total number of enterocytes would be
determined, they proposed, by estimation of the DNA content of a
mucosal homogenate. They suggested that this would enable
comparisons between absorption rates estimated from different regions
of the intestine and between normal and experimentally altered
intestines. However, it must be recognised that the intestinal
epithelium consists of an heterogeneous population of cells in which
only the mature enterocytes at the tips of the villi are responsible
for absorption. Therefore estimation of the mucosal DNA content,
though an index of the total cell numbers, is not, as implied by
Batt and Peters (1976), a specific index for absorbing cells. This
will be exemplified below by the results of the effects of
5-fluorouracil on the intestine.
During the course of the work for this thesis the suppliers of
the 5-fluorouracil (Roche Products Ltd) changed the salt form of the
drug supplied. Initially the Tris salt of 5-fluorouracil was
supplied from out-dated stock. In November 1978, Roche ceased
139 '
marketing the Tris salt of 5-Tluorouracil in the U.K. and introduced
the sodium salt. Administration of the Tris salt of 5-fliiorouracil
to rats was, without exception, followed within a few hours by-
obvious signs of severe toxicity- which occasionally resulted in death.
In contrast, administration of the sodium salt of 5-Tlnorourac.il at
the same dose had no effect on the gross appearance of the rats and
was never associated with mortality. It is not clear why Roche
changed the salt form of 5-Tlnorouracil. They stated that there were
problems with the stability of 5-flnorouracil at a concentration of
50 mg/ml but gave no details, and it is of note that the sodium salt
of 5-fluorouracil is available in the U.S.A. at a concentration of
50 mg/ml (Calabresi and Parks, 1975)• However, in the U.K. the Tris
salt of 5-fluorouracil was supplied at a concentration of l}0 mg/ml.
Since Roche began marketing the sodium salt of 5-flnorouracil in the
U.K. they do not appear to have received any other reports of a
difference in the toxicities of the two salts of 5-fluorouracil. It
was, therefore, of great interest to study further the differential
toxicities of the two salts.
Although there are obvious differences in the systemic
toxicities of the Tris and sodium salts of 5-flu.orouracil and in the
effects on body weights and food intakes, the changes in water
absorption rates following administration of either salt were found
to be very similar. The differential effects of the Tris and sodium
salts of 5~flu-0rouraci1 on intestinal absorption are therefore incl¬
uded in this chapter since they offer a further means of
dissociating the effects of 5-fluorouracil on the intestine from
those of the reduced food intake.
There are several possible reasons for the severe toxicity of
1lfO
the Tris salt of 5-fku.orouracil 'and some of these have been studied.
A difference in the pharmacokinetics of the two salts of
5-fluorouracil is discussed in the next chapter (Chapter 9)- A
matched Tris placebo wa,s obtained from Roche and administered to
rats in order to determine whether the toxicity was due to the Tris
base rather than to the 5-fluorouracil. The Tris salt has a very
high osmolarity and is supplied at twice the concentration of the
sodium salt of 5-f'luorouracil. Therefore the effects of the
concentration and osmolarity of the 5-fluorouraeil injection on the
gross appearance of rats and on intestinal absorption have been
studied. As a further control experiment the effects of temporary
light ether anaesthesia, as used during administration of
5-fTuorouracil, on intestinal absorption have been determined since
ether itself is known to stress animals (Martindale, 1977? P- 696;
The Pharmaceutical Codex 1979> P- 337)•
The majority of the results presented in this chapter were
obtained, during the period before the sodium salt of 5-fluorouracil
was available. Therefore the effects of food restriction were based
on the observation of food intakes of female rats after administra¬
tion of the Tris salt of 5-fluorouracil. During the course of the
work for this thesis it became clear that there were several
advantages to be gained from the use of male rats. These were
concerned with ease of handling and the adaptabilitjr of male rats to
dietary modification. Therefore the differential toxicities of the
two salts of 5-fluorouracil were studied in male rats rather than in
female rats. However, results will be presented which suggest that
the intestinal toxicity of 5-fPuorouracil is independent of the sex
of rat used. Thus it is justifiable to compare absorption results
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from male and female rats. It must be noted, however, that the food
intakes and growth rates of male rats are much greater than those of
female rats and therefore effects on body weights and food intakes
should only be compared within a single sex.
A paper containing the results presented in this chapter has
been published (Gardner and Plumb, 1981a).
METHODS
5-Eluorouracil administration
Male and female rats weighing 160 •- 200 g were injected intra-
peritoneally whilst under temporary light ether anaesthesia with
either the Tris (50 mg/ml, 384>3 mmol/l) or the sodium (25 mg/ml,
192.2 mmol/l) salt of 5-fluorouracil at a mean dose of 1.44 mmol/kg
body weight unless otherwise specified. All injections were given
between 10:00 and 10:30.
As controls for the injected rats, 8 rats were exposed to
temporary light ether anaesthesia only and another 8 rats received
an injection of a matched Tris placebo (Roche Products Ltd) whilst
under anaesthesia. The volume of placebo administered was equal to
the volume containing the appropriate dose of the Tris salt of
5-fluorouracil.
All rats were caged in groups of 4 before and after injection
and daily food intakes, body weights (measured between 10:00 and
10:30) and the incidence of diarrhoea were noted.
Experimental procedure
Intestinal water absorption rates and dry weights (for method
see Chapter 3) were estimated in control uninjected rats and on
either the first or the third day after injection or exposure to
ether, except in one experiment in which they were estimated on each
of the first 5 days after injection of the Tris or sodium salts of
5-fluorouracil.
The mucosal DMA content was estimated by the method described
in Chapter 5 in control (uninjected) rats and on the first and third
days after administration of the Tris or sodium salts of
5-fluorouracil.
Osmolarlty estimation
The osmolarities of the two salts of 5-fluorouracil were
estimated on 0.5 ml samples in an 'Osmette S Automatic osmometer'
(Precision Systems, Waltham, Massachusetts). The sodium salt was
used undiluted and the Tris salt was used both undiluted and diluted
1:1 with distilled water. The osmometer was calibrated with two
commercial standards (lOO and 500 mOsm/l) before use.
Food restriction
In order to determine the effects of the reduced food .intake
following 5-fluorouracil administration the food intake of a group of
rats was restricted to that observed during the first 5 days follow¬
ing injection of 5-fluorouracil. These experiments were carried out
before the sodium salt of 5-fluorouracil became available and
therefore refer only to the Tris salt of 5-fluorouracil in female
rats.
In a preliminary experiment the daily food intakes of 8 rats
(2 cages of 4 rats) were recorded on each of the first 5 days after
5-fluorouracil (Tris salt) administration. The food intakes of a
further group of rats was restricted to these observed food intakes
of 0, 0, and 5*4 g/uat for the first, second and third days
respectively.* For this experiment rats were caged in groups of 4
*The regime adopted differs slightly from the food intakes shown in
Fig. 8.7 since this figure includes all observations on food intakes
whereas the food restriction regime was based only on a preliminary
experiment.
m
for the first 48 hours and then caged individually and given 54 g
of the Oxoid diet each, Coprophagy was not prevented but cages and
bedding were changed daily during food restriction in order to
minimise it.
Some rats were fasted for 24 hours and used either for measure¬
ment of intestinal water absorption and dry weight or for mucosal
DNA estimation. Others were fasted for 48 hours and then given
5.4 B of the Oxoid diet during the next 24 hours. These rats were
then used on the third day of food restriction for the estimation
of intestinal absorption, dry weight and mucosal UNA contents.
This regime is referred to throughout the chapter as the food
restriction regime.
Estimation of mucosal DMA content
Since there is a small loss (about 16% per hour) of mucosal
DNA during luminal perfusion, DNA estimations cannot reliably be
carried out on intestines after perfusion (see Chapter 6). There¬
fore the mucosal DNA content was estimated on unperfused intestines;
hence estimates of water absorption and mucosal DNA content were
not available.for the same intestine. Absorption per mg DNA was
therefore calculated from the ratio of the mean absorption rate per
whole small intestine and the mean mucosal DNA content. The
variance of a ratio can be calculated by the approximation given by
CornishTBowden (1976, p. 173)• IB the covariance of the numerator
and denominator is assumed to be zero this simplifies as follows:
—2 —
variance jx I--- variance (x) + x variance (v) - 2x covariance (xy)
|y| _2" ~„4 ' " _5
y y y
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This formula probably over-estimates the variance since it is
assumed that absorption rates and mucosal DNA contents do not vary
systematically together and hence that the covariance term is zero.
This assumption was necessary since the covariance is unknown and
could not be estimated. However, it must be noted that this error
will tend to under-estimate .the significance of any differences.
RESULTS
Gross appearance of rats following administration of 5-fluorouracil
Within a few hours after injection of the Tris salt of
5-fluorouracil all rats became very cold and lethargic with obvious
respiratory distress. In some cases the toxicity was so severe that
death resulted, usually within the first 24 hours after treatment.
The earliest deaths occurred about 5 hours after injection. These
toxic symptoms continued through the second, and third days after
injection by which time most of the rats had developed diarrhoea.
The diarrhoea was transient, seen only on the third and fourth days
after administration of the drug. By the fifth day after
5-fluorouracil injection the obvious signs of toxicity were absent
and the gross appearance of the rats was normal.
Internally, severe macroscopic haemorrhagic lesions on the
surface of the pancreas were noted on the third day after injection.
In contrast, administration of the sodium salt of
5-fluorouracil at the same molar dosage had no effect on the gross
appearance of rats and was never associated with mortality.
Diarrhoea and the consequent malaise was present on the third and
fourth days after injection but otherwise none of the toxic symptoms
observed in rats injected with the Tris salt of 5~fTuorouracil were
noted.
Mortality
Table 8.1 summarises the mortalities after administration of








































Fig. 8.1 Daily food intakes of control, uninfected, male rats
(Day O) and of male rats during the first 5 days following administra¬
tion of either the Tris or the sodium salt of 5-fluorouracil. Values
are the mean - S.E.M. and the number of observations on groups of 4
rats is shown above the bars.
l*f8
thesis.* Results from rats 'fed on an 'elemental' diet are included
since these are similar to those from rats fed on a standard diet
(see Chapter 10).
t
Table 8.1 Mortality in male and female rats during the first "d days
after administration of the Tris or sodium salt of 5-fluorouracil
Salt of Total No. Total
Sex "j-fluorouracil injected deaths ToMortal1 ty
Female Tris 177 21 11.9
Male Tris 142 27 19.0
Female Sodium 13 0 0
Male Sodium 436 0 0
Whilst a significant mortality was observed in both male (19.0%)
and female rats following administration of the Tris salt of
5-fluorouracil, no deaths were observed after injection of a total of
449 rats with the sodium salt of 5-1luorouracil.
Effects of 9-fluorouracil on food intakes
Pig. 8.1 shows the food intakes of control, uninfected, rats and
on each of the first 5 days after administration of either the Tris
or sodium salt of 5-Huorouracil. Male rats were used. Taring the
first 24 hours after injection of the Tris salt of 5-fluorouraci1 the
food intake decreased to only 7% of the normal daily intake. Then
there was a gradual increase in the daily food intakes over the next
*excluding those used, for pharmacokinetics experiments since these
were also subjected to prolonged anaesthesia and surgery.
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few days such that "by the fifth day after 5-fluorouracil administra¬
tion the total food intake over the 5 day period was 16% of the
normal intake over the same period.
In contrast, when the sodium salt of 5-fluorouracil was
administered the food intake during the first 24 hours after injection
decreased only to 50% of the normal daily intake and had only
decreased to 7% of normal by the third day after injection. The
total food intake during the first 3 days after administration of the
sodium salt of 5-fluorouracil (34% of the normal intake) was three
times that after administration of the Tris salt of 5-fluorouracil
(ll% of the normal intake). The food intake increased to 55% of the
normal daily intake on the fifth day after administration of the sodium
salt: thus the total food intake over the 5 day period (34% of the
normal intake) was twice that observed after administration of the
Tris salt of 5~fluorouracil.
Effects of S-fluorouracil on body weights
Fig. 8.2 shows the body weights of male rats on each of the first
5 days after administration of either the Tris or the sodium salt of
5-fluorouracil. Although the body weight of all rats was decreased
by about 20 - 30 g by the third day after 5-fluorouracil administra¬
tion, no statistically significant effect on body weight would be
observed if the mean body weight of all the rats was compared by an
unpaired test, since the initial body weights ranged from 160 - 200 g.
However, when the body weight was expressed as a percentage of the
body weight on the day of injection significant effects on body
weights were observed.




































Pig. 8.2 Body weights of male rats on each of the first 5 days
after administration of either the Tris or sodium salt of
5~fluorouracil. Values are the mean - S.E.M. of the weights
expressed as a percentage of the body weight on the day of injection
(Bay 0). Numbers of observations, each on a single animal, are shown
within the bars for Bay 0.
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injection of either the Tris' or the sodium salt of 5-f'Tuorouracil.
On the fifth day after administration of the Tris salt the "body
weights decreased further, whereas they increased on the fifth day
after administration of the sodium salt of 5-f'luorouracil. On each
of the first 4 days after 5-fbaorouracil administration the body
weight losses were consistently significantly greater after
administration of the Tris salt than after administration of the
sodium salt (P-^rO.02).
Intestinal water absorption rates and dry weights on each of the
first five days after administration of the Tris or sodium salt of
5-fluorouracil
Pigs. 8.3 and 8.4 show the water absorption rates and dry
weights respectively of intestines from control male rats and on
each of the first 5 days after administration of the Tris and sodium
salts of 5-flaorouracil in male rats. Changes in both water
absorption rates and dry weights were similar after injection of each
salt of 5-fluorouracil. Water absorption rates were unchanged on the
first day after 5-fluorouracil injection but had decreased to about
26% of the control rates (i.e; in uninjected rats) by the third day.
By the fifth day the absorption rates had increased to about 70% of
the control rates.
In contrast, there was a rapid decrease in intestinal dry weight
to about 50% of that of control intestines from uninjected rats by
the first day after 5~fTaorouracil injection. There was a further
decrease to about 42% of controls by the third day after which
intestinal dry weights increased gradually to about 63% of controls
by the fifth day.
200-
Confrol Day 1 Day 2 Day 3 Day 4 Day 5
Fig. 8.3. Water absorption rates in jejunum plus ileum from male
rats on each of the first 5 days following injection of the Tris
salt (open bars) and the sodium salt (hatched bars) of
5-fluorouracil and in control rats (stippled bars). Values are
•f*
mean - S.E.M. and the number of intestines is shown within the bars.
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Control Day 1 Day 2 Day 3 Day 4 Day 5
Fig. 8.4 Dry weights of jejunum plus ileum from male rats on each
of the first 5 days following injection of the Tris salt (open bars)
and sodium salt (hatched bans) of 5-fluorcuracil and in control rats
(stippled bars). Values are mean - S.E.M. and the number of
intestines is shown within the bars.
Comparison of absorption rates from male and female rats
Pigs. 8.5 and 8.6 show the intestinal water absorption rates and
dry weights respectively from control, uninfected, rats and from rats
1 and 3 days after injection of either the Tris or the sodium salts of
5-fluorouracil. Both male and female rats were used and the results
are shown separately. There was no difference between the intestinal
water absorption rates of male and female control rats, although the
dry weights of intestines from males were significantly greater than
those from females (P-=:0.0l). Although both water absorption rales
and dry weights on the third day after 5-fluorouracil administration
were slightly greater in female rats than those in male rats, this
difference was not significant (P^O.l). Water absorption rales
and dry weights were decreased to a similar extent after administra¬
tion of either salt of 5~fluorouracil regardless of the sex of rat
used.
Effects of ether anaesthesia and a Tris placebo injection on
intestinal absorption and dry weight
5-Pluorouracil was administered under light ether anaesthesia.
Since ether is known to stress rats (Martindale, 1977 5 p. 696; The
Pharmaceutical Codex 1979? P« 337) and since the effects of ether
anaesthesia and of Tris base on the intestine are not known,
intestinal water absorption and dry weights were determined on the
third day after exposure of female rats to temporary light ether
anaesthesia alone or combined with an intraperitoneal injection of
a matched Tris placebo. The results are shown in Table 8.2 and
those from control female rats are included for comparison.
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Fig. 8.5 Water absorption rates in jejunum plus ileum from male
(hatched bars) and female (open bars) rats injected 1 or 5 days
previously with either the Tris or sodium salt of 5-bluorouracil and
from control rats (bay 0). Values are the mean — S.E.M. and the
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Days after 5~fluorouracil injection
Fig. 8.6 Dry weights of jejunum plus ileum from male (hatched
bars) and female (open bars) rats injected 1 or 3 days previously
with either the Tris or sodium salt of 5-flr.orouracil and from
control rats (Day 0). Values are the mean - S.E.M. and the number
of intestines is shown within the bars.
157
Table 8.2 Effect of temporary ether anaesthesia and of a Tris
placebo injection on Intestinal water absorption rate-s and dry
weights 5 days after treatment
Water absorption rate Intestinal dry weight
Stress (pi/cin/hr) (mg/cm)
None 138.69 - 9.01 (13) 11.51 - 0.37 (10)
Ether 143.34 - 7-00 ( 6) 11.49 - 0.41 ( 6)
Ether + 141.53 - 5.32 ( 6) 11.34 ± 0.28 ( 6)
Placebo
Values are the mean - S.E.M. and the number of intestines is shown
in parentheses.
significant effect cn intestinal water absorption rates or dry
weights. Also injection of the Tris placebo had no effect on the
food intake (Fig. 8.7), whereas injection of female rats with the
Tris salt of 5-fluorouracil resulted in a marked decrease in the food
intake similar to that seen in male rats (Fig. 8.1).
Effects of concentration and osmolarlty of the Tris salt of
5-fluorouracil
The pH of the two preparation (sodium and Tris salts) of
5-fluorouracil is similar: 9-1 a11^ 8.8 for the sodium and Tris
salts respectively. However, the osmolarities of the two preparations
differ (Table 8.3). That of the sodium salt (335 mOsm/l) is within
the normal physiological range of plasma whereas that of the Tris
salt is much higher (992 mOsm/l). Also, the concentration of the













































Fig. 8.7 Daily food intakes of female rats during the first 3 days
after injection of the Tris salt of 5-Dbuorouracil or a Tris placebo.
Values are the mean ^ S.E.M. and the number of observations on groups
of 4 rats is shown above the bars.
Table 8,/la Effect of concentration amd osmolarity of the Tris salt
of 5-fluorouracil on mortality, food intake and the incidence of
diarrhoea in male rats during the first 3 days after administration
Mortality Incidence of Pood intake
Injection (%) diarrhoea (%) (g/rat/3 days)
5-fluorouracil 20.0 (70) 80.0 (20) 6.7 (5)
5-fluorouracil/ 25.0 ( 8) 83.5 ( 6) 9.0 (l)
placebo 1:1
5-fluorouracil/ 12.5 ( 8) 85-7 ( 7) 8.4 (l)
water Isl
The total number of animals observed is shorn in parentheses except
for food .intakes for which the number of observations on groups of 4
rats is shown in parentheses.
Table 8.4b Effect of concentration and osmolarity of the Tris salt
of 5-fluorouracil on intestinal water absorption and dry weights on
the third day after administration in male rats
Water absorption rate Intestinal dry weight
Injection (pl/cm/hr) (mg/em)
5-fluorouracil 38.1 - 5.41 (12) 7.O5 - 0.36 (20)
^lace^o0iTfcil// 36'7 "5-31 ( 5) 7.67 - 0.71 ( 6)
5~fluorouracil/ 34.4 ^ 8.12 ( 4) 6.84-0.16(7)
water 1:1
+
Values are means - S.E.M. and the number of intestines is shown in
parentheses.
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Tris 384 8.8 992
Sodium 192 9.1 335
* Data supplied by Roche Products Ltd.
(25 mg/ml, "192 mmol/l). In order to determine whether either the
osmolarity or the concentration of the Tris salt was responsible for
the severe systemic toxicity associated with this salt, the effects
of dilution of the Tris sa.lt 1:1 with the matched Tris placebo (to
give 5-fluorouracil concentration 25 mg/ml; osmolarity 1000 mOsm/l)
and of dilution of the Tris salt 1:1 with distilled water (to give
5--fluorouracil concentration 25 mg/ml; osmolarity 500 mOsm/l) were
determined.
Table 8.4a shows the mortality, food intak.es and the incidence
of diarrhoea during the first 3 days after administration of the
Tris salt of 5-fTaorouracil and after administration of the two
dilutions of the Tris salt in male rats. Intestinal absorption
rates and dry weights on the third day after injection are also
shown in Table 8.4b. Neither of the two dilutions of the Tris salt
had any significant effect on the severity of the toxicity observed
after administration of the Tris salt of 5-fluorouracil, either in
terms of the gross appearance of the rats or in terms of any of the
measurements shown in Tables 8.4a and b. A significant mortality
was observed in all cases.
Effects of the dose of 5-fluorouracil on mortality and on intestinal
absorption end dry weight
Fig. 8.8 shows the intestinal water absorption rates and dry
weights estimated on the third day after injection of male rats with
the Tfis salt of 5-Bluorouracil at various doses. Both water
absorption rates and dry weights decreased in a similar manner with
increasing doses of luorouracil; water absorption rates
expressed per mg dry weight also decreased with increasing doses of
5-fluorouracil (Table 8.5). However, the ratio of the decrease in
absorption rates and the decrease in intestinal dry weight is
constant except for the lowest dose of 5-flnorouracil (Table 8.5).
Table 8.8 Effect of the dose of 9-fluorouracil on Intestinal
water absorption rates expressed per mg dry weight
Dose of Decrease in a.bs. rate
5-fluorouracil Water absorption rate Decrease in dry weight
(mmol/kg body wt) (ul/mg dry weight/h) (ul/mg dry weigbt/hr)
1.44 5.24 - 0.70 (12) 11.1
1.08 6.01 - I.34 ( 5) 11.4
0.72 7-44 - 0.70 ( 6) 11.3
0.36 9.46 - 1.68 ( 7) 9-4
Control 10.30 - 0.75 (9)
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Fig. 8.8 Water absorption rates (e) and dry weights (o) of
I
intestines from male rats 3 days after administration of various
•f
doses of the Tris salt of 5-flu-orouracil. Values are the mean -
S.E.M. and the number of intestines is shown below the points.
At all doses of 5~flworouracil water absorption rates and dry weights
were decreased significantly (P-^0.02, P-=D.01, P«=-0.01,
P==:0.001 for doses of O.36, O.72, 1.08 and 1.44 mmol/kg respectively)
when compared with those from control, uninfected, rats. There were
no deaths following administration of the two lower doses of
5-fluorouracil (0.36 and 0.72 mmol/kg). The mortalities at doses of
1.08 and 1.44 mmol/kg were similar, 18.2% (2 out of 11) and 21.4%
(6 out of 28) respectively, and the slight difference between the
absorption rates at these two doses was not significant (P.e=-0.5).
The gross appearance of the rats was consistent with these
observations. At a dose of 1.08 mmol/kg the gross appearance of the
rats was as described for rats injected with 5-fluorouracil at a
dose of 1.44 mmol/kg. All 7 rats that survived the dose of 1.08
mmol/kg had diarrhoea by the third day as did 80% of the rats
injected at a dose of 1.44 mmol/kg. None of the rats injected at
the two lower doses of 5-flnorouracil (0.36 and 0.72 mmol/kg)
developed diarrhoea.
Effects of 3-fluorouracll (Tris salt.) and food restriction on body
weight
Fig. 8.9 shows the body weights of female rats on each of the
first 3 days ofafood restriction regime designed to mimic the food
intake after 5-fluorouracil administration and on each of the first
3 days after injection of the Tris salt of 5-fluorouracil. Those
from control female rats and from female rats injected with the
Tris placebo are included for comparison. The body weight decreased
both after 5-fluorouracil injection and after food restriction. The
decrease following food restriction was slightly greater over the
Fig.8.9Bodyweightsfc ntrolfemaleratsanoe cfthfi s





































first two days than that after 5-fluoror.racil treatment (P--=v-0,02).
The increased food intake- "between the second and third day resulted
in an increase in the body weight of the food restricted rats; in
contrast, the body weight of the 5-fl"u.orouracil-injected rats
continued to decrease over this period.
The placebo and its associated temporary anaesthesia .
had no effect on the growth rate of the rats.
Effects of 5-fluorouracil (Tris and sodium salts) and food
restriction on mucosal MA content
The mucosal DNA content of female rats on the first and third
days of a food restriction regime and on the first and third days
after injection of the Tris or sodium salt of 5-flnorouracil is
shown in Pig. 8.10. The mucosa,! DNA content had decreased to 47%
of the normal content on the first day after administration of the
Tris or sodium, salt of 5-fluorouracil; in contrast, food
deprivation for 1 day had no effect on the mucosal DNA content. By
the third day after 5-fluorouracil injection the DNA content had
decreased to 38% of the control value; food restriction for three
days resulted in a much smaller, but significant (P=0.02), decrease
in the mucosal DNA content to 86% of the control value.
Effects of 3-fluorouracil (Tris salt) and food restriction on water
absorption
The rates of water absorption after injection of 5-fluorouracil
or after food restriction were determined: these rates have been .
expressed relative to (a) total jejunum plus ileum, (b) unit length
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Fig. 8.10 DNA content of the mucosa from the whole jejunum plus
ileum from control female rats, and on the first and third days of
the food restriction regime and following administration of either
the Tris or sodium salt of 5-fluorouracil. Values are the mean 4
S.E.M. and the numbers of intestines are shown within the bars.
The significance levels of the differences from values in control
rats are indicated thus: *"x"* E "=-0.001, ** P-^O.OO, N.S. Pr=-0.05.
1
mucosal DNA content (Figs. 8.11 and 8.12). There was no significant
change in water absorption rate.a-expressed per whole small intestine
one dajr after 5-flnorouracil treatment; by the third day after
5-fluorouracil injection they had decreased to 30% of control values.
On the other hand, when absorption rates were expressed relative to
total intestinal dry weight or to the mucosal DNA content, a dramatic
increase was observed after one day and. by the third day the
absorption rates had decreased to 70 - 80% of control values (Fig.
8.11).
After food deprivation for one or three days the water absorption
rate expressed per whole small intestine was decreased to approxi¬
mately 70% of the control rate (Fig. 8.12). The decreased absorption
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Days after 5-fluorouracil injection
Pig. 8.11 Water absorption rates in jejunum plus ileum from female
control rats and from female rats which had received 5-fluorouracil
(Tris salt) 1 or 3 days previously. Rates are expressed as a
percentage of control (Day 0) rates using four different reference
systems: whole small intestine, cm length of intestine, mg dry
weight of intestine and mg mucosal DNA content. Values are means
4
- S.E.M. and the numbers of intestines are shown within the bars.
The significance levels of the differences from the values in control
rats are indicated thus: *"** P«= 0,001, ** P*-—0.01, * P-^0.02,
N.S. P —0.05.
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Fig 8.12 Water absorption rates in jejunum, plus ileum from control
female rats and from female rats following food deprivation for 1 day
or food restriction for 3 days. Rates are expressed as a percentage
of control rates using each of four different reference systems:
whole small intestine, cm length of intestine, mg dry weight of
•J*
intestine and mg mucosal MA content. Values are means - S.E.M. and
the numbers of intestines are shown within the bars. The signifi¬
cance levels of the differences from the value in control rats are
indicated thus: ** P^0.02, N.S. . P:=-0.05.
DISCUSSION
This chapter describes the differential effects of
5-fluorouracil and starvation on the intestine. During this study .
the suppliers of the 5-fluorouracil changed the salt form of the
drug supplied and this resulted in the totally unexpected
observation of the differential toxicities of the Tris and sodium
salts of 5-fluorouracil. It soon became clear that the two salts
have very different effects on the food intakes of rats but the
intestinal toxicities of the two salts are very similar. It is,
therefore, appropriate to discuss the differential toxicities of the
Tris and sodium salts of 5~fluoroura.cil in this chapter since the
two salts offer a further means of dissociating the effects of
5-fluorouracil per se from those of the reduced food intake. Tlius
the first part of this discussion is concerned with the intestinal
toxicity of 5-fluorouracil and includes a discussion of the
differences in the systemic toxicities of the two salts of
5-fluorouracil. The effects of 5-fluorouracil on the intestine fire
then compared with those of starvation. Finally, the effects of the
choice of reference system for the expression of intestinal
absorption are discussed.
Intestinal toxicity of 5-fluorouracil
The most striking (and novel) observation reported in this
chapter was that of the differential toxicities of the two salts of
5-fluorouracil. The difference was clear simply from the appearance
of the rats a few hours after administration of 5-fluorouracil. All
those injected with the Tris salt of 5-fluorouracil became very cold
and lethargic and, out of a. total of 519 rats injected, 48 rats died.
In contrast, administration of the sodium salt of 5-fluorouracir to
rats was never associated with any of these signs of systemic
toxicity and no deaths were recorded after injection of 449 rats.
Since there was no obvious explanation for the marked difference in
the systemic toxicities of the two salts the effects of the Tris
and the sodium salts of 5-fluorouracil on the rat were studied in
detail.
.The difference in the systemic toxicities of the two salts was
also apparent in the effects on food intakes and body weights. The
Tris and sodium salts of 5-fluorouracil had very different effects
on the food intakes of rats (Fig. 8.1). During the first 24 hours
after administration of the Tris salt of 5-fluorouracil the food
intake decreased to only 7% of the normal daily intake. The food
intake gradually increased over the next few days such that by the
fifth day the food intake was only 24% of the normal daily intake.
In contrast, during the first 24 hours after administration of the
sodium salt of 5~fluorouracil, the food intake decreased only to
50% of the normal daily intake. The food intake decreased further
to only 7% of the normal intake by the third day but rapidly
increased to 55% by the fifth day. The total food intake during the
first 5 days after administration of the sodium salt (34% of the
normal intake over the same period) was twice that after administra¬
tion of the Tris salt of 5-fluorouracil, (l6% of the normal intake).
These different effects on food intakes were reflected by the
changes in body weight following 5-flu.orouracil administration.
During the first four days after administration of 5-fluorouracil
the decreased in body weight was consistently significantly greater
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after administration of the 'Tris salt than after administration of the
sodium salt of the drug (P—-0.02). The increase in food intake on
the fifth day after administration of the sodium salt of 5~fluorouracil
resulted in an increase in the hody weight of the rats, whereas the
body weights of rats injected with the Tris salt continued to decrease
(Pig. 8.2).
Although these marked differences were observed in the systemic
toxicities and the effects on food intakes and body weights, the
intestinal toxicities of the two salts of 5-fluorouracil were
similar (Figs. 8.3 and 8.4). There was no significant difference
between either water absorption rates or intestinal dry weights on
each of the first 5 days after administration of the Tris and sodium
salts of 5-flu-orouracil (Figs. 8.3 and 8.4 respectively). Water
absorption rates were not affected on the first day after
5-fluorouracil administration. Severe impairment of water absorption
to 26% of that in control, uninjected, rats was observed by the
third day after injection of either salt of 5-fluorouracil. By the
fifth day absorption rates had increased to about 70% of the control
rate. These observations differ from those of Gardner et. al (1978).
They reported increased rates of water and glucose absorption, to
150% and 120% of control rates respectively, on the first day after
administration of the Tris salt of 5-fluorouracil in female rats.
Also, glucose and water absorption rates were decreased to about
40% of the control rate by the third day but showed no recovery on
the fifth day, as observed in this study. However, the control rate
for water absorption reported by Gardner et al (1978) of 13'. 5 - 5-75
pl/cm/hr agrees well with the control rate observed in the present
study (138.7 - 9-0 pl/cm/hr). These differences cannot be explained
Vb
but it is of note that Roche et al (1970) clicL not observe any effect
on glucose absorption in■vivo in rats on the first day after
5-fluorouracil administration. Thus their results are consistent
with those reported here, and not with those of Gardner et al (1978).
Although there was no effect 011 water absorption on the first
day after 5-fluorouracil administration, both the intestinal dry
weight and the mucosal HNA content had decreased to about *jQ% of
the normal values (figs. 8.4 and 8.10). Therefore, if the water
absorption rates were expressed relative to dry weight or to the
mucosal DNA content, a dramatic increase would be observed on the
first day after 5-fluorouracil administration. This observation
is discussed further below.
The differential toxicities of the Tris and sodium salts of
5-fluorouracil
The actual cause of the severe systemic toxicity associated
with the Tris salt of 5-fluorouracil is not known. Tris base has
been reported to be toxic to some tissues (Roberton, 1970).
However, no toxic symptoms were observed following ether anaesthesia and
injection of a matched Tris placebo (Table 8.2). Also, the toxicity
does not appear to be associated with the higher concentration and
osmolarity of the Tris salt of 5-fluorouracil since reduction of
both by a factor of two had no significant effect on the severity
of the toxic symptoms or on the mortality (Table 8.4a).
In Chapter 9 a difference in the pharmacokinetics of the two
salts of 5-fluorouracil is reported. Higher plasma levels of
5-fluorouracil are obtained after intraperitoneal injection of the
Tris salt than after injection of the sodium, salt at the same molar
dose. The higher plasma levels of 5-fluorouracil might explain the
differential toxicities of the^fewo salts but, as discussed in Chapter
9, this is thought to be unlikely. It is concluded that the
difference in the pharmacokinetics is evidence of a fundamental
difference in the properties of the Tris and sodium salts of
5-fluorouracil and that it is probably a property of the Tris salt
of 5-fTuorouracil per se that is responsible for the severe systemic
toxicity and mortality associated with its used.
Although the cause of death is not known, severe pancreatic
damage was observed on the third day after injection of the Tris
salt of 5-flnorouracil but not after injection of the sodium salt
of 5-fluorouracil. Similarly, Martin et al (1969) reported
pancreatic damage in rats after three consecutive days of
5-fluorouracil administration.* They reported an accumulation of
zymogen granules in the pancreas of 5-fluorouracil-treated rats and
suggested that 5-fluorouracil inhibits the normal secretory
mechanism of the pancreas. Although it is not known how soon after
5-fluorouracil administration pancreatic damage is apparent, Liss
and Chadwick (1974) reported extensive accumulation of 5-fTuorouracil-
2-C"^ in tissues of rats and mice 2 hours after an intravenous
injection and these included the pancreas. Therefore pancreatic
damage might be partly responsible for the toxic symptoms observed
3 to 4 hours after an intraperitoneal injection of the Tris salt of
5-fluorouracil. Acute pancreatitis is a potential cause of death.
*Assumed to be the Tris salt of 5-fluorourac.il since it must have been
supplied during the period in which only the Tris salt.was available
from Roche in the U.K.
Intes1inal absorption in male and female rats
Fisher (1955) repox°ted a difference in the intestinal absorption
rates of both glucose and water between male and female rats. The
mean intestinal water absorption rate in female rats was 236 pl/cm/hr
compared with 188 pi/cm/hr in male rats. Both of these rates,
estimated by the re-circulation perfusion technique of Fisher and .
Parsons (l949)j vers higher than those of Gardner et al (1978) suuT
those estimated in the present study by the method of Fisher and
Gardner (1974); "the difference is probably due to the use of
different techniques and strain of rats.
In this study no difference was observed between the intestinal
water absorption rates estimated in male and female rats. This was
true for animals fed on a standard diet (Fig. 8.5) or on an
'elemental' diet (Chapter 10, Table 10.9). Although the dry weights
of intestines from male rats vexe ^>0% greater than those from female
rats, the mucosal DNA contents did not differ (females - 32.0 mg/
intestine; males - 35*5 mg/intestine reported in Chapter 11). This
suggests that the higher intestinal dry weight observed in male rats
is not due to a greater number of intestinal epithelial cells, but
may be due to a greater size of the cells .or a greater thickness of
the muscle layer.
The intestinal toxicity of 5-PTu.oroura.cil is similar in male and
female rats. There is no significant difference in the intestinal
absorption rate on the third day after administration of either salt
of 5-fTu.orouracil in male and female rats (Fig. 8.5). Intestinal dry
weights are also similar on the third day after 5-fTuorouracil
administration in male and female rats (Fig. 8.6). Since the dry
weight of intestines from male rats is greater than that of female
rats, the decrease in dry weight was greater in male rats (56/0) than
in female rats (35%). If "the intestinal epithelial cells of male
rats are larger than those of female rats, or if the muscle layer
is larger, this difference may not exclude the loss of a similar
number of cells from the intestinal epithelium of the two sexes.
The effects of 5~fluorouracil on food intakes and body weights
of male and female rats were also similar (Figs. 8.1 and 8.7 and
Figs. 8.2 and 8.9 respectively). However, the daily food intakes
and growth rates of male rats were 20% and 146%gceater respectively
than those of female rats (see Chapter 10, Table 10.7), and there¬
fore direct comparisons of these parameters shoxxld not be made between
the two sexes.
Differential effects of 9-fluorouracll and starvation on the
intestine
The results presented in this chapter show clearly several
fundamental differences between the changes in absorption rates
following 5~fluorouracil injection and those after the food
restriction regime designed to mimic the animals' food intake after
5-fluorouracil injection.
Water absorption by the whole small intestine is greatly
decreased after 5-fluorouracil injection (Fig. 8.1l). However, the
reduced food intake by itself results in a much smaller, although
significant (P=^0.02), decreased in water absorption (Fig. 8.12).
Hence the effects of 5-fluorouracil on absorption cannot wholly be
attributed to food restriction. This result agrees with Levins'
(1968) observation of decreased.absorption of glucose, galactose and
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fructose in fasted rats after injection of 5-fluorouraci.1 when
compared with fasted controls - "but see below. Also, the use of both
the Tris and sodium salts of 5-fluorouracil, which have different
effects on the food intake pattern after injection, has demonstrated
further the difference between the effects of 5-fluorouracil on
absorption"and the effects of the consequent reduced food intake on
absorption. The intestinal toxicity of the two salts is similar
(Figs. 8.3 and 8.4) and they have identical effects on the mucosal
DNA content (Pig. 8.10) although the overall food intake during the
first 3 days after injection of the sodium salt of 5-fluorouracil is
three times that after injection of the Tris salt of 5-fluorouracil.
Bounous' and Maestracci (1976) reported a greater reduction in
intestinal sucrase and leucylnaphthylamide-hydrolysing activities in
rats following 5-fluorouracil administration than was observed when
the daily food intake of rats was restricted to that observed during
5-fluorouracil treatment. They also reported that body weight losses
after 5-fluorouracil (sodium salt) administration were greater than
those observed after the reduced food intake. In contrast, body
weight losses after food restriction based on the food intakes
observed after administration of the Tris salt of 5-fluorouracil,
were greater on the first two days than after administration of the
Tris salt of 5~fluorouracil (Pig. 8.9). This is consistent with the
observations, reported in this chapter, that the food intakes after
injection of the sodium salt were greater than those after injection
of the Tris salt of 5-fluorouracil. Hence the food restriction
regime for the Tris salt allowed less food than would that for the•
sodium salt of 5-fluorouracil.
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As noted in the introduction to this chapter, the food
restriction regime could not mimic exactly the feeding pattern of
rats after 5-fluorouracil injection,, but did mimic the total daily
intake. The regime adopted differs slightly from the food intakes
shown in Fig. 8.7, since this figure includes all observations on
food intakes whereas the food restriction regime was based only on a,
preliminary experiment. The daily food intake can be controlled,
but the hour-to-hour food intake of the rats is not easy to control.
For example, when the food intake of rats was restricted all the
food (5.4 g) presented on the second day was eaten immediately,
thus leaving a fast of at least 12 hours before perfusion on the
third day. However, this reservation does not apply to the first
day after injection of the Tris salt of 5-flw.orouracil since the
food intake then was negligible. A 24 hour fast has considerable
effects on absorption; water absorption by the whole small
intestine is decreased by 32% of control values (Fig. 8.12). This
indicates the potential hazard in the practice of preparing animals
for absorption studies by an overnight fast as is routinely
performed in many laboratories (Heller, 1954, Steiner and Gray,
1969; Cheng et al, 1971) especially since this, for a nocturnal
feeder (see Chapter 11), is equivalent to a 24 hour fast. This is
claimed to aid removal of the intestinal lumen contents prior to use
of the intestine. However, experience from this study suggested that
the 24 hour fast did not completely clear the intestine of solid
debris and there thus seems to be little merit in this practice.
Effects of 8-fluorouracil on cell numbers and cell function
A change in absorption rates could be a result of, either a
change in the number of absorbing cells or of a change in the
1
absorbing capacity of individual cells. Thus the decreased
absorption rates following 5-DPuorouracil administration could be a
direct result of a loss of cells from the intestinal mucosa or a
result of damage to existing absorbing cells such that their function
is impaired or, it may result from both of these causes. Distinction
between these two causes of impaired absorption is important since
in the first case recovery of absorption is dependent upon production
of new cells, whereas in the latter case recovery may also occur via
repair of damaged cells. Batt and Peters (197&) have suggested that
absorption rates should be expressed per enterocyte, estimated by
mucosal DNA measurement, in order to differentiate between these two
possibilities. Although there was no effect on the absorption rale
by the whole small intestine on the first day after 5-fluorouracil
injection, the absorption rate expressed per mg DNA is doubled
(Fig. 8.1l). Roche et al (l970) also reported a change in cell
numbers with no change in absorption rates, expressed per unit
length of small .intestine, 1 day after 5-fluorouracil injection.
Since 5~fluorouracil inhibits DNA synthesis and therefore prevents
crypt cell division in the intestinal epithelium, the 54% decrease
in the mucosal DNA content 1 day after injection probably represents
a reduced number of crypt and immature villus cells (i.e. non-
absorbing cells) with, at this stage, little or no change in the
number of mature absorbing cells at the tip of the villi. Further¬
more, the mucosal DNA content also includes cells of the lamina
propria. Thus, since DNA is not a specific index of the number of
absorbing cells, it is not possible to use it in a study of the
effects of an antimetabolite on a heterogeneous population of cells
to determine whether the absorptive capacity of individual absorbing
cells has been altered.
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Levin (1968) suggested that changes in absorption rates after
5-fluorourac.il treatment were due to changes in cell numbers since
absorption rates expressed per unit dry weight of intestine were not
affected on the third day of three consecutive daily injections.
However, Levin (1968) starved the rats during 5-fluorourac.il treat¬
ment and compared the results with those from fasted controls. The
severity of the intestinal toxicity of 5-fluorouracil is increased
by a 24 hour fast before administration (see Chapter 11). This may
explain why the results of Levin (1968) differ from those observed
in this study; water absorption rates expressed per unit dry weight
of intestine were significantly less on the third day after
5-fluorouracil than the control rate and less than that on the third
day of food restriction. This result contrasts with that of Levin
(1968) but this does not unequivocally indicate that the decreased
absorption rate on the third day after 5-fluorouracil injection is a
result of a decrease in the absorptive capacity of individual cells
as well as a decrease in the number of absorbing cells. The
reservations already discussed with respect to DNA as a reference
basis also apply to the use of dry weight and unfortunately prevent
the solution of this problem.
The effects of varying the dose of 5~fluorouracil suggested
that the reduced water absorption rate seen on the third day after
5-fluorouracil injection might be due to a decrease in cell numbers.
The pattern of change in intestinal absorption rates and dry weights
is similar and there is a constant loss of absorptive capacity per
unit loss of dry weight (Fig. 8.8 and Table 8.5).
Thus, while it is not possible to conclude that only the number
of absorbing cells has been changed by 5-fluorouracil, and to exclude
the possibility that the absorptive capacity of individual cells has
also been reduced, it can be noted that the results are perfectly
consistent with this hypothesis. Further, the parallel changes seen
in Fig. 8.8 lend some support, though tentative, to it. Hence,
although Levin's actual observations (discussed above) differ from
those reported here, it seems likely that his conclusion was correct.
The effects of different reference systems
Water absorption rates have been expressed with respect to four
different reference systems: whole small intestine, unit length of
intestine, unit dry weight of intestine and mucosal XffiTA content.
The results illustrate clearly how the choice of reference system
effects both the quantitative and qualitative pattern of results.
Whilst absorption rates are not affected on the first day after
5-fluorouracil administration when referred to whole small intestine
or per unit length of intestine, there is a significant increase in
absorption rates referred to unit dry weight or mucosal UNA content
(Fig. 8.1l). On the third day after 5-fluorouracil administration
the absorption rates are decreased significantly except when they
are referred to the mucosal DNA content. The effect of the reference
system on changes in absorption rates following the food restriction
regime is less dramatic. However, whilst there is a significant
decrease in absorption by the whole small intestine, none of the
other three reference systems reflect this effect (Fig. 8.12).
Levin et.al (1965) showed that the direction of change of enzyme
activities as a result of starvation can even be reversed by use of a
different reference system. The total peptide hydrolase activity
against L-Leu-Gly was decreased on an absolute basis in ra.ts after a
3 day fast but there was an increase when the activity was referred
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to unit wet weight of intestine'. Food restriction or starvation can
cause a decrease in absorption rates when referred to the whole or a
specific length of the small intestine or, in contrast, an increase
when expressed on a weight basis (Kershaw et al, I96O; Levin, 1970;
Lis et al, 1972; Newey et al, 1970). Newey et al (1970) and Lis et.
al (1972) have discussed the possibility of obtaining misleading
results when absorption rates are expressed on a, weight basis. Newey
et al (l970) point out that although the absorption rate referred to
intestinal weight is increased in fasted animals this is of no
importance to the rat in vivo, since the total weight of the
intestine is decreased. Lis et al (1972) stress the difficulty in
comparing results from studies of the effects of starvation on
intestinal absorption due to the use of different reference systems.
They conclude that since the length of the small intestine is not
affected by starvation, it is a more suitable reference basis than
intestinal weight. The results presented in this chapter agree with
this conclusion since both food restriction and 5-flnorouracil
injection affect the intestinal dry weight and mucosal MA content
and changes in absorption referred to these two reference systems do
not reflect the changes in the total absorptive capacity of the small
intestine. Absorption per whole small intestine is a useful index,
especially when seeking the overall effect on physiological function.
Nevertheless, Gardner and Heading (1979) reported that the length cf
the intestine was reduced by 5-f-luorouracil. Although this effect
was not confirmed in this study the observation of Gardner and
Heading (l979) detracts from the value of expressing absorption
rates in terms of unit length.
CHAPTER 9
Plasma, pharmacokinetics of the Tris and sodrum salts of 5~fluorouracil
in the rat
Introduction
The differential toxicities of the Tris and. sodium salts of
5-fluorouracil were described in the previous chapter (Chapter 8).
It became clear that administration of the Tris salt of
5-fluorouracil was associated (particularly) with an obvious general
malaise which was seen in all rats, significant mortality (l6%) and
pancreatic lesions. In contrast, no such toxicity was associated
with the sodium salt of 5~fluorouracil.
There are many examples of differences in the bioavailability*
and therapeutic response between various commercial preparations of
the same drug (Bowman and Rand, 1980), but such a marked difference
in the systemic toxicities of two forms of the same drug is uncommon.
Although there are well defined guidelines to the pharmaceutical
industry for testing new medicinal products (e.g. A.B.P.I. 1977)»
the differential toxicities of the two salts of 5-fluorouracil
appear not to have been detected. It was, therefore, of great
interest to determine the nature of the difference in the systemic
toxicities of the two salts.
* The bioavailability of a drug refers to that quantity of the
administered dose which arrives in a suitable form and concentration
at the sites within the body where it will exert its biological
effect.
A difference in the bioavailability or simply in the rate of
absorption of the Tris and sodium salts of 5~fluorouracil might
explain the different systemic toxicities observed following
administration of each salt. Therefore a method was developed to
study the plasma pharmacokinetics of the two salts of 5~fluorouracil
in the rat.
Blood sampling
The removal of a number of blood samples from the conscious rat
presents a major problem because of the lack of accessible blood
vessels. 'Tail-snips' are commonly used to obtain small blood
samples but this method is unsuited to pharmacokinetic studies
since the bleeding cannot be controlled and there is no opportunity
for fluid replacement. A significant change in the blood volume is
undesirable since it will interfere with the pharmacokinetics.
Therefore blood sampling was carried out on the anaesthetised rat
via a cannulated blood vessel. Although anaesthesia may affect the
pharmacokinetics of 5-fluorouracil, the studies were simply
comparative between the two salts, and so this was not considered to
be an overriding disadvantage. The carotid artery was chosen for
cannulation because it is a large vessel (about 0.5 mm diameter),
is easily located and is able to withstand reasonably rough handling.
An artery is preferable to a vein since the arterial pressure aids
blood sampling and since veins tend to collapse around the cannula.
The withdrawn fluid was replaced immediately with heparinized saline
both to keep the cannula patent and to maintain the blood volume.
The preparation was viable for around 4 hours. However, after
injection of the Tris salt of 5~fluorouracil, mortality was high
during the third and fourth hours and few animals survived the 4 hour
experimental period; after injection of the sodium salt of
5-fluorouracil most animals survived for at least 200 minutes.
This mortality was presumably due to a combination of the toxic
effects of 5-fluorouracil, anaesthesia and surgery. However, the
deaths did not appear to interfere with the pharmacokinetic studies;
in retrospect, the plasma levels of 5-fluorouracil were similar in
rats that died and in those that survived (see Fig. 9.6).
Estimation of plasma 5-fluorouracil
There are several methods available for determination of
5-fluorouracil at low concentrations (ng/ml) in plasma. However,
these methods are complex and most involve the use of high pressure
liquid chromatography or gas-liquid chromatography. These two
techniques were not available and are not easily developed. The
high pressure liquid chromatography technique used in the University
Department of Clinical Pharmacology in the Royal Infirmary,
Edinburgh, had already been abandoned because of such difficulties.
Gustavsson et al (1979) published an isotacophoretic method for the
estimation of 5-fluorouracil, but this too is complex and time
consuming. De Leenheer et al (1974) reported a simple column
chromatographic method for the estimation of plasma 5-fluorouracil
concentrations in which 5-fluorouracil is separated from plasma
proteins on a 'Sephadex' G10 column and 5-fluorouracil is determined
in the eluent simply by its UV absorbance at 266 rim. This method
was investigated and proved to be very successful; recoveries of
5-fluorouracil from the column were good (96%) and 5-fDuorouracil
estimations were reproducible (C.V. 3.2%, n = 10). However, the
method had two characteristics which made it unsuitable for use in ■
this study. The sensitivity was low such that the pharmacokinetic
study would involve removal of 25% of the total blood volume of the
rat. Also, each estimation took over 4 hours to complete.
Therefore a method was developed in which plasma samples were
deproteinized by ultrafiltration through an 'Ultrafree* drug filter
(Millipore (U.K.) Ltd., London) before measurement of absorbance at
267 nm. The filters, described below, are normally used to determine
free, as opposed to bound, anticonvulsant drug concentrations in
plasma. Control experiments and recovery experiments indicated the
general suitability of the method. Furthermore, estimations could
be made on as little as 0.3 ml of blood and in only 30 minutes.
Therefore this method was adopted.
Pharmacokinetic studies
Plasma concentrations of 5-fluorouracil were determined during
the first 4 hours after an intraperitoneal injection of either salt
of 5-fl'aorouracil. Since the plasma concentrations of 5-TTuorouracil
after an intraperitoneal injection are determined both by the rate of
absorption of the drug into the blood stream and by the rate of
clearance of the drug from the blood, clearance was studied
independently after an intra-arterial injection of each salt of
5-fluorouracil.
The results from this investigation have been accepted for











Fig. 9*1 apparatus used for cannulation of the carotid artery.
A section of tubing (about 10 cm) cut from a Bradley miniature
catheter is connected via a short section of flexible tubing and a
blunt needle to a 10 ml syringe. The syringe and the dead space of
the tubing is filled with about 5 ml of heparinized saline and when
in position in the artery, the arterial pressure is opposed by a




Female rats, weighing 195 - 205 g>* were anaesthetised 1 hour
before use by subcutaneous injection of urethane (l.2 ml of
0.8 mg/ml solution) while under temporary light ether anaesthesia.
With the rat supine on a pad of cellulose wadding B.P.C. ('Cellosene'
supplied by Robinsons of Chesterfield) and head nearest the operator,
a small area (about 1 cm square) of the neck skin was raised with
forceps and excised. The subcutaneous tissue was dissected apart
with forceps to reveal the salivary glands and neck muscles. The
left carotid artery was located by blunt dissection beneath the
sternohyoideus and omohyoideus muscles and adjacent to the trachea.
The artery was separated from the nerve by blunt dissection with
two pairs of forceps. A loop of fine thread (Dewhurst 'Silko' 50)
was passed under the carotid artery and the loop cut. Two loose
ligatures were tied and one placed at each end of the exposed section
of the artery. One was tightened at the distal end of the isolated
section. The artery was clamped proximally, about 1cm from the
distal ligature, with a pair of fine artery forceps which had short
sections of PVC tubing over the clamps to prevent damage to the
artery. The cannula comprised of a short section (about 10 cm) of
tubing cut from a Bradley miniature catheter (Portex) about 0.5 mm
diameter (see Pig. 9«l)* One en^ was bevelled at an angle of 45°
and the other was connected via a short section (about 5 cm) of
"x" Por these studies alone, special care was taken to use rats of
particularly similar weights.
'Tygon' FVC pump tubing (Technicon) and a blunt needle to a 10 ml
syringe. The syringe was filietT with 5 ffll of heparinized bicarbonate
saline (o.l g sodiuxa heparin, Sigma Grade 1, in 20 ml of a solution
containing 120 romol/l NaCl and 25 mmol/l WaHC0v). A small amount
was expressed into a beaker of saline with the open end of the
cannula below the surface of the liquid. Once the entire cannula was
filled with saline, the tip of the cannula was removed slowly from
the saline so that the meniscus was held at the tip of the cannula.
This ensured that no air was injected into the artery upon
cannulation. The isolated section of the artery was supported by a
pair of open dental packing forceps and a tiny incision was made in
the artery wall, close to the distal ligature, with a pair of fine
sharp scissors held at an angle of 45° to the length of the artery.
The cannula "was passed into the artery with the aid of the bevelled
tip and a tight ligature was tied around the artery and cannula.. The
clamp was then removed and the arterial pressure opposed by pressure
on the syringe plunger, although no saline was injected at this
stage. The artery forceps were then clamped round the short section
of flexible tubing on the cannula to prevent blood flow.
The neck incision was then covered by a small piece of
'Cellosene' dipped in saline and the rat was kept warm with an
overhead lamp. Arterial cannulation was accomplished in less than
5 minutes.
Blood sampling
Blood samples were taken from the carotid artery via the
cannula. The 10 ml syringe was replaced by a 1 ml syringe in which
the dead space had been filled with heparinized saline, the clamp
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was removed and 0.3 ml of blood withdrawn. The blood sample was
heparinized with the heparin already present in the cannula and in
the dead space of the syringe (about'0.05 ml and it was the same for
all samples). The clamp was then replaced, the syringe removed, and
the 10 ml syringe replaced with its eccentric luer fitting downwards.
The clamp was again removed and the syringe plunger withdrawn gently
to remove the inevitable air bubble from the cannula. About 0.3 ml
of heparinized saline was injected via the cannula and the clamp was
replaced. The whole procedure could be carried out in about
5 seconds.
A clamp on the cannula to allow blood sampling was chosen in
preference to a tap. This method has the advantage of a very small
dead space which was essential in view of the small size of the
blood samples.
5-ffLuorouracil administration
The Tris salt of 5-fluorouracil was diluted 1:1 with the Tris
placebo just before use .so that equal volumes of the Tris and sodium
salts were administered. The effect of administration volume is not
known but it may be important, especially since the replacement
saline did not contain colloid.
(a) Intraperitoneal injection. Preliminary studies indicated
a need to minimise variability in the site of injection and a need
to avoid injection into the intestine. Therefore 5-flu-orouracil
was administered via a laparotomy. The position was standardised to
the middle of the lower left abdomen. A small piece of skin was cut










Pig. 9.2 Ultrafiltration of plasma samples through an 'TJltrafree'
filter. A 1 ml syringe, with the plunger as far into the syringe as
it will go, is attached to the luer fitting in the base of the
filtration unit and the unit is placed in the 'Ultrafree' stand.
The plasma sample is poured into the cup and allowed to diffuse into
the membrane fop about 2 minutes before the syringe plunger is with¬
drawn maximally and clamped into the lower part of the stand. The
negative pressure produced in the syringe draws the filtrate through
the membrane and into the syringe. Approximately 20 minutes is
required for production of 1 ml of ultrafiltrate.
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St. Louis, U.S.A.) angled towards the centre of the diaphragm.
5-fluorouracil (l.44 mmol/kg body weight) was injected via the
cannula and the cannula withdrawn. The skin was closed by a single
stitch.
(b) Intra-arterial injection. 5-fluorouracil (0«576 mmol/kg
body weight, i.e. 0.6 ml/rat) was administered via the carotid artery
cannula. The 5-fluorouracil injection was followed immediately by
0.2 ml of heparin!zed saline to wash out the cannula.
Injection via the sampling cannula is not ideal but was
preferable to the alternative of a second arterial cannulation. It
was justifiable in this instance because the carotid artery was
cannulated close to the branch from the aorta. Thus all of the
injected drug enters the aorta and should be rapidly dispersed
throughout the blood volume.
Estimation of 5-fluorouracil
Blood samples were transferred to 4 ml capped plastic tubes and
centrifuge! at about 4000 g for 5 minutes at room temperature in an
M.S.E. bench centrifuge. 5-fluorouracil was determined by the
absorbance at 267 nm after ultrafiltration of the plasma, diluted at
least ten-fold with pH 7.0 potassium phosphate buffer (291 ml 0.1
mol/l NaOH + 500 ml 0.1 mol/l KH P0 as used in the method of De
c. *-{-
Leenheer et al (1974) for the column chromatography of 5~f-luorouracil)
through an 'Ultrafree' filter (see Pig. 9-2 for details). Control
plasma treated in this way showed no absorbance at 267 nm read
against a blank of the potassium phosphate buffer. The buffer was
used to standardise the pH at which absorbance was determined.
Absorbance. was measured in a 'Unlearn' SP5OO spectrophotometer.
5-Fluorourac:L~l calibration curve
A calibration curve was prepared for each salt of
5-fluorouracil in the range 2.5 - 12.5 ng/ml (0.019 - O.O96 umol/l)
in pH 7.0 buffer. The curve was linear in this range (fig. 9-5)
there was no difference between the two salts. The concentrations
of 5-Uluorouraeil in samples were determined from the first order
regression line of the calibration curve.
Recovery of 5-fluorouracll from plasma
A calibration curve was prepared from a stock solution
containing 250 ng 5-fluorouraci1/ml plasma. The samples were ultra-
filtered and the absorbance, measured at 267 nm, were compared with
those from plasma free samples. The results for the sodium salt are
shown in Pig. 9-4. The total recovery was 99*5% - 3-9% (n = 5). A
similar value was obtained for the Tris salt (99•1% - 4-1% n = 5) •
5~fluorouracil (ng/ml, sodium salt)
Fig. S«3 Calibration curve for assay of 5-fluorouracil in the
ultrafiltrate of plasma. Absorbance was measured at 26f nm with a
1 cm light path. The first, order regression line has been drawn


























Pig. 9.4 Recovery of 5-fluorouracil from plasma. Calibration
curves were prepared from a stock solution of 5-flnorouracil and from
a stock solution containing 250 ng 5-fluorouracil/ml plasma. The
absorbance of the latter samples after ultrafiltration (ordinate)
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Pig. 9.5 Plasma levels of 5-fluorouracil after intraperitoneal
injection of either the sodium salt (©) or the Tris salt (o) in
anaesthetised female rats. Values are the mean - S.E.M. and the
number of observations is shown adjacent to each point.
RESULTS
Intraperitoneal injection
Rig. 9.5 shows the plasma levels of 5-flnorouracil over the
first 240 minutes following- a single intraperitoneal injection of
either the Tris or the sodium salt of 5-fluorouracil. Plasma levels
of 5-fluorouracil were consistently higher after injection of the
Tris salt than after injection of the sodium salt, although this
difference was only just significant, by a 't test', at the
individual points corresponding to 100, 150 and 200 minutes after
injection (p-«c0.05). However, the fact that at each of the sampling
times the plasma 5-fluorouracil concentration was greater after
administration of the Tris salt than after administration of the
sodium salt indicates that there is a real difference between the
two curves. This has been tested by a statistical test which
combines the probabilities of all observations in an overall test of
the significance of the difference between the two curves (Fisher,
1967) and, indeed, the difference is significant (P=0.02).
The number of observations decreased with time, especially after
administration of the Tris salt of 5~fluorouracil, due to deaths
during the experiment. It is possible that mortality might have been
systematically associated with higher plasma 5-fluorouracil levels.
Therefore the results shown in Fig. 9*5 were replotted as a series
of curves, each representing the mean plasma levels observed in a
group of rats, each of which survived for longer than a specified
period (Fig. J.6). Removal of observations in this manner had no
significant effect on the mean plasma levels of 5-fluorouracil,














































© all animals n=15
a those that survived > 20 min n=14
+ those that survived > 60 min n =11
g those that survived >100 min n=6
x those that survived >150 min n=3
60 80 100 120
Time after 5-fluorouracil i.p. injection (minj
Fig. 9.6 Plasma levels of 5-fluorouracil after intraperitoneal
injection of the Tris salt of 5-fluorouracil. The results shown in
9-5 have been re-plotted to exclude animals that died a.t
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Fig. 9.7 Plasma levels of 5-fluorouracil after intra-arterial
injection of either the sodium salt (©) or the Tris salt (o) in
x +
anaesthetised female rats. Values are the mean - S.E.M. and each




Pig. 9*7 shows the plasma levels of 5-fluorouracil during the
first 60 minutes after intra-arterial injection of the Tris or the
sodium salt of 5-fluorouracil. Plasma levels of 5-fluorouracil were
very similar at all times after injection of the two salts of
5-fluorourac.il. There was a very rapid clearance of 5-fluorouracil
during the first 10 minutes and the estimations of plasma levels of
5-fluorouracil during this period were associated with high
variability. Plasma levels of 5-fluorouracil decreased very slowly
over the next 50 minutes.
The curves shown in Pig. 9*7 can be described by the sum of two
exponentials. Pig. 9*8 shows the separation of these two exponential
for the Tris and sodium salts. The natural logarithm of the plasma
5-fluorouracil concentration is plotted against the time after
injection of 5-fluorouracil (e). The parameters of the exponential
term v.dth a slow rate constant were obtained from the regression line
through the last four points for each curve. By extrapolation of the
exponential back to time 0, the expected plasma concentrations of
5-fluorouracil for the first three or four observations were
calculated. These values were subtracted from the observed plasma
concentrations and the natural logarithm of the differences plotted
in Pig. 9-8 (A)* The regression line through these points gave an
estimate of the parameters of the second exponential term. These
were not very reliable due to the small number of points.
This method produced the following two equations for the curves:
Tris salt; plasma 5-fluorouracil = 131*3 e + 787*3 e ^
concentration
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Pig. 9-8 Separation of the two exponential functions which
describe the results shown in Pig. 9«7* The natural log of the
plasma 5-fTuorouracil concentration is plotted against the time
after injection of 5-fluorouracil (©). The parameters of the
exponential term with a slow rate constant were obtained from the
regression line through the last four points for each curve. By-
extrapolation back to time 0, the expected plasma concentrations of
5-fluorouracil for the first 3 (Tris salt) or 4 (sodium salt)
observations were calculated. These values were subtracted from the
observed plasma concentrations and the natural log of the difference
is also plotted (a). The regression line through these points gives
an estimate of the parameters of the second exponential term.
)
-14- r 4--1 ' -1 i -a r -O.oost r/ -0.48tsodium salt; plasma p-fln-orourac.il = I48.6 e + (yO.[ e
concentration
and the two half lives for the Tris salt were 1.8 and 99 minutes
and for the sodium salt were 1.4 and 86 minutes.
Curve fitting
An attempt was made to analyse the results obtained after intra¬
arterial injection of 5~fluorouracil by curve fitting with the aid
of a digital computer program for fitting the sums of decaying
exponentials by non-linear regression analysis. The program,
described by Atkins (l97l)» requires initial estimates of the para¬
meters and uses an iterative procedure to adjust the parameters until
the sum of squares of residuals has converged to a minimum. The
program was run on the ICL 2980 computer at the Edinburgh Regional
Computing Centre. The data were entered unweighted and the following
best-fit equations were obtained:
Tris salt;
plasma 5-fluorouracil = (178.6 - 19«5)e ~ 0.005)t
concentration /_ 07[_ + .
+ (1579-9 ± 23.5)<T(°-855 - 0-045)1
sodium salt;
plasma 5-fluorouracil = (155*6 - 8.4)e (^.011 - 0.002)t
concentration /_ ,ne. +
+ (1582.2 ± 8.4)e - 0-0n^
and the two half lives for the Tris salt were O.85 and 53*7 minutes
and for the sodium salt were 1.1 and 64.8 minutes.
These parameters compare moderately well with those obtained
by the graphical method and both methods demonstrate the similarity
between the plasma pharmacokinetics of the Iris and sodium salts of •
5-fluorouracil after intra-arterial injection.
An attempt to analyse the results obtained after an intra¬
peritoneal injection by curve fitting was unsuccessful, thus




That the Tris and sodium salts of 5~-tluorouracil have such
remarkably different systemic toxicities in the rat was both
interesting and puzzling. This observation suggested either that
the cytotoxicity of the Tris salt was greater than that of the sodium
salt or that the two salts of 5-fl'uorouracil were associated with •
different pharmacokinetics.
Therefore, the plasma pharmacokinetics of the two salts have
been studied and, indeed, there is a difference after intraperitoneal
injection. Higher plasma levels were achieved and sustained after
injection of.the Tins salt than after injection of the sodium salt
of 5-fluorouracil (Fig. 9*5) and this difference was significant
(Pc.0.02).
In contrast, when 5-fluorouracil was administered by the intra¬
arterial route, the pharmacokinetics of the two salts were very
similar (Fig. 9*7)• Clearance of 5-fluorouracil from the blood can
be described by a two-exponential equation combining a very rapid
clearance with a much slower process. Similarly, Kirkwood et al
(1980) and Finch et al (1979) have reported that plasma clearance of
5-fluorouracil after intravenous injection in the human could be
described as a biexponential decay function. As in the rat, the
clearance of plasma 5-flf.orouracil in the human involved a rapid
(t^ =7*8 minutes) and a slow (ti = 36.8 minutes) process. Rough
2 • 2
estimates were obtained for the two half lives of these processes
in the rat and these were of the same order as those in the human
(about 1.6 and 93 minutes or 0.97 and 59-3 minutes depending on the
method used). However, since Finch et al (1979) demonstrated that
that the- plasma kinetics of 5~flrorouracil are dose dependent direct
comparisons must not be made.
The dose dependence of the pharmacokinetics cannot explain the
difference between those of the Tris and sodium salts of
5-fluorouracil, since identical doses were used and since the
difference was apparent only following intraperitoneal injection of
the drug. That the difference was seen following intraperitoneal
injection arid not after intra-arterial injection also confirms that
the difference was a real one, and was not due to some characteristic
of the technique used to study the pharmacokinetics.
Since the clearance of 5-fluorouracil from plasma after intra¬
arterial injection was independent of the salt of 5-flnorouracil
administered, the difference observed after intraperitoneal injection
was probably due to a more rapid uptake of the Tris salt from the
peritoneal cavity rather than due to a slower clearance of the Tris
salt from the blood. Drug absorption from the peritoneal cavity may
occur by diffusion of the non-ionised form of the drug across the
lipid membrane of cells. Therefore, it may be relevant that Tris
base is a weaker base (pKa = 8.1 at 25°C - Dawson et al, 19^9 ) than
sodium hydroxide. Hence the Tris salt of"5-fluorouracil is likely to
be less dissociated, and thus may permeate some membranes more
rapidly according to current theories of non-ionic diffusion
(Rowland, 1972). In this respect it may be relevant that the Tris
and sodium salts were administered at a slightly different pH; that
of the Tris salt was 8.8 and that of the sodium salt was 9-1
(Chapter 8, Table 8.3), and this might have influenced the
dissociation of the two salts. However, the pH of the peritoneal
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fluid is maintained by the buffering capacity of the blood and it is
probable that the pH of the injected fluid would be rapidly equi¬
librated with that in the peritoneum. Nevertheless, it would have
been preferable to have administered the two salts at exactly the
same pH as well in order to eliminate this possibility,
These•observations suggest two possible explanations for the
differential toxicities of the two salts of 5-f-luorouracilt
(1) The higher plasma levels of 5-fluorouracil after
intraperitoneal administration of the Tris salt
might explain directly the differential toxicities
of the Tris and sodium salts of 5-fluorouracil; or
(2) There is a fundamental difference between the
properties of the Tris and sodium salts of
5-fluorouracil, and that it is a property of the
Tris salt per se that is responsible for the
severe systemic toxicity and mortality associated
with its use. .
The first alternative would imply that this differential
toxicity would not be seen with intra-arterial or intra-venous
dosage - the routes generally used in clinical practice. In this
case these observations, although interesting, would not be relevant
to clinical chemotherapy. On the other hand, Speyer et al (198O)
(see also Dedrick ejfc al, 1978) have advocated the use of
5-fluorouracil in peritoneal dialysis in the chemotherapy of various
metastatic tumours; the observations discussed above would be
relevant to this method of administration of 5-fluorour'acil in
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humans. However, mortality and the systemic toxicity of the Tris
salt were equally severe when the dose was reduced from 1.44 mmol/kg
body weight to 1.08 mmol/kg (Chapter 8, Fig. 8.8). Since Speyer et
al (i960) showed that the rate of clearance of 5-fluorouracil from
the peritoneal cavity is directly dependent upon the concentration
of 5-fluorouracil in the peritoneal fluid, this alternative is
considered to be unlikely. Observations on the systemic toxicities
of the two salt forms following intra-arterial or intra.-venous
administration are required before a definite conclusion can be
drawn.
It is therefore possible that there is a fundamental difference
between the properties of the Tris and. sodium salts of 5-fiuorouracil.
The results suggest faster uptake of the Tris salt across the
peritoneum; the same may be true of some other membranes, although
it is not true for the overall tissue uptake, since differences in
plasma clearance were not seen after intra-arterial administration.
However, this might explain the pancreatic damage observed
specifically after administration of the Tris salt of the drug
(Chapter 8).
It is important that the cause of the differences between the
Tris and sodium salts of 5-fluorouracil is resolved, especially
since the clinical use of 5-fluorouracil is severely limited by the
toxic side effects of the drug. Although the Tris salt of
5-fluorohracil is no longer in clinical use, these observations on
the differential toxicities of the two salts may be of relevance to
the clinical use of 5~fluorourao.il, especially in the U.K. where
the sodium salt ha,s only been in use since 1978- Much of the
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knowledge of the side effects of 5-fluorouracil has, therefore, been
gained from experience with the Tris salt of 5-fluorouracil, and this
may not apply to the sodium salt.
CHAPTER 10
Can 'elemental' diets reduce the Intestinal toxicity of
9-fluorourac.il?
Introduction
So-called 'elemental' diets originate from efforts to produce a
chemically defined diet, composed of relatively simple nutrients
requiring minimal digestion, that would nevertheless enable humans
to grow, reproduce and maintain a satisfactory nutritional status.
This was first achieved by Rose and his associates in the late 1940's
with a diet composed, of corn starch, sucrose, butterfat, com oil,
inorganic salts, vitamins and hydrolysed casein (Rose, 1949; Rose
and Wixom, 1955)* These diets are not 'elemental' in the strict
sense; some people prefer to use the term 'chemically defined diets'
but this, too, is not correct for diets containing partial, e.g.
enzymic, hydrolysates of protein.
The American aerospace programme initiated great interest in the
development of 'elemental' diets as a possible source of nutrition
for astronauts; hence the references to 'elemental' diets as 'space-
diets'. These diets have a high nutritional value and therefore only
small amounts are required daily, an important consideration where
storage space and weight are limited. Also, the low residue of the
diets considerably reduces the faecal output and thus reduces the
problems of waste disposal.
The composition of 'elemental' diets is very flexible and in
theory can be adjusted to suit any specific nutritional, requirements.
Several 'elemental' diets are commercially available in the U.K.;
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two are used on a large scale and, therefore, have "been used in the'
present work. These are 'Flexical' (Mead-Johnson, Bristol
Laboratories, Langley, Slough, U.K.) and 'Vivonex-standard' or
'Vivonex-HN' (Eaton Laboratories, Woking, Surrey, U.K.) and they
differ markedly in their composition - see below. Two others,
'Pregestimil1 and 1 Hutramigen! (both Mead-Johnson) are fornrula.ted
for use in infants.
Since it is now known that both amino acids and small peptides
are absorbed from the intestinal lumen by independent mechanisms
(Craft et al, 1968; Asatoor et al. 1970; Matthews, 1972; Milne,
1972) and that the absorption of some amino acids may be more rapid
when they are presented as small peptides rather than as free amino
acids (Matthews, 1975; Silk, 1977) it is not necessarily an
advantage to include only free amino acids in 'elemental' diets. In
the human, similar proportions of each of the-constituent amino
acids are absorbed from an enzymic hydrolysate of casein, but the
proportions differ when the hydrolysate is replaced by an amino acid
mixture simulating casein (Silk, 1977)- Also there is evidence which
suggests that the growth rate of animals, is not as good on mixtures
of free L-amino acids as on protein with the same amino acid
composition (Fisher, 1954j P- 104). Furthermore, enzymic hydro¬
lysate s exert a. lower osmotic pressure than equivalent solution of
free amino acids and thus are less liable to cause the 'dumping
syndrome'. It is possible, therefore, that 'elemental' diets
should contain an enzymic hydrolysate as the nitrogen source
rather than only free amino acids.
The compositions of the two commercially available 'elemental'
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diets used in this study are very different. A comparison of the
distribution of calories between carbohydrate, fat and amino-nitrogen
of 1Vivonex-standard1, Vivonex-EN and. 'Flexical' is shown in
Table 10.1. Fr.ee amino acids are the nitrogen source in the two
Table 10.1 A comparison of the compositions of 'Vivonex',
'Vivonex-BIT' arid 'Flexical'
% of total calories
Component 'Vivonex' 'Ylvonex-HH' 'Flexical1
Carbohydrate 90.2 81.0 61.0
Free amino acids 8.5 18.3 6.3
Small peptides 0 0 2.7
Fat 1-3 0.8 30.0
'Vivonex' formulations, representing either 8.5% of the total
calories in 'Vivonex-standard1 or 18.3% in 'Vivonex-HK'. In
'Flexical' 9•0% of the calories are supplied, by an enzymic hydro-
lysate of casein in which 70% of the nitrogen is present as free
amino acids and 30% as small peptides. The size of the peptides is
not specified 'but they are dialysable and are probably between 2 and
4 amino acids. All but 1% of the rest of the calories in 1Vivonex'
are supplied by carbohydrate in the form of glucose and small
oligosaccharides. The remaining 1% of the calories are present as
highly purified safflower oil (80% as triglyceride of linoleic
acid). 'Flexical', in contrast, contains much less carbohydrate,
6l% of the total calories, in the form of sucrose and small oligo¬
saccharides and contains a large amount of fat, 30% of the total
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calories. Of the fats present, soy oil, soy lecithin and medium
chain triglycerides, the latter-do not require micelle formation
and therefore, in principle, should be easily absorbed (Kaunitz,
197l)- To-date, however, there have been no direct comparative
studies of the two diets, and so there is no evidence to suggest
that either diet has a clinical advantage over the other.
The diets are supplied as dry powders and are consumed as a
solution or suspension in water, as a jelly or as a solution in
water frozen to form a solid 'ice'. A variety of flavours can be
added to the diets but, as stated by Pestana (1977> P- 141)» these
"modify only slightly the basic taste of rotten fish" due to the
presence of some free amino acids and peptides. Because of this
many patients find the diets intolerably unpalatable and this
apparently was the rea.son why they were abandoned as the source of
nutrition for astronauts (Koretz and Meyer, 198O). In order to
overcome unpalatability of the diets they may be fed by a naso¬
gastric tube, but this too is unpleasant and can be associated with
problems such as aspiration. At the standard dilution the diets
have a very high osmolarity (840 mOsm/l for 'Yivonex-HN') due to the
high content of low molecular weight carbohydrate and this can
result in several undesirable side effects such as nausea,
diarrhoea, delayed gastric emptying and the 'dumping syndrome',
especially in susceptible individuals. The osmolarity of the diets
can be reduced by replacement of monosaccharides by disaccbarides
or small oligosaccharides, or by further dilution of the diet. The
latter method has the disadvantage of increasing the volume of diet
to be consumed. One of the main complications of the use of
'elemental' diets is reported to be involved with the osmolar load
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and the rate of administration of the diet (Young et al, 1975).
Clinical trials with 'Flexical' and with diets similar to
'Yivonex' suggest that humans can he maintained in good health for
periods of at least 22 weeks with no apparent adverse effects
(Perrault et al, 1973? Winitz et al, 1970)■ However, there have
been reports of pancreatic damage and haemolytic anaemia, when
'elemental' diets containing free amino acids were fed to rats for
prolonged periods (Geever et al, 1970; Levenson et al, 1971)•
Since damage was not observed in rats fed on 'elemental' diets
containing enzymic hydrolysates of protein, this suggests that
there is an advantage from inclusion of peptides in 'elemental'
diets, although it is hard to provide a rational explanation.
Many patients with a number of acute and chronic diseases and
many undergoing surgery develop a negative nitrogen balance due to
a high rate of protein catabolism (Cuthbertson, 193&; Moore, 1959)-
Intravenous administration of mixtures of hydrolysed protein and
glucose has been used with considerable success during the surgical
treatment of many diseases (hudrick et al, 1968; hudrick and
Rhoads, 197l). However, intravenous administration of nutrients
requires a central catheter, is costly and is associated with the
risks of sepsis due to the intravenous catheter and with metabolic
acidosis. Therefore successful enteral nutrition in such patients
would have considerable advantages. Recently 'elemental' diets have
been used in a number of clinical conditions. The diets can be fed
orally and their 'elemental' nature should enable their use when the
digestive process is severely impaired. They are absorbed almost
entirely by the upper small•intestine such that only the endogenous
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residue (normally minimal) enters the large intestine.
Nutritional support from 'elemental' diets has been reported
to benefit the recovery of patients with various gastrointestinal
diseases such as acute inflammatory bowel disease and other
diarrhoeal conditions and gastrointestinal fistulae (Bode and
Hendren, 1970; Bury et al, 1969; Goode et al, 1976; Grundy, 1971;
Pincus et al, 1971; Rocchio et al, 1974; Stephens and Randall, 1969;
Voitk et al, 1973a; Wolfe et al, 1972). 'Elemental' diets have
also been reported to provide adequate nutrition to patients who
have undergone extensive gut resection where there is insufficient
gut remaining to cope with the digestion and absorption of
conventional foods (Thompson et al, 1969; Voitk et al, 1975b;
Weinberger and Rowe, 1973). Furthermore, nutrition via the gastro¬
intestinal. tract may well be preferable to parenteral nutrition in
these patients since the presence of food in the gut is said to be
a necessary stimulus for mucosal growth following resection
(Feldman et al, "1974). Since 'elemental' diets do not require the
action of pancreatic proteases these diets have been used for the
nutritional support of patients with pancreatic insufficiency or
pancreatitis where the production of pancreatic proteases is
reduced (Pincus et al, 1971; Stephens and Randall, 1969; Voitk,
1973c). Also, it has been suggested that the intra-jejunal use of
'elemental' diets avoids stimulation of pancreatic secretion and
that this is favourable in the treatment of pancreatitis (Ragins et
al, 1973).
In general, few of the uses discussed above have been assessed
in adequate trials including appropriate controls and therefore
little can be concluded as t'o the real benefits, if any, of the use
of 'elemental' diets in these patients. However, controlled studies
have been carried out to determine whether the low residue nature of
the diets is useful in colonic preparation for colonoscopy (league
et al, 1973) or as a general bowel preparation (Cooney et al. 1974;
Gurry and Ellis-Pegler, 1976; Johnson, 1974; Matheson et al. 1978;
Tomlinson et al, 1976). All of these studies concluded that there
was no advantage in the use of 'elemental' diets instead of the
conventional method for bowel preparation.
In 1967 Bounous and his associates suggested a novel application
of 'elemental' diets in the prophylaxis of experimental haemorrhagic
shock and intestinal ischaemia (Bounous et al, 1967). The
implications of this application (see below) are important and have
attracted a great deal of attention. Bounous .et al (1967) suggest
that during the digestion and absorption of normal food the
intestine is highly susceptible to ischaemia, and that an 'elemental'
diet reduces this susceptibility.
Subsequently, Bounous et al (l971a) went on to claim that the
intestinal damage observed on the first few days after administrat¬
ion of the antimetabolite 5-fluorouracil in rats was markedly reduced
when the rats were fed on an 'elemental' diet. Three days after
5-fluorouracil administration the intestines from control rats, fed
on a standard diet, showed total atony throughout the entire length,
oedema, congestion and extensive necrosis. In contrast, those from
rats fed on the 'elemental' diet showed normal, tonicity in most
cases with no oedema and the villi were preserved. The weight loss
normally observed after 5-fluorouracil administration "was not
observed in rats fed on an 'elemental' diet. Bounous et al (l971a<)
sxiggested that the diet is of benefit to the intestine during
recovery from injury rather than in reducing the severity of the
injury. This seemed to be plausible since intestinal cells are
reported to incorporate into protein amino acids absorbed from the
lumen to a greater extent than amino acids supplied systemically
(Hirschfield and Kern, 1969). Since Bounous et al (1971a) reported
a decrease in peptide hydrolase activities in the intestinal mucosa
on the first day after 5-flnorouracil administration they suggested
that the supply of amino acids to the mucosa from an urihydrolysed
diet would be severely limited. On the other hand, an 'elemental'
diet supplies amino acids directly to the mucosal cells without the
need for digestion.
The intestinal damage resulting from irradiation is similar to
that after 5-flnorouracil administration (Robinson, 1972). Hugon
and Bounous (1972) claimed that the same 'elemental' diet provides
a beneficial effect to the animal during irradiation. They showed
that the 30 day survival of mice, following whole body irradiation,
was increased when mice were fed on an 'elemental' diet; at high
doses of irradiation (lO Gy) this benefit .was not observed. They
also claimed that at lower doses of irradiation (7 Gy) the
'elemental' diet stimulated a more rapid recovery of the intestinal
mucosa. However, histological evidence indicated that the
'elemental' diet did not protect crypt cells from irradiation damage
but may have protected the villus cells.
The 'elemental' diet '^lexical' was developed from Diet 3200-AS
used by Bounous et al (l971h) and was used in clinical trials
(Bounous et al, 1971b) before being marketed. A number of patients
with advanced metastatic .carcinomas of the gastrointestinal tract,
lung or breast were fed either on normal hospital food or on
'Flexical' for 4 days before and during 5-Bluoroura-cil chemotherapy.
Patients fed on the 'elemental' diet did not suffer any weight loss
nor the rectal lesions seen in patients given normal hospital food.
5-Fluorouracil administration in rats is followed by severe
impairment of intestinal absorption of both glucose and water and of
cytoplasmic peptide hydrolase activities'(Gardner et al, 1978;
Levin, 1968). When the normal diet was replaced by one of a number
of 'elemental' diets, both commercial and home-made, the intestinal
toxicity of ^-flu-orouracil was of similar severity to that observed
in the control rats, fed 011 a standard diet, from which Gardner and
Heading (1979) concluded that a direct effect on intestinal
absorption could not account for the beneficial effects of
'elemental' diets claimed by Bounous et al (1971a)* However,
Bounous and Maestracci (197&) noted that it is the replacement of
intact protein by a protein hydrolysate in 'elemental' diets that is
responsible for protecting the intestine from the toxic effects of
5-fluorouracil. If the protein hydrolysate content of the diet is
reduced by 30% and the difference made up with intact protein, the
beneficial effects of the diet are lost. The diets used by Gardner
and Heading (1979) contained either free amino acids only ('Vivonex')
or intact protein (casein or lactalbumin) or an enzymic hydrolysate
of casein or lactalbumin. All the diets, except for 'Vivonex',
contained a significant quantity of intact protein (about 6% by
weight of the diet) present in the flour used in the diets. In
contrast, the nitrogen source in the 'elemental' diets used by
Bounous et al (l971a and b) was both free amino acids and small
peptides instead of protein ('Diet B and 'Flexical'). Thus none of the
diets used by Gardner and Heading (l979) sme exactly comparable, in
terms of the nitrogen source, to those used by Bounous et al (l9?la
and b) and this might explain the lack of effect observed by
Gardner and Heading (l979)»
Very little is known about the physiological effects of
'elemental' diets on the gastrointestinal system, Bounous et al
(l971a) reported that mucosal peptide hydrolase activities were
decreased in rats fed on an 'elemental' diet. However, Gardner and
Heading (1979) showed that the effects of 'elemental' diets on
intestinal peptide hydrolase activities depends also upon the actual
nitrogen source in the diet and upon the particular enzymes whose
activities are measured. Thus it is possible that the beneficial
effects observed by Bounous et al (l971a and b) were due to some
aspect of the diet other than its 'elemental' nature.
The claims made by Bounous and associates are of enormous
significance: if the adverse effects associated with chemotherapy
and irradiation can be reduced by simple dietary modification, this
would be highly valuable in clinical practice. Apart from a single
investigation of the therapeutic effect of an 'elemental' diet on
proline absorption across the irradiated rat small intestine by
Mohiuddin and Kramer (1978) (discussed on p.263) the work of Bounous
and associates is the only evidence in favour of dietary modification
to reduce 5-fluorouracil toxicity. Gardner and Heading's findings
did not support Bounous's claim. Furthermore, Stanford et al (1977)
concluded that the protein hydrolysate content of 'elemental' diets
was responsible for the increased toxicity of 5-fluorouracil that
they observed in rats fed on.arr''elemental' diet.
■ Therefore this chapter describes a study of the physiological
effects of 'elemental' diets on the small intestine and of the
effects of 'elemental' diets on the intestinal toxicity of
5-fluorouracil. Hie food intakes and growth rates of rats fed on
three 'elemental' diets have been compared with those of rats fed on
a standard diet as an indication of the suitability of the diets for
the nutrition of rats. One of the diets used, Diet B, has a
composition as close as could be achieved to that used by Bounous
et al (l971a). Intestinal absorption, cytoplasmic peptide hydrolase
activities and mucosal DMA contents have been estimated in rats fed
on these 'elemental' diets and in rats fed on an 'elemental' diet
before and after 5~fluorouracil administration. Intestinal water
absorption rates have been used as the measurement of intestinal
function, since water absorption correlates with glucose absorption
(Gardner _et al, 1978; Gardner and Heading, 1979) aud thus it is the
simplest index of absorptive activity. The diets have been fed for
various times prior to 5-f'luorouracil administration since there is
no information available on the optimum duration of dietary treat¬
ment. Also, both male and female rats have been used, since Pageau
et al (1977) reported that the effects of 'elemental' diets on the
immune system differ between male and female rats. YZhile Bounous et
al (l971a) studied male rats, Gardner and Heading studied female





Three 'elemental' diets were used in this study; two commercial
diets - 'Flexical' (supplied "by Mead-Johnson, Bristol Laboratories,
Langley, Slough, U.K.) and 'Vivonex-HM' (supplied by Eaton
Laboratories, Woking, Surrey, U.K.) - and one home-made diet, Diet B.
The compositions of these diets are shown in Tables 10.2, 10.3 and
10.4 respectively. 'Flexical' and Diet B were similar in composition
(see Table 10.5); the main difference was the higher casein hydro-
lysate content (20% of the calories) of Diet B compared with 9% of
Table 10.5 Comparison of the composition of 'Flexj.ce!' and Diet B
% of total calories




the calories in 'Flexical'. Diet B was formulated by Bounous et al
(1971a) in accordance with the nutritional requirements of rats
(see Warner, 1952) and 'Flexical' was developed from Diet B for
human use by reduction of the casein hydrolysate content to produce
a diet more palatable for humans. 'Vivonex-HN' was included as a
comparison; the amino nitrogen content is similar to that of Diet
B but is present as free amino acids only (Table 10.3). The
calorific values of the diets are shown in Table 10.6.









Each 454 grams of FLEXICAL powder when
reconstituted with 1656 ml. water supplies
approximately 2000 kilocalories in 2000 ml.
Each 2000 kilocal. provides:





Protein equivalent kilocal. kilocal.
(9.0%) 45.0 180
Fat (30.0%) 68.0 602
Soy oil' 53.4 480
MCT 13.2 109

















Methionine 1.46 0.66 2.12
Cystine 0.20'
Total Sulphur Amino Acids 2.32
Phenylalanine 2.24 2.24
Tyrosine 0.65' 0.53 1.18
Total Aromatic Amino Acids 3.42
Threonine 2.19 2.19
Tryptophan 0.49 0.22 0.71
Valine 3.54 3.54
Alanine 1.69 1.69
Aspartic acid 3.79 3.79





Vitamins and Minerals (per 2000 kiloca!.)
Vitamin A, mg ^-72
Vitamin D, mg 0.01
Vitamin E, i.u. 45.
Vitamin C (ascorbic acid) mg 300.
Vitamin B, (thiamine), mg 3.8
Vitamin B2 (riboflavin^), mg 4.3
Vitamin B6 (pyridoxine), mg 5.
Vitamin B,2i meg 15.
Niacin, mg 50.
Folic acid, meg 400.
Choline, mg 500
Biotin, meg 300.













The approximate percentages of fatty
acids present in FLEXICAL when prepared
according to directions are as follows:
Percent of
Grams per Total
tty Acid 2000 kilocal Fatty Acids
Octanoic (C8) 10.9 16.1
Decanoic (C,0)_ 3.9 5.7
Laurie (C,2) — tr
Myristic (C,4) — tr
Palmitic (C16) 6.2 9.1
Stearic (C,8) 2 1 3.1
Oleic (C18) 21.7 32.0
Linoleic (C,3 2) 18.0 26.5




Tabic -10. 5 Composition of 'Vivoncx-HJi' 22k
Nutritional Information







Available nitrogen in the form of pure
amino acids (amino acid content
12.93g) 2.00g
Fat as highly purified safflower oil
(80% triglyceride of linoleic acid) 0.261 g
Carbohydrate as glucose solids 63.1 g
Caloric contribution:
'• Amino acids 18.26%
Fat 0.78%
Carbohydrate 80.96%
Ten packets of Vivonex HN supply 20.Og of available nitrogen,
2.61 g fat. 631 g carbohydrate and the following vitamins, amino














amino acids: 36.54% 47.25
% Total
NON-ESSENTIAL Amino g/10
AMINO ACIDS Acids packets
L-Alanine 5.11 6.61
L-Arginine 3.99 5.16












80g in 300 ml mg/80g mg/10
Cations m-equiv/100 ml pocket mg/1 OOg packets
Sodium 3.35 231.3 289 2313
Potassium 1.79 210 5 203 2105
Calcium 1.33 80.0 100 800
Magnesium 0.958 35.0 43.75 350
Manganese 0.00340 0.281 0.35 2.81
Iron 0.0119 1.00 1.25 10.0
Copper 0.00203 0.194 0.24 1.94
Zinc 0.0127 1.25 1.56 12.5
Anions
mg/80g mg/10
m-equiv/1 OO ml packet mg/1 OOg packets
Chloride 5.24 557.3 696.6 5573
Phosphate 2.58' 80.0 100 800
(as P)
Acetate 0.0211 3.74 4.68 37.4
Sulphate 0.02391 1.15 1.44 11.5
(as S)
'"Iodide 0.000038 0.0144 0.02 0.144
Sorbate 0.268 89.2 111.5 892
Ten packets also contain 0.22 pg Cobalt as Vitamin B 1 2
Vitamins
• Per 80g Per 100g tn ten 8Cg
packet packets
Vitamin A (Retinol) pg 150 187.5 1500
Vitamin D2 (Ergocalciferol) pg 1.0 1.25 10
Vitamin E I.U. 3.0 3.75 30
Vitamin K, pg 6.7 8.38 67
d-Riotin mg 0.02 0.03 0.2
Choline bitartrate mg 15.4 19.25 154
Vitamin B , 3 pg 0.5 0.63 5
Folic acid mg 0.01 0.01 0.1
Inositol mg 11.65 14.56 116.5
Nicotinamide mg 1.33 1.66 13.3
d-Ca!cium pantothenate mg 1.0 1.25 10
Pyridoxine HC! mg 0.2 0.25 2
Vitamin B, (Thiamine) mg 0.12 0.15 1.2
Vitamin B2 (Riboflavine) mg 0.12 0.15 1.2
Vitamin C (Ascorbic acid) mg 7.0 , 8.75 70
Information reproduced from Eaton Laboratories product information
sheet
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Table 10.4- Composition of Diet B












Cow & Gate Ltd.
Trowbridge, Wilts.
6.9
Corn oil Ma zola 4-3
Olive oil Pacchini Oil
Importing Co. Ltd, Glasgow
10.4
Cod liver oil British Cod Liver
Oils Ltd, Marfleet, Hull
1.3








* Altman and Dittmer (1972)
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'Oxoid Diet 86' O.64
The diets were presented in dry form in glass bowls in the
cages of. the rats. In some instances flavouring (supplied by Eaton
Laboratories for use with 1Vivonex-HN1) was added to Diet B
(l sachet/lOO g of diet).
Animal s
The rats were caged individually or in groups of 4 and fed on
an 'elemental' diet for 1, 2 or 6 weeks prior to use and the diet was
continued after 5-fluorouracil administration. Bod3'- weights and food,
intakes were recorded daily.
5-fluorouracj.l administration
Bats were weighed and 5-fluorouracil"was administered under
light ether anaesthesia at a mean dose of 1.44 mmol/kg body weight.
In view of the different systemic toxicities of the two salts of
5-fluorouracil (discussed in Chapter 8) both the Tris and the sodium
salts of 5-fluorouracil were used.
Water absorption
Water absorption rates by the whole jejunum plus ileum were
estimated in vitro by the method described in Chapter 3 in control •
(uninfected) rats and on the first and third days after
5-fluorouracil administration.
Peptide hydrolase activities and. MA estimation
Mucosal MA contents and cytoplasmic peptide hydrolase
activities against three dipeptide substrates - Gly-L-Met, L-Leu-Gly
and L-Val-L-Leu - were estimated in the whole jejunum plus ileum from
control (uninfected)rats and on the first and third days after
5-fluorouracil administration. The methods were those described in
Chapter's 5 ahd 4 respectively.
Proline absorption
Proline absorption rates were estimated in vitro in the
perfused small intestine by addition of about 1 mrnol proline/l
(Sigma London Chemical Co.) to the perfusate; proline was estimated
in the serosal secretion collected over a 15 minute period commencing
45 minutes after the start of perfusion. The composition of the
secretion reaches a steady state during this period and the
appearance of proline in the serosal secretion is equivalent to net
absorption or transport if measured under steady state conditions
(Fisher and Gardner, 1974; Gardner, 1976).
Proline estimation
The serosal secretion was deproteinised by addition of solid
sulphosalicylic acid (30 mg/ml) and after 20 minutes samples were
centrifuged for 20 minutes at 4000 g at room temperature. Proline
was estimated in the supernatant and in the perfusate on a Locarte
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floor model Mark 37V amino acid analyser. Details of the amino acid-
analysis programme, by stepwise elution with sodium citrate buffers
on a single column, were given by Gardner (l98l)
Elliot and Gardner (1976) described a method for the estimation
of proline in the presence of amino acids which used isatin as a
chromogen. It was hoped that this method could be used for the
rapid determination of proline in the serosal secretion. However,
whilst the method was satisfactory for the estimation- of proline
dissolved in citrate buffer (0.1 mol/l) or in the perfusate in the
absence of glucose, addition of glucose prevented development of the
blue complex between proline and isatin. The method was therefore
unsuitable for the estimation of proline in the serosa,! secretion.
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Table 10.7 Effects of 'elemental' diets on growth rates and food
intakes of male and female rats
Females
Pood intake Weight gain
Diet (g/dav/rat) (kJ/dav/rat) (g/day/rat) (mg/day/kJ)
'Oxoid Diet 86' 16.8 - 0.41
(12)
188.5 2.46 - 0.24
(8)
13.1
1Vivonex-HN1 15-7 - 0.60
(12)
246.5 1.71 - 0.29
(8)
6.9
'Flexical' 14.8 - 0.62
(12)
273.0 2.09 ~ 0.19
(8)
7.7
Diet B 11.3 - 0.50
(12)











'Oxoid Diet 86' 20.2 - 0.31
(32)
226.6 6.05 - 0.21
(34)
26.7
Diet B 16.3 - 0.30
(78)















353-7 6.50 - O.36
(8)
18.4.
Numbers of observations are shown in parentheses. Those for food
intakes refer to observations on groups of 4 rats (excluding *)
and those for body weights refer to individual rats, observed over




CONTROL EXPERIMENTS OH BATS NOT IUJBGTBD WITH 5-ffLUOROURACIL
Growth rates and food intakes of rats fed on 'elemental' diets
All .female rats fed on an 'elemental' diet lost weight, varying
from 5-15 E Per rat, over the first two days on the diet. This was
associated with a lower food intake, by 4-0 - 50%? than was observed
subsequently. This phenomenon was less apparent in male rats in
which the maximum body weight loss was 8 g and in most instances the
food intake over the first 24 hours on the diet was only 20% less than
that observed subsequently. The first two days on the 'elemental'
diet have therefore been excluded from the estimates of food intakes
and growth rates since this period probably represents adapta.tion to
a change of diet.
Table 10.7 shows the daily body weight gains and food intakes of
both male and female rats fed for 1 week on the standard diet, Oxoid
Diet 86, or on one of three 'elemental' diets. The weight gain is
also expressed per kJ food intake. Daily food intakes and growth
rates of both male and female rats were reduced (by 5 - 38% depending
on the diet) when the standard diet was replaced by an 'elemental'
diet; the weight gain per kJ intake was also reduced, by about 43%
in females and 33% in males, although the total energy intake was
increased by between 11% and 45% in female rats and between 33% and
56% in male rats. Both the growth rates and food intakes of male
rats were greater than those of female rats; growth rates were 46%
greater and food intakes were 20% greater in male than in female
rats. Also the weight gain per kJ intake was greater by a factor of
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2 in male than in female rat's.
Effect of flavouring the diet' on food intakes and, growth rates
Since food intakes and growth rates were reduced in rats fed on
an 'elemental1 diet, an attempt was made to increase the spontaneous
intake of food by the addition of flavouring to the diet. The
flavours used were those supplied by Eaton Laboratories for
addition to unflavoured 'Vivonex-HE' and they were added to Diet B
(l sachet/lOO g diet). Two male rats were caged individually and
given 4- bowls of Diet B, each with a different flavour added. The
position of the bowls in the cages was varied daily and the food
intake from each bowl was recorded over the next 7 days. The results
are shown in Table 10.8. Both rats ate a much greater amount of
'Tomato' flavoured diet than of the other three flavours.
Subsequently, when both male and female rats were fed solely on
'Tomato flavoured Diet B' the food intakes were greater by 21% and
T% respectively, and growth rates were greater by 21% and 5^
respectively, than those observed in rats fed on unflavoured Diet B
(Table 10.7). When male rats were caged individually and fed on
'Tomato flavoured Diet B' the' growth rate was slightly greater, by
T%, than those observed in rats fed on the Oxoid diet.
Gross appearance of intestines from rats fed on 'elemental' diets
Intestines from rats fed on 'Vivonex-HE' were similar in gross
appearance to those from rats fed on the standard diet, Oxoid Diet
86. In contrast, those from rats fed on 'Flexical' or on Diet B
were very pale in colour and there was a large deposit of fat around
the mesentery. The serosal secretion from perfused intestines
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Table 10.8 Distribution of the food intake of male rats between
four alternative flavours of Diet B
Pood intake (g/day) Intake over % of
Flavour Day 12 5 4 5 6 7 7 days (g) total
Rat 1 Strawberry 0 3 1 0 3 1 1 9 8.8
Orange 0 0 0 1 2 0 1 4 3.9
Beef 1 1 0 9 7 3 2 23 22.6
Tomato 0 1 11 12 13 14 15 66 64-7
Total 102
Rat 2 Strawberry 0 3 0 1 1 1 1 7 5.8
Orange 0 3 0 0 1 0 1 5 4.2
Beef 1 2 3 1 1 1 0 9 7-5
Tomato 1 7 17 12 21 20 21 99 82.5
Total 120
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Table 10.9__ Intestinal, water absorption rates and, dry weights in
rats .fed for 1, 2 or 6 weeks on 'elemental' diets
Time on
diet Water absorption Dry weight
Diet Bex (weeks) rate (ul/cm/hr) (rag/cm1
'Oxoid P : - 138.7 - 9.0 (13) 11.5 - 0-37 (10)
Diet 861
'Flexical1 P 1 154-6 - 8.6 ( 9) 14.8 - 0.77 ( 8)
N.S. **
+
'Flexical' P 2 197-3 - 24-4 ( 4)
**
'Vivonex F 1 190.1 - 10.5 (12) 10.3 - 0.42 (l2)@
-HN' **
'Vivonex F 6 184.2 - 11.3 ( 5) 10.6 - 0.37 ( 5)
-HN' ' ** U.S.
Diet B P 1 I64.5 - 10.9 ( 7) 13-8 - 0.41 ( 8)
N.S. **
'Oxoid M - 138.6 - 8.9 ( 9) 13-7 - 0.83 ( 9)
Diet 86'
Diet B M 1 165.4 - 11.4 ( 7) 15-9 - 1.17 ( 8)
N.S. **
Values are the mean - S.E.M. and the number of observations is shown
in parentheses. The significance levels of the differences from the
values in Oxoid-fed animals are indicated thus:
** PcO.02, N.S. Pr^O.l.
@ The values for rats fed for 1 week on 'Vivonex--HN' are from
Gardner and Heading (1979)-
! No estimate available.
removed from rats fed on 'Flexical' or Diet B was opaque, presumably
a reflection of the high fat content of these diets.
Effect of 'elemental' diets on intestinal absorption, dr.y weights and
peptide hydrolase activities
Table 10.9 shows the water absorption rates and. dry weights of
intestines from rats fed on the Oxoid diet and from rats fed on
various 'elemental' diets for 1, 2 or 6 weeks previously. Water
absorption rates were increased significantly (p^0.02) in female
rats fed for 2 weeks on 'Flexical' or for 1 (results from Gardner and
Heading, 1979) a^d. 6 weeks on 'Vivonex-HN' when compared with those
from rats fed on the Oxoid diet. Although absorption rates were
increased in both male and female rats fed for "1 week on Diet B and
in female rats fed for 1 week on 'Plexical', this increase was not
significant (Pr=-0.l). The intestinal dry weights were significantly
increased in rats fed on 'Flexical' or Diet B (P=^0.02).
The cytoplasmic peptide hydrolase activities in intestines
from rats fed for 1 or § weeks, on 'Flexical' were not significantly
different (Pr=- O.l) from those in intestines from rats fed on the
Oxoid diet (Fig. 10.l).
Absorption rates in male and female rats
The similarity between water absorption rates estimated on
intestines from male and female rats has already been discussed
(Chapter 3). This similarity is also apparent in rats fed on
Diet B (Table 10.9).
Fig. 10.1 Cytoplasmic peptide hydrolase activities in the mucosa
of the small intestine from rats fed on the Oxoid diet or for 1 or
2 weeks on 'Flexical'. Substrates were Gly-L~Met, L-Leu-Gly and
L-Val-L-Leu. Values are the mean - S.E.M. and the number of animals
is shown within the bars.

























































EXPERIMENTS OK BATS INJECTED WITH 5-FIIIOROURACIL
After establishment of the basic physiological effects of
'elemental1 diets on the intestine experiments were designed to test
whether these diets protect the intestine from the toxic effects of
5-fluorouracil. The following parameters were used as indices of
5-fluorouracil toxicity; food intake, body weight loss, mucosal BNA
content, peptide hydrolase activity, intestinal water absorption and
dry weight, and the incidence of diarrhoea.
Body weight losses and food intakes during the first 5 days after
5-fluorouracil administratlon
Body weights and food intakes are both severely reduced during
the first 3 days after administration of 5-fluorouracil (see Chapter
8). Figs. 10.2 and 10.3 show the total body weight losses and food
intakes respectively during the first 3 days after 5-fluorouracil
(Tris and sodium salts) administration in both female (Figs. 10.2A
and 10.3A) and male (Figs. 10.2B and 10.3-d) rats; the rats were fed
either on the Oxoid diet or on'an 'elemental' diet ('Flexical',
•Vivonex-HN' or Diet B with Tomato flavouring added) for at least
1 week prior to drag administration. Body weight losses were
significantly increased in female rats fed on 'Flexical' (P-^=u0.0l)
or 'Vivonex-HK' (P*=.0.02) prior to 5-fluorouracil administration;
the food intake of these rats was also decreased significantly
(P<==:0.05). contrast, body weight losses and food intakes were
similar when rats were fed on the Oxoid diet or Diet B. Thus if
body weight loss is regarded as a criterion of toxicity, then the
two commercial 'elemental' diets increase the toxicity of
5-fluorouracil.
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Fig. 10.2 Total body weight loss during the first 3 days after
administration of 5-fduorouracil (Tris or sodium salt) in female (A)
and in male (b) rats. The rats had been fed on the Oxoid diet or on
various 'elemental' diets for at least 1 week before 5-flrorouracil
administration and thereafter. Values are the mean - S.E.M. and the
number of animals is shown within the bars. The significance levels
of the differences from values in 'control' rats fed on the Oxoid
diet and injected with the same salt of 5-fluorouracil are indicated
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Fig. 10.3 Total food intakes during the first 3 days after
administration of 5-BTuorouracil (fris or sodium salt) in female (A)
and in male (b) rats. The rats had been fed on the Oxoid diet or
on various 'elemental' diets for at least 1 week before
5-fluorouracil administration and thereafter. Values are the mean
- s.e.m. of observations on groups of 4 rats and the number of
observations is shown within the bars. The significance levels of
the differences from values in rats fed on the Oxoid diet and injected
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-Tris salt- sodium salt
DietB Diet B
The effects of the Tris salt of 5-fluorouracii on body weights
and food intalces are greater than those of the sodium salt of
5-fluorouracil (see Chapter 8). This is also demonstrated in Figs.
10.2 and 10.3; "body weight losses were significantly less (P-=f0.02)
in rats, fed on the Oxoid diet or Diet B, injected with the sodium
salt of 5-fluorouracil, when compared with those injected with the
Tris salt of 5~fluorouracil. Similarly, the food intake during the
first 3 days after administration of the sodium salt was
significantly greater (P*=-0.00l) than after administration of the
Tris salt of 5-fluorouracil.
Mucosal DMA content and cytoplasmic peptide hydrolase activities
after 3-fluorouracil administration
Mucosal cytoplasmic peptide hydrolase activities and DNA
contents were estimated in control (uninjected) female rats and in
female rats that had been injected with 5-fluorouracil (Tris salt)
1 or 3 days previously. The rats were fed on the Oxoid diet or
'Flexical' for at least 7 days prior to and then after injection.
The results are shown in Figs. 10.4 and 10.5. There was a
significant decrease in the mucosal DMA content both 1 and 3 days
after 5-flu.orouracil administration, to about 47% and 38% of the
normal content respectively (P-=0.00l) and the decrease was
similar for both diets (Fig. 10.4). Cytoplasmic peptide hydrolase
activities were unaffected 1 day after 5-fluorouracil administration
but were, decreased to between J/6 and 71% of normal activities by the
third day after administration (PcO.Ol) depending upon the
activity measured (Fig. 10.5). This pattern was observed for all






Control Day 1 Day 3
Fig. 10.4 content of the mucosa from the whole jejunum plus
ileum from control female rats and on the first and third days after
administration of the Tris salt of 5-fTuorouracil. Rats were fed
(open bars) (hatched bars)
either on the Oxoid dietAor on 'Flexical'/ for 1 week before and
after 5~fluorouracil injection. Values are the mean - S.E.M. and
the number of animals is shown within the bars. The significance
levels of the differences from the respective controls are
indicated thus: *** P=r0.001
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Days after 5-fluorouracil injection
Fig. 10.5 Cytoplasmic peptide hydrolase activities in the mucosa
of the small intestine from control female rats, fed on the Oxoid
diet or on Diet B, and on the first and third days after
5-fluorouracil (Tris salt) administration in female rats fed on the
Oxoid diet or 'Flexical'. Substrates were Gly-L-Met, I>-Leu~Gly and
L-Val-L-Leu. "Values are the mean - S.E.M. and the number of animals
is shown within the bars. The significance levels of the
differences from the respective controls are indicated thus:
** P=r0.01, N.S. P>0.1.
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Intestinal absorption, dry weights and the incidence of diarrhoea
in rats fed on an 'elemental' diet before and after 5-fluorouracil
administration
Fig. 10.6 shows the intestinal water absorption rates and dry
weights on the third day after 5-fluorouracil administration in male
(hatched bars) and female (open bars) rats fed for 1, 2 or 6 weeks
previously on one of three 'elemental' diets. The results from rats
fed on the Oxoid diet are included for comparison and the results
from experiments with unflavoured and flavoured Diet B have been
combined since they were very similar. Water absorption rates on the
third day after 5-flt1orouracil administration are similar regardless
of the nature of the diet. This is true both in male and female rats
and for both the Tris and sodium salts of 5-fluorouracil. However,
intestinal dry weights on the third day after administration of
5--fluorouracil to rats fed on Diet B were significantly greater
(Pc0.05) than those from rats fed on the Oxoid diet. Table 10.10
shows the incidence of diarrhoea in these same animals (the number
that developed diarrhoea is expressed as a percentage of all rats
injected) during the first 3 days following 5-flnorouracil injection.
The incidence was very similar for all diets except in the case of
Diet B when there was a marked reduction in the incidence of
diarrhoea in both male and female rats. Diarrhoea was not observed
in control (uninjected) rats fed on any of the 'elemental' diets or
on the Oxoid diet.
Correlation between intestinal absorption and body weights
Intestinal water absorption rates were 54% greater on the third
day after 5-fliiorouracil (Tris salt) administration in rats fed on
Fig.10.6Intestinalwaterabsorptionratesnddryeightsoth thirddayafter5-fluorouracil(irissodiumlt)dminist tionn male(hatchedbars)nfeopenrats;twerdoth Oxoiddietornnef3'elemental'ietsf varioustib f r andthenfterinjection.Valu srmea-S.E.Mnumbe ofanimalsishownwithitheb rs.
Oxoid1week2 eaks6 eaDi tBOxoidtfB FlexicalVivonex-HN1rat/cage
2*1-8
Table 10.10 The incidence of diarrhoea 3 days after" administration
of the Tris or sodium salt of 3-fluorouracil in male and female rats













'Oxoid Diet 86' 83-3 ( 6) 80.0 (20) 87.5 (8) 87-5 ( 8)
'Flexical' 1 69.6 (15) - - -
'Flexical' 2 72.7 ( 6) - - --
'Flexical' 6 70.0 (10) - - -
'Vivonex-HN' 6 100.0 ( 4) ~ - -
Diet D 1 37.5 ( 8) 28.6 (28) 37.5 (6) 30.0 (20)
Diet B
(irat/cage)
1 - - - 25.0 ( 8)
The number of animals is shown in parentheses and the values are the
percentage of these animals that had diarrhoea.
- No estimate available.
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Diet B than the corresponding rates from animals fed on the Oxoid.
diet, although this difference was not significant due to the large
inter-animal variability (PoO.l). Pig. 10.7 shows the distribution
of absorption rates estimated on the third day after 5-flnorouracil
administration (Tris and sodium salts) in male rats fed either on
the Oxoid diet or on Diet B. It is clear from the results for
individual rats that some animals benefited from this particular
'elemental' diet. The absorption rates estimated on intestines from
rats fed on Diet B were distributed over a wider range than those
from rats fed on the Oxoid diet; some were within the range of
absorption rates observed in control (uninfected) Oxoid-fed rats.
Therefore the individual histories of the rats fed on Diet B prior
to 5~fluorouracil administration were studied closely, in order to
attempt to identify any features in the animals 'history' (e.g.
growth rate before 5-flnorouracil injection) which were correlated
with a good prognosis. Water absorption rates on the third day
after administration of the Tris salt of 5-flnorourac.il in male rats
fed on Diet B correlated positively with the body weight of the rats
both on the day of injection (Fig. 10.8a, P^O.Ol) and with the
body weight on the third day after injection (Pig. 10.8b, P*=^.0.001).
It should be stressed that the 5-fPuorouracil dose was calcula/fced for
each rat so that it was proportional to body weight at time of
injection. They did not correlate with the body weight at the start
of dietary modification (Pig. 10.8c, Pv=~0.l). No such correlations
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Fig. 10.7 Distribution of absorption rates measured on the third
day after administration of 5-Bluorouracil (Tris or sodium salt) to
male rats fed on Diet B (flavoured or unflavoured) for at least
1 week before injection and thereafter. Those from rats fed on
the Oxoid diet are shown for comparison. Also shown is the range
(mean - S.E.M.) of absorption rates observed in uninfected male
*
rats fed on the same diet (hatched bar).
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Pig. 10.8 Intestinal water absorption rates 3 days after
5-fluorouracil (Tris salt) administration to male rats fed on Diet B
(flavoured and unflavoured). Absorption rates, estimated on
individual intestines, are plotted against body weight at the time
of injection (a), body weight 3 days after 5-Hu.orouracil injection
(b), and body weight at the start of dietary treatment (c). Also
shown are the correlation coefficient (r), the significance level of
















































Effect of increased food intake and growth, ra/te on 5~fluorouracll
toxicity
The above observations suggest that the rats which benefited
from the 'elemental' diet may have been those with the highest growth
rates. Thus an attempt was made to increase the food intakes and
growth rates of rats fed on Diet B. Both food intakes and growth
rates were increased, by 18% and 22% respectively, when rats were
caged individually and fed on Diet B with Tomato flavouring added
(Table 10.7). However, water absorption rates on the third day after •
5-fluoroura.cil administration were not significantly greater in these
ra,ts than those of rats fed on the Oxoid diet and caged in groups of
4 (Eig. 10.6). Hence the correlations observed between absorption
rates on the third day after 5-flnorouracil administration and the
body weight at the time of injection probably does not indicate a
causal relationship and there is no benefit to be gained from
increasing the food intake.
Effects of 5-fluorouracil on intestinal proline absorption in rats
fed on an 'elemental' diet
Mohiuddin and Kramer (1978) reported that the intestinal
absorption of proline, estimated in vitro, was decreased in rats
following irradiation of the intestine in vivo and that the decrease
could be reduced if rats were fed on an 'elemental' diet. Their's
is the only independent evidence in favour of Bounous' theory;
hence it was of importance to perform similar studies and, therefore,
proline absorption rates were estimated on intestines from male rats
3 days after 5-fluorouracil administration. Eats were fed either on
the Oxoid diet or on Diet B (Tomato flavoiired) for 1 week before and
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Table 10.11 Bates of -proline trans-port, across intestines from male
rats fed for 10 days on Diet B and from male rats fed on the Oxold




Control (uninfected) Diet B 18.0 -2.2 (4)
5-fluorouracil (Day 3) Diet B 3*5 - 1*3 (6)
5-fluorouracil (Day 3) Oxoid Diet 86 3«9 - 1*7 (5)
Proline concentration in the perfusate = 1.3 mniol/l
Values are the mean - S.E.M. and the number of animals is shown in
parentheses.
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for 5 days after 5-flrorouracil administration. Fox1 comparison,
proline absorption rates were estimated in intestines from rats fed
for 10 days on Diet B. The perfusate contained proline (l.3mmol/l);
proline was estimated in the serosal secretion collected over a
15-minute period commencing 45 minutes after the start of perfusion.
Proline absorption rates were decreased to about 20%, of control
values (P--=- 0.001) by the third day after 5~Hnorouraci1
administration; the extent was the same regardless of whether the
diet was the standard one (Oxoid) or the 'elemental' one (Diet B,
Table 10.ll). Hence these results are completely at variance with
those of Mohiuddin and Kramer (1978) and lead to the same conclusion
as those already described above; namely that no beneficial effect
of an 'elemental' diet on 5-fPu.orouracil toxicity has been
demonstrated.
DISCUSSION
The results presented in this chapter represent an extensive
study of the effects of 'elemental' diets on the intestinal toxicity
of 5-flu.orouracil in an attempt to confirm and expand upon the
observations of Bounous et ad (l971a< b). In spite of close
adherence to the conditions used by Bounous et al (l971a) it is
concluded that the intestinal toxicity of 5-flrorouracil is not
reduced in ra/fcs fed on an 'elemental' diet. Previously, Gardner and
Heading (1979) came to a similar conclusion. However, as discussed
in the introduction to this chapter, there were several
inconsistencies between the work of Bounous et al (l971a) that
of Gardner and Heading ("1979) anJ these have now been eliminated.
I shall first discuss the effects of 'elemental' diets on the
'normal physiology' of the intestine, and then consider their
effects on the pathophysiology seen after 5-fIu-orouracil
administration.
Effects of 'elemental' diets on food intakes and growth ra/fces
Although it is true that rats gained weight when fed on
'elemental' diets, the daily weight gain was 7 to 38% less than that
of rats fed on a standard diet (Oxoid). Also, the food intake was.
less but, because of the high calorific value of these diets (see
Tables 10.6 and 10.7), the total daily energy intake was greater, by
11 to 56%, than that of rats fed on the Oxoid diet. Hence the
weight gain per kJoule intake was decreased by almost 50% when rats
were fed on an 'elemental' diet, suggesting that the energy
utilization from 'elemental' diets is very inefficient. These
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observations on the growth rates of rats fed on 'elemental1 diets
contrast with those of Bounous _et al (l97Ia)> who showed that growth
rates were similar in rats fed on hydrolysed and unhydrolysed diets,
but agree with those of Gardner and Heading (l979) ^d. those of
Bounous and Maestracci (l976), who reported that during the first
10 days the growth rates of rats fed on an 'elemental' diet were 20%
less than those of rats fed on an unhydrolysed diet. It is of note
that Bounous and Maestracci (l97^) do not offer any explanation for
the inconsistency of their results and those of Bounous et al
(l971a)» Since it has been shown that the intestinal toxicity of
5-fluorouracil is increased by an overnight fast prior to injection
(Chapter 11, Table 11.2), these observations of reduced food intakes
and growth rates do not argue in favour of the use of 'elemental'
diets during 5-flnorouracil administration.
The results also emphasise the observation, noted in Chapter 8,
that the food intakes and growth rates of male rats are greater than
those of female rats and indicate a potential advantage of the use
of male rats in dietary experiments since the changes in growth
rates and food intakes are larger and more easily detected.
Effects of 'elemental' diets on intestinal absorption
Intestinal water absorption rates were increased in rats fed on
an 'elemental diet, although the increase was not always significant
(Table 10.9)• Gardner and Heading (1979) suggested that the increase
might be due to the high carbohydrate content of 'Vivonex' and the
results presented in this chapter are consistent with their
suggestion. Intestinal water absorption rates in rats fed on
'Vivonex-HH' for 6 weeks were very similar to those observed in rats
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fed for 10 days on this diet' by Gardner and Heading (1979) (see
Table 10.9). The carbohydratejrrrtents of 'Flexical' (68%) and
Diet B (54%) are less than that of 'Yivonex-HN! (80%) and these two
diets did not produce a significant increase in water absorption
rates when fed to rats for 1 week. A significant increase, by 32
and 42%, was observed when 'Flexical' was fed to rats for 2 or
6 weeks respectively (Table 10.9). These results do not agree with
recent observa/tions by Nelson et al (198O), who reported that both
glucose and water absorption rates, estimated in vivo in jejunum and
ileum, were unchanged in rats fed on 'Vivonex' for 1 month, and were
decreased in rats fed on 'Flexical' for 1 month when compared with
control animals (diet unspecified). Gardner et al (1978) reported a
consistent and highly significant positive correlation between
glucose and water absorption rates and Gardner and Heading (1979)
also observed a similar increase in both glucose and water absorption
rates in rats fed on 'Yivonex-HN', suggesting that the correlation is
maintained in rats fed on 'elemental' diets. Thus, since water
absorption rates were increased in rats fed on 'Flexical' for 2 or
6 weeks, it is probable that glucose absorption rates would also be
increased and the difference between the results of Nelson et al
(1980) and those of Gardner and Heading, the latter confirmed. in
this study, cannot be explained.
The dry weights of intestines from rats fed on 'Flexical'or on
Diet B were significantly greater (P^=v0.001 for females, P*=r0.02
for males) than those from rats fed on the standard Oxoid diet
(Table IO.9). However, the mucosal DNA content (Fig. 10.4) and
cytoplasmic peptide hydrolase activities (Fig. 10.l) were not
affected by the 'elemental' diets. This suggests that the increase
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in intestinal dry weights and water absorption rates was not due to
an increase in the number of cells in the intestinal epithelium. The
increase in intestinal dry weight may have been due to accumulation
of fat in the intestine which was apparent both by the whitish
colour of the intestines and by the high content of fat in the
serosal secretion. An increase in the water absorption rate in the
absence of a change in the mucosal DNA content suggests that the
absorption rate per absorbing cell may have increased. However, as
discussed on p 179> this cannot be firmly concluded since the
proportions of 'mature' cells may have increased and there is
evidence which supports this possibility. Lehnert (1979) showed
that when mice were fed on an 'elemental' diet (3200-AS - 'Flexical')
instead of on an unhydrolysed diet, the number of cells per villus
in the jejunum was increased by 20% and the number of cells per
crypt in the jejunum was decreased by 30%*
'Elemental' diets and 9-fluorouracil toxicity
As discussed in Chapter 8 , the impairment of intestinal
absorption of both glucose and water in the animal model used here
is maximal by the third day after 5-fluorouracil administration.
The decrease in intestinal dry weight is also maximal on the third
day. As can be seen clearly in Fig. 10.6, none of the 'elemental'
diets produced a significant increase in intestinal water absorption
rates or in intestinal dry weights on the third day after
5-fluorouracil (Tris or sodium salt) administration. Furthermore,
the body weight losses over the first 3 days after 5-fluorouracil
injection were significantly greater in rats fed on 'Flexical'
(31%, P-cO.Ol) or 'Vivonex-HN' (38%s P^=:0.02) than those of rats
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fed on the Oxoid diet (Fig. 10.2). In contrast, Bounous et al (l971a)
demonstrated a small reduction in body weight losses (about 10%)
following 5~fluorouracil administration in rats fed on an 'elemental'
diet. However, Stanford et al (1977) observed similar weight losses
in rats fed on 'Flexical', 'Vivonex' or a standard diet during
5-fluorouracil administration.
A high incidence of diarrhoea following 5-fDuorouracil
administration was observed in rats fed on the Oxoid diet, 'Flexical'
or 'Vivonex-HN'. In contrast, a low incidence was observed in rats
fed on Diet B (Table 10.10). Stanford et al (1977) also reported a
high incidence of diarrhoea (90 - 100%) following 5-H'uorouracil
administration in rats fed on 'Flexical' or 'Vivonex' but reported
a much lower incidence (25%) in rats fed on a standard, unhydrolysed,
diet. (Purina Eat Chow). Diarrhoea following 5-DDu.orouracil
administration might be due to colonic damage rather than to injury
to the small intestine. Thus the lower incidence of diarrhoea
following 5-Dluorouracil administration in rats fed on Diet B might
be due to an alteration of the colonic damage.
The results presented in Figs. 10.2, 10.3 and 10.6 reiterate
the observation, discussed in Chapter 8, that the intestinal
toxicities of the Tris and sodium salts of 5-fDuorouracil are
similar, although the effects 011 body weight and food intakes
following administration of the sodium salt of 5-fluorouracil are
much less severe than those of the Tris salt. These observations
argue against the suggestion of Bounous et al (l971a) that the
beneficial effects of 'elemental' diets which they observed were due
to a direct supply of readily absorbable nutrients to the injured
intestine which aids recovery of the intestine. During the first 48
hours after administration of the Tris salt of 5-fluorouracil the
food intake of rats was negligible for all diets and during the next
24 hours the food intake was less than 25% of the normal daily
intake (see Chapter 8, Pig. 8.1). In contrast, during the first 48
hours after administration of the sodium salt of 5-fluorouracil, the
food intake was maintained at about 50% of the normal intake and
during this period there remains a significant digestive and
absorptive activity; absorption rates have decreased by only 20% of
control rates on the second day after 5-fluorouracil administration
(Chapter 8, Pig. 8.3). In spite of this difference in food intakes
alter administration of the two salts of ^-fluo^ouracil, the
intestinal absorptive activity has decreased to a similar extent.
If Bounous et al (l971a) were correct in their suggestion, one would
expect that rats injected with the sodium salt of 5~fl'u-orouracil
would demonstrate a greater response to 'elemental' diets than would
rats injected with the Tris salt of 5-fluorouracil,but this is not so
When male rats were fed on Diet B a positive correlation was
observed between the water absorption rates 3 days after
5-fluorouracil administration and the body weight either at the time
of injection or on the third day after injection (Pig. 10.8a and b).
Since no correlation was observed with the body weight at the start
of dietary modification (Pig. 10.8c) this result suggested that the
weight gain over the period that the rats were fed on Biet B might
be a relevant factor .in the protection of the intestine from
5-fluorouracil toxicity by an 'elemental' diet. However, this
theory was not supported by the results obtained from rats caged
individually and fed on Biet B with Tomato flavour added. Although
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the combination of dietary flavour and individual caging increased
the growth rate of rats fed on Diet 13 to 7% greater than that
observed in rats fed on the Oxoid diet (Table 10.6), water
absorption rates on the third day after 5'-flaorouracil administration
were not increased (Fig. 10.6). It is unlikely that the higher
absorption rates observed in heavier rats were due to differences
in the dosages of 5-fluorouracil since it is given on a body weight
basis calculated for each rat. Also, the body weight gains during
dietary modification was only about 15% and the intestinal toxicity
of 5-fluorouracil has been shown to be equally severe when the dose
was reduced from 1.44 mmol/kg to 1.08 mmol/kg (Chapter 8, Fig. 8.8).
No explanation can be suggested for the observed coxuelation and it
was not observed subsequently with Diet B or with any of the other
diets used.
Effects of 'elemental' diets on the intestinal transport of proline
Mohiuddin and Kramer (1978) reported that proline transport was
severely impaired following irradiation of the intestine and that
recovery from the injury was much more rapid in rats fed on an
'elemental1 diet than in rats fed on an uohydrolysed diet. This
observation was consistent with the suggestion of Bounous et al
(l971a) that 'elemental' diets aid recovery from injury by supplying
predigested nutrients directly to the intestine, thereby stimulating
a more rapid recovery of absorptive activity. However, in this
study, proline transport rates by the small intestine estimated on
the third day after 5-fluorouracil administration were similar in
rats fed on the Oxoid diet and in rats fed on Diet B, and both were
much less (by about 80%) than the rates observed in uninjected rats
(Table 10.ll) - a result that is entirely consistent with the
conclusion, drawn from the results on water absorption rates, that
the 'elemental' diets do not decrease the intestinal toxicity of
5-fluorouracil. The study by Mohiuddin and Kramer (1978) can be
criticised on a number of points. Firstly, they used an everted
sac preparation incubated in Krebs bicarbonate solution apparently
in the absence of glucose. As Fisher (1955) demonstrated, water
absorption rates by the perfused small intestine are very low in the
absence of glucose in the luminal perfusate since there is no energy
source. Also, Mohiuddin and Kramer (1978) express proline absorp¬
tion rates as the difference in concentration of proline in the sac
fluid before and after incubation. Since water absorption rates are
severely impaired after 5-fluorouracil administration (Chapter 8,
Fig. 8.3, Fig. 10.6, also Gardner et al, 1978) and since the changes
in absorptive activity of the small intestine are similar after
5-fluorouracil administration and after irradiation (Robinson 1972),
estimations of concentration differences are meaningless unless an
estimation of the water absorption rate is also obtained. Further¬
more, the relative absorption rates of proline in Mohiuddin and
Kramer's (1978) control preparations were 50% greater than the
corresponding control values reported in a previous paper (Mohiuddin
et al, 1978). Hence, one must question the adequacy of the controls
and the consistency of the observations reported by Mohiuddin and
Kramer (1978). In view of these criticisms, it must be concluded
that there is no evidence to suggest that 'elemental' diets
influence beneficially the effects of 5-TTuorouracil Dn intestinal
proline absorption.
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Effects of 'elemental' diets and 3-fluorouracil on peptide hydrolase,
activities
Intestinal cytoplasmic peptide hydrolase activities were
unaffected 24 hours after 5-flaorouracil administration in rats fed
on the Oxoid diet or on 'Flexical' and were decreased to 30 - 60% of
normal by the third day (Fig. 10.5). This observation contrasts with
that of Bounous et al (1971&) who reported a marked decrease in
dipeptide hydrolase activities, to 6 - 12% of normal, both 1 and 3
days after 5-fluorouracil administration. Also, whereas dipeptidase
activities were unchanged in intestines from uninfected rats fed on
'Flexical' (itg. 10.l), Bounous et al (l971a) reported a marked
decrease in dipeptidase activities in intestines from rats fed on
an 'elemental' diet (Diet B). However, as Gardner and Heading (1979)
demonstrated, the effects of 'elemental' diets on intestinal
dipeptidase activities depends on the 'elemental' diet and on the
particular enzymic activity studied. Since activities against
different substrates were estimated, this might explain part of the
disagreement between the results of this study and those of Bounous
et al (l971a). Furthermore, it is of note that Hugon and Bounous
(1972) suggested that the decreased peptide hydrolase activity in
intestines from rats fed on an 'elemental' diet which they claimed
previously (Bounous et al, 1971a) may have been caused by "a
selective decay of the enzyme when the tissue is preserved frozen".
This may well have been the cause since it was found that all three
activities estimated in this study were decreased upon storage at
- 26° C ( see p. 45)* Also, Bounous et _al (l971a) expressed enzyme
activity per milligram nitrogen and therefore activities will be
affected both by changes in the total activity of the enzyme and by
changes in the composition of the cell cytoplasm. However,- Gardner
and Heading (1979) also observed similar changes to those reported
here when they expressed dipeptidase activity with reference to
protein; hence the use of different reference systems may not have
contributed to the discrepancy. In view of the effects of
5-fluorouracil on the mucosal cell population (discussed in Chapter
P 179)7 "khe expression of activity with reference to the whole
small intestine, as used in this study, is probably the most useful
index of enzyme activity.
It is also of note that Bounous et al (1971a) reported an
increase in intestinal sucrase activity 2.4 hours after administration
of 5-fluaouracil• However, sucrase is exclusively a brush border
enzyme (Semenza, 1968) and Bounous et al (1971a) estimated this
activity in the supernatant fraction of a mucosal homogenate. Since
Gardner et al (1978) reported that less than J'/a of the intestinal
sucrase activity is present in the supernatant, it is not relevant
to estimate the activity in this fraction. Hence the activities
reported by Bounous et al (1971a) were probably due to a brush
border contamination of their supernatant.
Although Bounous et al (1971a) reported that an 'elemental'
diet reduced the intestinal toxicity of 5-fluorouracil at a dosage
of 150 mg/rat, they did not observe any reduction when the dose was
raised to 200 mg/rat. At the higher dose the mortality was similar
(64/) in rats fed on an 'elemental' diet and in rats fed on a
standard diet. Furthermore, Bounous et _al (1978a and b) have since
reported that mortality is increased at high doses of
5-fluorouracil (450 mg/krg body weight or 50 mg/kg body' weight for
4 days) when rats have been fed on an 'elemental' diet, and these
observations have been confirmed by Stanford et al (1977) at a dose
of 25 mg/kg body weight for 6 days. However, all of these doses
are much greater than the recommended initial clinical dosage in
humans of 12 mg/kg body weight for 4 days (llartindale, 1977)*
Although the dose of 5~Tluoi>ouracil used, in this study (l87 mg/kg)
was also greater than the normal human dose, it was less than half
the dose at which Bounous et al (1971a) observed the beneficial
effects of an 'elemental' diet. Also after injecting more than 500
rats with the sodium salt of 5-Tkuorouracil at this dose no deaths
have occurred. It is presumed that Bounous et al (1971&) used the
sodium salt of 5-Tluorouracil since Hugon and Bounous (1972) did.
Thus, it seems unlikely that the high dose of 5-flu.orouracil used
in this study has prevented observation of the effects of 'elemental'
diets on 5-fku-orouracil toxicity reported by Bounous et al (l971a)«
Furthermore, if the mortality is increased in rats fed on an
'elemental' diet then this must argue against the use of 'elemental'
diets, regardless of their effects on intestinal function.
It must therefore be concluded that the intestinal toxicity of
5-fluorouracil is not significantly reduced in rats fed on an
'elemental' diet. Bounous et al (l971a) claimed that 'elemental'
diets aid recovery from injury since the degree of mitotic arrest
in the intestine was similar for rats fed on an 'elemental' diet
and for rats fed on a standard diet. The mitotic arrest results in
a 65% reduction in mucosal DNA content (Fig. 10.4) and hence a large
reduction in the number of epithelial cells. The malabsorption
symptoms following 5-fluorouracil administration are probably a
direct result of this decrease in the epithelial cell population
(see Chapter 8). It would, therefore, appear more profitable to
prevent this decrease in cell-ui"fimbers rather than to aid recovery
which is already a rapid process.
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CHAPTER 11
The effects of the time of feeding and the time of 5-fluorouracil
administration on the intestinal toxicity of 5-fluoro-qracil -
A-1Chronopharmacological1 approach
Introduction
The severe impairment of intestinal absorption observed following
administration of 5-fluorouracil is probably a direct result of a
reduction in the number of intestinal absorptive cells (Chapter 8).
In Chapter 10 it was concluded that 'elemental' diets do not protect
either the whole body or the small intestine from the toxic effects of
5-fluorouracil and that attempts to reduce this toxicity should
instead be aimed at reducing the initial damage to intestinal cells.
Ecknauer and Rommel (1978) suggested, in principle, that this might be
achieved by relating the time of administration of an antimetabolite to
the cell cycle of the mucosal cells. One might expect that least
damage to the cells would result if the drug were administered during
the resting phase (G^) of the cell cycle.
Skipper _et al (19^7) reported that the ability of cytosine
arabinoside to kill mouse leukaemia cells is greatly dependent upon
the interval between administration of sequential doses of the drug
and that the drug is most effective when the interval takes advantage
of the S-phase specificity of the antimetabolite. Also, Devik and
Hagen (19.73) found that the general systemic toxicity of various anti¬
cancer agents, estimated by body weight loss and mortality, depended
on the time interval between administration of sequential doses of the
drugs: for hydroxyurea and methotrexate they suggested that this
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effect was related to the timing of the cell cycle. Haus et al (1974)
presented results to show that the timing of irradiation can influence
the severity of whole body and gastrointestinal radiation damage.
Willems (1979) in his authoritative review in The Scientific Basis of
Gastroenterology stated that this was the case, but did not give any
supporting evidence or references.
This general approach has been advocated by others especially in
the U.S.A. where the term 'chronopharmacology' has been coined, (see
Reinberg and Halberg, 1979) hut has received little attention in this
country. Although an Editorial in the British Medical Journal (1978)
reviewed favourably the application of 'chronotherapeutics', this
aspect of therapeutics is not widely recognised, and certainly is
seldom exploited.. However, observations mentioned above indicate that
substantial benefits in terms of reduced toxicity of antimetabolites
might be achieved in this way.
Many antimetabolites including hydroxyurea and cytosine arabino-
side are only toxic to cells actually synthesising DNA (i.e. cells in
S-phase) (Heidelberger, 19735 Lozzio, 19^9 5 Sinclair, 1965). However,
it has been suggested that cells are susceptible to 5-fluorouracil and
the related compound fluorodeoxyuridine in all phases of the cell cycle
(Bruce and Meeker, 19&7; lozzio, 19^9) although 5-fluorouracil is more
toxic to rapidly proliferating cells than to non-proliferating cells
(Bruce and Meeker, 1967). Therefore 5-fluorouracil administration time
cannot be related to the cell cycle in order to reduce the intestinal
toxicity of the drug but it might be possible to relate the drug
administration time to the diurnal variation in intestinal cell
proliferation and in the number of villus cells (Al-Dewachi et al,
1976; Stevenson et al, 1979)- These diurnal variations as well as
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those of various intestinal absorptive and enzymic activities have •
been shown to be related to the feeding time in rats (fisher and
Gardner, 1976; Stevenson et_al, 1975; Stevenson and Fierstein, 1976;
Stevenson et al, 1979 )•
All these observations point to the potential value of exploring
the temporal relationships between 5~flu.orouracil injection time, the
cell proliferation cycle, animal feeding time and the subsequent
5~fiu.oroura.cil toxicity; this chapter is therefore devoted to such an
approach to minimizing 5-ffu.orouracil toxicity on the rat small
intestine. Since the intestinal toxicity of 5-fluorouracil might
depend upon the proliferation cycle in the intestinal epithelium, which
in turn is influenced by the feeding time of the animals, there are two
possible approaches to such a study. Both of these have been investi¬
gated - by systematic experimental variation in feeding time while
keeping 5-fluorouracil administration time constant and by systematic
variation in 5~fiuorouracil administration time while keeping feeding
time constant.
Initial observations indicated that 5-ffuorouracil was more toxic
to the intestine when administered in the afternoon than when
administered in the morning and that the toxicity was increased by
fasting the rats overnight prior to 5-fluorouracil injection. These
differences in toxicity might, however, be related to the effects of
feeding time on the proliferative cycle in the intestinal epithelium.
Further, since rats are nocturnal feeders, these differences could
indicate a direct relationship between either the presence of food in
the intestine or the digestive and absorptive activity of the intestine
at the time of injection and the subsequent toxicity of 5-fluorouracil.
Both of these possibilities have been investigated in a study of the
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effects of manipulating the -feeding time of rats on the intestinal
toxicity of 5-fluorouracil. As will he discussed, this approach had
various shortcomings and was eventually discontinued in favour of the
alternative approach in which the effects of a systematic variation in
injection time on the intestinal toxicity of 5-flnorouracil were
studied concurrently with observations of the feeding pattern on
various diets. This chapter describes the results obtained in these
two series of experiments.
2
METHODS
Preliminary studies of the effects of infection time
Initially, 5-fluorouracil (Tris salt, 1.44 mmol/kg body weight)
was administered intraperitoneally to female rats at either 09:00 or
15:30 water absorption rates by the whole jejunum plus ileum were
estimated in vitro on the fifth day after 5-fluorouracil administration.•
Although maximal intestinal toxicity is observed on the third and
fourth days after injection of 5-fluorouracil (Chapter 8), absorption
rates were estimated on the fifth day in order that the 6J- hour
difference in injection time would be small relative to the interval
between injection and absorption measurement. The rats had free access
to the Oxoid diet for at least 7 days prior to 5-fluorouracil
administration and thereafter.
In a second experiment, the effects of intestinal digestive
activity, i.e. the presence of food in the gut at the time of
5-fluorouracil administration, were investigated. 5-fluorouracil
(Tris salt, 1.44 mmol/kg body weight) was administered near to the end
of the normal feeding period (07:00) to two groups of female rats; one
group had free access to Oxoid for 7 days prior to 5-fluorouracil
administration and the other group was fasted from 11:00 on the day
prior to 5-fluorouracil administration. All rats had free access to
the Oxoid diet after injection. Water absorption rates by the whole
*
jejunum plus ileum were estimated in vitro on the third day after drug
administration.
Restriction of feeding time
5-fluorouracil (Tris salt, 1.44 mmol/kg body weight) was
administered intraperitoneally to rats at a fixed time, viz. 10:00;
rats were from two groups, one of which was fed immediately before the
time of drug administration and the other was fed 12 hours prior to tli
time of drug administration. Since rats fed ad lib consume 40% of
their whole days food intake between the hours of 19:00 and 22:00
(see Fig. II.14b), and since preliminary observations indicated that
rats whose feeding was restricted to 3 hours each day would adapt to
consume the same amount of food as that consumed by rats fed ad lib,
the two groups were fed for only 3 hours each day, either between
07:00 and 10:00 or between 19:00 and 22:00, for two weeks prior to
5-fluorouracil administration. A short feeding period has the
advantage that it minimises variability in feeding times between
animals. Also, Fisher and Gardner (1976) had claimed that normal
growth rates were observed in rats fed for only 3 hours each day.
In most experiments access to food was limited by use of the
automatic feeder cages described in Chapter 2 (p. 15). However, this
method was not suitable for use with a non-pelleted 'elemental' diet
and therefore when this diet, Diet 33, was used and in some experiments
where the Oxoid diet was used,access to food was limited manually.
In all experiments in which access to food was limited, the rats
were caged in groups of 4 since this was the maximum number of rats
that could be housed together such that all rats showed an overall
weight gain over the 14 day period of restricted access to food (see
p 286). It was not practical to put less than 4 rats in each cage due
to lack of space in the animal house although this would have been
ideal.
Body weights and food intakes were recorded daily and the feeding
regimes were continued after 5-Bluorouracil administration. Control
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rats received no injection.
Water absorption rates by the whole jejunum plus ileum were
estimated in vitro by the method described in Chapter 3 all
measurements were made between 10:00 and 16:00 on the third day after
5-fluorouracil injection or, in control rats, on the 17th day of the
food restriction regime (i.e. 14 days + 3 days).
Variation of 5-fluorouracil administration time
5-fluorouracil (sodium salt, 1.44 mmol/kg body weight) was
administered intraperitoneally to male rats at various times of the
day and night. All injections were given within 10 minutes of the
specified time. Body weights, food intakes and the incidence of
diarrhoea were recorded subsequently at 10:00 each day. The last was
obvious upon inspection of the rats.
Initially, all the rats had free access to the Oxoid diet before
and after 5-fluorouracil administration. In some instances, specified
below, the diet was replaced by an 'elemental' diet (Diet B) and in
some other experiments access to the diet (Oxoid or Diet B) was
restricted to the period 19:00 to 22:00 for 14 days prior to
5-fluorouracil-administration. All rats were caged in groups of 4
unless otherwise stated and had free access to food after 5-fluorouracil
administration.
Absorption rates were measured between 3 and 4 days a-fter
5-fluorouracil injection since the lowest absorption rates following
injection at 10:00 had been observed on the third and fourth days (see
Chapter 8, fig. 8.3). Since there is a diurnal variation in water
absorption rates, all absorption measurements were made between 10:00
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and 16:00. Thus, absorption rates were estimated on the third day-
after injection between 00:00 and 11:00 inclusive and on the fourth
day after injection between 15:00 and 23:00 inclusive.
The dry weight of intestines was not used as a parameter to
estimate intestinal damage in these experiments. Because of the
diurnal variation in absorption rates it is not possible to estimate
absorption rates and dry weight at a fixed time after administration
of 5-fluorouracil. Absorption rates were similar on the third and
fourth days after injection of the drug at 10:00 and therefore it is
probable that any variation in the absorption rates estimated between
the third and fourth days will be due to the variation in drug
administration time. However, there is an increase in the intestinal
dry weight between the third and fourth days after administration of
5-fluorouracil at 10:00 (Chapter 8, Fig.8.4) and therefore variations
in the intestinal dry weight between the third and fourth days after
drug administration cannot solely be attributed to the time of drug
administration.
Plasma pharmacokinetics
Male rats, weighing 200 g, were anaesthetised 1 hour before use by
subcutaneous injection of urethane (l.5 Eil of 0.8 g/ml solution) while
under temporary light ether anaesthesia. Plasma pharmacokinetics were
estimated after an intraperitoneal injection of 5-fluorouracil (sodium
salt, 1.44 mmol/kg body weight) at either 10:00 or 02:00 by the method
described in Chapter 9.
DNA estimation
The DNA content of the mucosa from whole jejunum plus ileum from
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control, uninfected, male rats was estimated at various times of the
day and night by the method described in Chapter 5•
Feeding pattern
The hour to hour food consumption of rats was determined by
changing the lid of the cage which contained the food, or by removal
of the food bowl when an 'elemental' diet was used, at 1 hour intervals
and noting the weight of food remaining. Special care was taken to
minimise the disturbance to the animals; thus, the cage lid was
replaced by one into which the weighed diet had already been quietly
placed, and the lighting in the animal rooms was not interfered with
even though it became necessary to perform these operations in the
dark. All rats were allowed 1 week prior to observation to adjust to
the housing or dietary regime. They were either caged individually or
in groups of 4 and fed on the Oxoid diet or they were caged in groups
of 4 and fed on the 'elemental' diet, Diet B. In order to determine
whether the hourly disturbance associated with this method of
observation materially influenced the feeding pattern of the rats a
further two cages of 4 rats, fed on the Oxoid diet, were observed at
2 hour intervals.
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Table 11,1 Intestinal water absorption rates and dry weights on the
fifth day after 5-f7"U-orouracil (Tris salt) administration to female
rats at either 09:00 or 15*50
Injection Water absorption rate
time (pl/cm/hr) % of control
09 s 00 106.7 - 13.5 (7)') 76.9
xx
15:30 52.3 - 7-8 (7) \ 37-7
Intestinal dry weight
(mg/cm)
09:00 10.72 - 0.48 (7)'") 93.1
15:30 8.34 - O.38 (7)J 72.5
Values are the mean - S.E.M, and the number of animals is shown in
parentheses. The significance levels of the differences between
injection times are indicated thus: ** P^O.01.
280
RESULTS
Preliminary observations on the effects of injection time on intestinal
absorption and dry weight
Table 11.1 shows the water absorption rates and dry weights of
intestines from rats which had been injected with 5 -fluorourac.il 5
days previously at either 09:00 or 15:30. The results are also
expressed as a percentage of those from control (uninjected) rats. On
the fifth day after 5-fluorouracil administration at 09:00 intestinal
water absorption rates were 77% of control rates, which is significantly
greater (P^dO.Ol) by a factor of 2 than those observed on the fifth
day after administration of 5-fluorouracil at 15:30. Similarly, the
dry weights of intestines from rats injected at 09:00 were significantly
greater (P-=r0.0l) by 29% on the fifth day after injection than those
from rats injected at 15:30.
Effects of previous starvation on the intestinal toxicity of
5-fluorouracil
Table 11.2 shows the water absorption rates and dry weights of
intestines from rats which had been injected 3 days previously with
5-fluorouracil at 07:00. The rats had either had free access to Oxoid
prior to 5-fluorouracil injection or had been fasted for 20 hours prior
to injection.
Water absorption rates on the third day after 5-fluorouracil
administration were decreased by 72% in 'fed' rats and by 88% in fasted*
rats and the difference was significant (P< O.OOl). Similarly the
* Both are compared with 'fed' control rates
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Table 11.2 Intestinal water absorption rates and, dry weights on the
third day after 5-fluorouracil (Tris salt) administration to female










38.5 - 2.3 (6) 1
L ***








6.59 - 0.60 (8)




Values are the mean - S.E.M. and the number of animals is shown in
parentheses. The significance levels of the differences are
indicated thus: *** p«= 0.001; ** P < 0.02.
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decrease in intestinal dry weight on the third day after 5-fluorouracil
injection was significantly^greater in fasted rats (55%) than in 'fed'
rats (43%, P-^0.002).
Effects of restricted access to food on food intakes and growth rates
The'results shown in Tables 11.1 and 11.2 show that the intestinal
toxicity differs with the time of injection of 5-f-luorouracil; this
might be related to the feeding time of the rats or to the functional
activity of the small intestine at the time of 5-fluorouracil
administration. These possibilities have been investigated by deter¬
mining the effects of two different feeding regimes on the intestinal
toxicity of 5~fluorouracil. Animals were fed either immediately before
the time of 5-fluorouracil injection or some 12 hours previously.
Pig. 11.1 shows the daily food intake of two groups of rats fed
ad lib on the Oxoid diet for five days and then allowed access to the
Oxoid diet between 19:00 and 22:00 (Pig. 11.1A) or between 07:00 and
10:00 (Pig. 11.1B). After a decrease in the daily food intake at the
start of the period of restricted access to food there was a gradual
daily increase in food intake such that by the eighth day of the
dietary regime the daily food intake was within the normal range of
daily food intakes observed when the rats had free access to Oxoid. A
similar pattern was observed when the Oxoid diet was replaced by an
'elemental' diet, Diet B (results not presented).
Although the daily food intake of rats with restricted access to
the Oxoid diet became similar to that of rats fed ad lib, the growth
rate of the rats with restricted access to food was decreased. Table
11.3 shows the growth rate of rats with free access to food and of those
that had access to food for only' 3 hours each day. The growth rate of
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Pig. 11.1 Daily food intakes of male rats fed ad lib on the Oxoid
diet for 5 days and then allowed access to food only between 19:00 and
22:00 (a) or between 07:00 and 10:00 (b) each day for the next 14 days.
Results are the mean daily food intake per rat from 1 cage of 4 rats




























































Table 11,5 Daily body weight p;alns of male rats on various dietary
regimes
Daily body weight gain % of gain on
Diet Feeding time (g/day/rat) ad lib regime
Oxoid ad lib 6.05
T
0.21 (34) 100
Diet B ad lib 5.31
+
0.35 (32) 100
Oxoid 07:00 - 10:00 5.22
+
0.19 (32) 86.3
Diet B 07:00 - 10:00 5-33
+
0.40 (34) 100.4
Oxoid 19:00 - 22:00 4-41
+
0.34 (40) 72.9
Diet B 19:00 - 22:00 5-43
+
0.23 (48) 102.3
Results axe the mean - S.E.M. and the number of observations is shown
in parentheses. When rats had restricted access to food 1 observation
refers to the mean body weight gain of a rat between the seventh and
fourteenth days of the dietary regime.
rats fed on Oxoid was decreased'by 14% (P*=0,0l) when access was
limited to between 07:00 and 10:00 and by 27% (P-=-0.00l) when access
was limited to between 19:00 and 22:00.
However, when access to Diet B was limited to only 3 hours each
day both the food intake and the growth rate between the eighth and
fourteenth days of the dietary regime were equal to those of rats with
free access to Diet B. It should be noted, however, that the growth
rate of rats with free access to Diet B was significantly less by 12%
(PcO.Ol) than that of rats with free access to the Oxoid diet.
Effects of animal housing on growth rates
Pigs. 11.2 and 11.3 show the body weights of individual rats on
each of the first 14 days of a food restriction regime. The rats were
fed on Oxoid between 19:00 and 22:00 and were caged in a group of 5
(Pig. 11.2) or in a group of 4 (Fig. 11.3)- After an initial loss of
body weight a steady growth rate was observed when rats were caged in
a group of 4 and the mean weight gain over the 14 day period was 34-3
+5*8 g/rat. However when rats were housed in a group of 5 the mean
weight gain over the 14 dajr period was only 11.8 + 6.1 g/rat and one
rat (Pig. 11.2D) failed to regain its initial body weight. The food
intakes of these two groups of rats also differed. Whilst that for the
group of 4 (19• 5 + 0 42 g/day/rat) was not significantly different
from the food intake of rats fed ad lib (P< 0.5) the food intake
of the group of 5 (15*0 ± 0.71 g/day/rat) was significantly less
(P<0.02).
Effects of restricted access to food on the intestinal toxicity of
5-fluorouracil




































































































Time from start of dietary regime (days)
Figs. 11.2 and 11.3 Daily body weights of individual rats on each
of the first 14 days of a dietary regime in which rats were only
allowed access to food (Oxoid diet) between 19:00 and 22:00 each day.
The rats were either caged in a group of 5 (Fig. 11.2) or in a group
of 4 (Fig. 11.3). The mean daily body weight gain of each rat
between the seventh and fourteenth days of the dietary regime is
shorn in parentheses.
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Fig. 11.4 Intestinal water absorption rates by the small intestine
from rat's fed ad lib on the Oxoid diet or Diet B and of rats fed on
the Oxoid diet or Diet B between 07:00 and 10:00 or between 19:00 and
22:00 each day (open bars). Also shown are the water absorption rates
estimated on the third day after 5-Hnorouracil injection at 10:00 on
the fourteenth day of each of these dietary regimes (hatched bars).












































































Fig. 11.5 Intestinal dry weights from rats fed on the Oxoid diet
or Diet B ad lib or between 07:00 and 10:00 or between 19:00 and
22:00 each day (open bars). Also shorn are the intestinal dry weights
measured on the third day after 5-fluorouracil injection at 10:00 on
the fourteenth day of each of these dietary regimes (hatched bars-).
Values are the means ~ S.E.M. and the number of observations is
shown within the bars.
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small intestine of rats' fed on the Oxoid diet or on Diet B either ad
lib or for only 3 hours each day. Also shown (hatched bar's) are the
absorption rates on the third day after 5-fluorouracil injection at
10:00 on the fourteenth day of each of these dietary regimes.
When access to the Oxoid diet or to Diet B was restricted to
between 07:00 and 10:00 each day, water absorption rates by control
intestines (uninjected rats) were significantly higher (P=0.00l),
by 5&% and. 39% respectively, than those from rats fed ad lib on the
same diet. In contrast, water absorption rates were the same when
access to food was limited to between 19:00 and 22:00 each day (P^=0.5)
as when unrestricted access to food was given.
However, neither regime had any effect on the intestinal toxicity
of 5-flnorouracil when rats were fed on the Oxoid diet. Although the
intestinal -water absorption rate on the third day after 5-fluorouracil
administration was slightly greater when rats were fed on Diet B ad lib
rather than the Oxoid diet ad lib, this difference was not significant
(P>0.l).* However, when access to Diet B was limited to only 3 hours
in each day the water absorption rates were significantly lower on the
third day after 5-fluorouracil administration than those observed when
the rats had free access to Diet B prior to 5-fluorouracil injection
(P«=0.0l).
The dry weight of the intestine of control (uninjected) rats was
not affected when access to the Oxoid diet was limited to between
* The skewed distribution of absorption rates 3 days after 5-fluorour-
acil administration to rats fed ad lib on Diet B indicating that this
diet may be of benefit to some ra.ts is discussed further in Chapter 10.
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Fig. 11.6 Vater absorption rates by rat small intestine 3 or 4 days
after 5-fluorouracil injection at various times of the day and night.
Absorption rates were measured on the third day after injection
between 00:00 and 11:00 inclusive (©) and on the fourth day after
injection between 15:00 and 23:00 inclusive (o). Values are the
•f*
means - S.E.M. and the number of animals used is shown above each
point. The timing of the light-dark cycle is shown on the abscissa.
29k
07:00 and 10:00 each day hut it was decreased by 18% (P-=r 0.05) when
access to the Oxoid diet-was limited to between 19:00 and 22:00
(Fig. 11.5). The intestinal dry weight was significantly greater,
by 17%, when Diet B was supplied rather than the Oxoid diet (P-=^0.02),
and this was also observed when access to the diet was limited to only
5 hours each day. The intestinal dry weight on the third day after
5-fluorouracil administration was also greater, by about 18%
(p-=r0.05) when rats were fed on Diet B rather than on the Oxoid diet.
Effects of injection time on water absorption and the incidence of
diarrhoea
Pig. 11.6 shows the intestinal water absorption rates measured
in vitro between 3 and 4 days after 5-fluorouracil administration at
various times of the day and night. It is clear that the water-
absorption rates varied systematically with the time of
5-fluorouracil administration. The highest absorption rates were
observed following injection at 02:00 and these were greater by a
factor of 3 than those observed after injection at 01:00 (PcO.Ol).
Absorption rates after injection at all other times were less than
those after injection at 03:00. Furthermore, the least incidence of
diarrhoea in vivo occurred following injection at 02:00 and 03:00
(Pig. 11.7)• Administration of 5-fluorouracil at all other times was
associated with a remarkably high incidence of diarrhoea and an
obvious general malaise in the rats by the third day after drug
administration. This difference is clearly demonstrated in Plate 11.1
which shows the general appearance of two rats on the third day after
5-fluorouracil administration. One rat was injected at 02:00


































































5- FLUOROURACIL INJECTION TIME
Fig. 11.7 The incidence of diarrhoea observed over 3 days
immediately after a single injection of 5-fluorouracil administered
at various times of the day and night. Values are the percentage of




(A) Injection time 02:00
(B) Injection time 15:00
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However, the injection time had no obvious effect on the food
intake of these rats during—the period between drug administration and
estimation of intestinal water absorption (Pig. 11.8). In order to
allow for the hour to hour variation in food intake and to compare the
food intakes of the rats they were expressed as a percentage of the
expected food intake of uninjected rats over the same period which
was calculated from the results shown in Pig. 11.14b.
Water absorption rates on each of the first 7 days after 5-fluorouracil
injection at 02:00 and 15:00
Two injection times were then selected representative of minimum
and maximum intestinal toxicity, 02:00 and 15:00 respectively.
Pig. 11.9 shows the water absorption rates measured on each of the
first 7 days after 5-fluorouracil injection at these two times. Apart
from an initial rise on the first day after administration at 15:00,
the absorption rates were consistently higher after injection at 02:00
than after injection at 15:00. Absorption rates have returned to
normal between the sixth and seventh days after injection at either
time and were slightly, though not significantly (P>0.l) greater
than control rates by the seventh day.
The maximum decrease in body weight occurred on the fourth day
after injection at 02:00 when the body weight was 88% of that prior to
injection (Pig. 11.10). In contrast, after injection at 15:00 the
body weight decreased further between the fourth and fifth days, such
that by the fifth day it was only 82% of that prior to injection.
The time of injection did not affect the pattern of change in
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Fig. 11.8 Total food intake over the three to four day period
between 5~fluorouracil administration and estimation of intestinal
absorption of male rats injected with 5-fluorouracil at various time
of the day and night. Values are expressed as a percentage of the
normal food intake of uninjected rats over a similar period.
Estimates of food intake were obtained from 2 cages of 4 rats for
each injection time. The timing of the light-dark cycle is shown on
the abscissa.
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Fig. 11.9 Water absorption rates by rat small intestine on each of
the first 7 days following 5-fluorouracil injection at 02:00 (solid
line) and 15:00 (broken line). Absorption rates (means ~ S.E.M.) are
plotted against the interval between injection and absorption






































Time after 5-fluorouracil injection (days)
Fig. 11.10 Body weights of rats on each of the first 5 days after
5-fluorouracil administration at either 02:00 (solid circles) or 15;00
(open circles). Body weights (mean - S.E.M.) are expressed as a
percentage of the body weight at 10:00 on the day before 5-fTuorouracil
administration. The number of observations for both injection times
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Fig. 11.11 Dry weights of rat small intestine on each of the first
7 days following 5-fluorouracil injection at 02:00 (o) and 15:00 (o).
Dry weights (mean - S.E.M.) are plotted against the interval between
injection and removal of the intestine for dry weight measurement.
The number of animals used is shown above each point.
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presented but see Fig. 11.8).
Plasma pharmacokinetics of 5-fluorouracil after administration at 02;CO
The decreased intestinal toxicity of 5-fluorouracil after
administration at 02:00 could be the result of a difference in either
absorption or metabolism of the drug at this time. This possibility
was investigated by measurement of the plasma pharmacokinetics of
5-fluorouracil after an intraperitoneal injection at either 02:00 or
10:00. There was no significant difference in the plasma levels of
5-fluorouracil during the first 240 minutes after 5-flnorouracil
administration at these two times (Fig. 11.12). The number of
animals studied, however, is insufficient to permit the definite
exclusion of this possibility.
Mucosal DNA content
Fig. 11.13 shows the DNA content of the small intestinal mucosa
of control (uninfected) rats estimated at various times of the day
and night There is an obvious diurnal variation in the mucosal DNA
content which is at a maximum between 03:00 and 04:00 and a minimum
around 15;00.
Feeding pattern
Fig. 11.14 shows the food intake of rats fed on the Oxoid diet or
Diet B observed over a single 24 hour period. When rats were fed on
Oxoid arid caged in groups of 4j 40% of the total daily food intake was
consumed within a 3 hour period, 19:00 - 22:00, which coincided with
the start of the dark period (Fig. 11.14b). Throughout the rest of
the 24 hours there was a small, but sustained, food intake of about
0.5 g/h/rat. This pattern was observed regardless of whether the
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Time after 5-fluorouracil i.p. injection (min)
Pig. 11.12 Plasma levels of 5-fluorouracil after a single intra¬
peritoneal injection at either 10:00 (o) or 02:00 (©) in anaesthetised,
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Fig. 11.13 Mucosal DNA content of rat small intestine (whole
jejunum plus ileum) estimated at various times of the day and night.
Values are the means - S.E.M. of estimates from 4 rats. The timing of
the light dark cycle is shown on the abscissa.
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Pig. 11.14 Pood intakes of rats observed over a single 24 hour
period. Rats were either fed on the Oxoid diet and (a) caged
individually, (b) caged in groups of 4 and "the food intake observed at
1 hour intervals, (c) caged in groups of 4 and the food intake
observed at 2 hour intervals or (d) rats were fed on Diet B and caged
in groups of 4- Values are the mean hourly food intake observed over
the period represented by the width of the bars. Where there are no
bars shown the food intake was zero. The numbers of animals used
were (a) 12 rats, (b) - (d) 2 cages of 4 rats. The timing of the
light-dark cycle is shown below the abscissa.
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(a) Oxoid lrat/cage
(b) Oxoid 4 rats/cage
(c) Oxoid 4 rats/cage
(d) Diet B 4 rats/cage
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observations were made at 1 or 2 hour intervals (Fig. 11.14b and. 14c).
However, when the rats were caged individually a strikingly
different pattern of consumption of the Oxoid diet was observed
(Fig. 11.14a). There was a sustained food intake of about 1.5 g/h/rat
throughout the period from 17:00 to 06:00. During the remaining
11 hours the food intake was negligible (0.7 g/rat). The total daily
food intake of rats caged individually (24 g/day/rat) was 26% greater
than that of rats caged in groups of 4 (19 g/day/rat).
When rats were fed on the 'elemental' diet, Diet B, and caged in
groups of 4 there was a sustained food intake of about 1.5 g/h/rat
throughout the period from 17:00 to 06:00 and the food intake during
the rest of the 24 hours was negligible (l.3 g/rat) (Fig. 11.14d).
Thus this pattern was similar to that observed in the individually
caged rats eating the Oxoid diet (Fig. 11.14a).
Relationship between feeding time and the intestinal toxicity of
5-fluorouracil
The relationship between the different feeding times observed
under different caging patterns and the intestinal toxicity of
5-fluorouracil was then examined. Fig. 11.15 shows the water absorption
rates by the small intestine from uninfected control rats (hatched
bars) and of rats 3 days after 5-fluorouracil injection at either 02:00,
03:00 or 10:00. The animals had been caged in groups of 4 and fed ad
lib on either the Oxoid diet or Diet B, or had been caged individually
with free access to the Oxoid diet for at least 1 week before
5-fluorouracil administration. Also shown are the results from rats
which had restricted access either to the Oxoid diet or to Diet B only
between 19:00 and 22:00 for 14 days prior to 5-fluorouracil
administration. All the rats had free access to food after
5-fluorouracil injection.
The daily body weight gain of uninfected rats on each of the
dietary regimes is also shown in the upper part of Fig. 11.15.
Fig. 11.15 shows that the intestinal toxicity of 5~fluoroura.cil
was much less severe after injection at 02:00 than after injection
at 10:00 when rats were fed ad lib on the Oxoid diet and caged in
groups of 4 as already shown in Figs. 11.6 and 11.7. Prior to
injection these rats consumed A£P/o of their total daily food intake
between 19:00 and 22:00 (Fig. 11.14b). However, the intestinal
toxicity of 5-flr.orouracil was not reduced by administration at 02:00
when rats were caged individually and fed on the Oxoid diet (P'ig. 11.
15b). These individually caged rats (unlike those caged in groups of
4) did not show any peak in their food intake between 19:00 and 22:00
- see Fig. 11.14a. Similarly, there was no peak in the food intake
between 19:00 and 22:00 when rats were fed on Diet B and caged in
groups of 4 (Fig. 11.14d); likewise, the intestinal toxicity of
5-fluorouracil in these animals was not reduced by injection at
02:00 (Fig. 11.15d). However, when access to Diet B was limited to
only 3 hours each day (19:00 - 22:00) the intestinal toxicity was
reduced by drug administration at 02:00 (Fig. 11.15e). When rats
were allowed access to the Oxoid diet during this period (19:00 -
22:00) each day there was no beneficial effect of administration of
5-fluorouracil at 02:00 (Fig. 11.15c). Although the food intake of
the rats on this regime was similar to that of rats with free access
to the Oxoid diet, the growth rate was only about 65% of that of the
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5 - FLUOROURACIL INJECTION TIME
Fig. 11.15 Water absorption rates by the small intestine of control,
uninfected, rats (hatched bars) and of rats 5 days after 5~fluorouracil
injection at various times. Rats were either caged individually with
free access to the Oxoid diet, or were caged in groups of 4 and either
had free access to the Oxoid diet or Diet B or had access to the Oxoid
diet or Diet B between 19:00 and 22:00 only each day. Values are
Hieans - S.E.K. and the number of animals used is shown within the bars.
The daily weight gain of the rats, prior to 5~fluoroura.cil injection,
on each of the dietary regimes is also shown in the top part of the
4*
Figure. Values are means - S.E.M. and the number of observations is
shown within the bars.
DISCUSSION
The preliminary study, the results of which are shown in Tables
11.1 and 11.2, makes it quite clear that the intestinal toxicity of
5-fluorouracil is influenced by either (l) the feeding time of the
animals, (2) the time of drug administration, or (3) the relationship
between these two factors. Hence this suggested an obvious line of
enquiry which ought to be pursued in any attempt to find conditions
under which the toxicity of 5-fluorouracil may be minimised. The
experiments in which the feeding time was restricted were not
successful. As discussed below these experiments have various weak¬
nesses and it is clear that an unmanageable number of dietary regimes
would have to be tested before a definitive assessment of the value of
this approach could be obtained. Therefore the approach of altering
the time of injection whilst keeping the feeding time constant was
pursued and it is this approach which has given the most promising
results with a view to minimising the intestinal toxicity of
5-fluorouracil. One of the difficulties in designing sound experiments
to test the value of manipulation of 5-fluorouracil injection time is
that it is not possible to alter only one of the three possible
temporal factors, viz. injection time, time of measurement of absorption,
and the interval between these two procedures.
Restriction of feeding time
Although Fisher and Gardner (1976) reported that the growth rate
of rats was normal when access to food was limited to only 3 hours each
day, others have shown that food restriction results in severely
reduced growth rates (Callahan, 1979; Stevenson et al, 1975; Stevenson
and Fierstein, 197^). The results presented in this study demonstrate
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that when access to food is limited, the growth rate of rats can be
affected by the diet, the number of animals in each cage and the actual
time of day during which access is allowed.
Although the food intake of rats allowed access to the Oxoid diet
for only 3 hours each day became very similar by the eighth day of the
regime to that of rats fed ad lib, the daily gain in body weight was
markedly reduced (Fig. 11.1 and Table 11.3). The decrease was greatest
(27%) when rats were fed in the evening only (19:00 -'22:00). This was
surprising since rats fed ad lib consume 40% of their total daily food
intake during this period (Fig. 11.14b) and it was expected, therefore,
that this feeding regime would involve minimal adaptation. A severe
reduction of the growth rate of some rats was observed when rats were
caged in groups of 5 instead of in groups of 4 (Figs. 11.2 and 11.3);
the food intakes of these rats was only 77% of' that of rats fed ad lib.
It was also noted that rats, fed ad lib on the Oxoid diet, consume 26%
more food when caged individually than when caged in groups of 4«
These observations may indicate competition between rats for access to
food during a short feeding period. Although this suggests that the
growth rate of rats fed on the Oxoid diet for only 3 hours each day
might have been increased if the rats were caged individually,
unfortunately this was not practical due to limited space in the
animal house.
However, when rats were fed on the 'elemental' diet, Diet B, the
growth rate of those fed for only 3 hours each day was similar to that
of rats fed ad lib. Although the growth rate of the latter group was
12% less than that of rats fed ad lib on the Oxoid diet, there is no
evidence to suggest that the intestinal toxicity of 5-fluorouracil is
greater in rats fed on this diet. Indeed there is some evidence which
indicates that Diet B may reduce""'bhe intestinal toxicity of
5-fluorouracil in some rats (see Chapter 10).
Thus it is concluded that a 3 hour feeding period was insufficient
to support the normal growth rate of rats fed on an unhydrolysed diet.
It may be possible to maintain the growth rate under similar conditions
either by housing the rats individually or by extending the feeding
period to 4 hours each day. In contrast, when rats are fed on an
'elemental' diet the growth rate and food intakes are unaffected when
access to food is limited. Further support for this conclusion is
apjjarent from the decrease in the dry weight of intestines from rats
fed for only 3 hours each day on the Oxoid diet (Fig. 11.5). Also,
the dry weight of intestines from rats fed ad lib on Diet B was 17%
greater than those from rats fed ad lib on the Oxoid diet, and this
increase was also apparent in intestines from rats fed for only 3 hours
each day on Diet B.
Since it was shown that the intestinal toxicity of 5~fluorourac.il
is increased by an overnight fast prior to administration of the drug
(Table 11.2) these observations indicate that the two feeding regimes
(07:00 - 10:00 and 19:00 - 22:00) with the Oxoid diet may increase the
intestinal toxicity of 5-fluorouracil. Thus it was of interest to
include the two feeding regimes with the 'elemental1 diet in this study,
since the growth rates and food intakes of rats with restricted access
to Diet B were similar to those of rats fed ad lib.
Effects of restricted access to food on intestinal absorption
Previously, Fisher and Gardner (1976) showed that both glucose and
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water absorption by the isolated small intestine was 50-60% greater at
night than during the day and, furthermore, they showed that this
diurnal rhythm was related to the feeding time of the rats. The
results presented in Pig. 11.4 are consistent with these observations;
water absorption rates by intestines from rats allowed access to the
Oxoid diet between 07:00 and 10:00 each day were 59% greater than those
from rats fed ad lib on the Oxoid diet (Pig. 11.4). When the Oxoid
diet was replaced by Diet B, absorption rates were 20% greater in rats
fed ad lib, although this increase was not significant (P:=>0.l);
these rates were also increased by 39% when access to the diet was
restricted to the period 07:00 to 10:00. However, absorption rates
were unaffected when access to either diet was limited to the period
19:00 to 22:00, which ended at least 12 hours prior to measurement of
absorption. This was expected, since this period corresponds to that
during which rats fed ad lib on Oxoid consume 40% of their total daily
food intake.
Effects of restricted access to food on 5-fluorouracil toxicity
The tiro feeding regimes were chosen such that 5-fluorouracil was
administered immediately after the end of the feeding period (07:00 -
10:00) or 12 hours after the end of the feeding period (19:00 - 22:00).
Since intestinal water absorption was impaired to a similar extent in
rats fed ad lib on the Oxoid diet and in rats fed for only 3 hours each
day on this diet, it is concluded that the intestinal toxicity of
5-fluorouracil is not directly influenced by the presence or absence of
food in the gastrointestinal tract, or by the digestive and absorptive
activity of the small intestine at the time of drug administration.
No conclusion can be drawn with respect to the effects of feeding
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time on the intestinal toxicity of 5-fluorouracil since only two feeding
regimes were used. When rats were fed on the Oxoid diet, intestinal
water absorption and dry weights were decreased to a similar extent
in rats fed ad lib and in rats fed for only 3 hours each day (fig. 11.4
and 11.5). However, when rats had limited access to Diet B the slight
and equivocal benefit, observed in rats fed ad lib on this diet prior
to 5-fluorouracil administration, was no longer observed. Since the
cause of the decrease in the severity of the toxicity of 5-flu.orouracil
in some rats fed on Diet B is not known (see Chapter 10), the effects
of the feeding regimes cannot be explained.
These results do not exclude the possibility that a relationship
exists between feeding time and drug toxicity. However, in order to
obtain sufficient information to enable firm conclusions to be drawn a
large, and unmanageable, number of feeding regimes would have to be
used. A further problem associated both with this approach and with
that of varying the drug administration time arises because the
quantity of drug administered is calculated on a body weight basis.
Consequently a larger dose of 5-fluorouracil (about 12% greater) was
administered to rats injected during or just after the feeding period
than was administered to rats injected some time after the end of the
feeding period. However, it was shown in Chapter 8 (Fig. 8.8) that the
intestinal toxicity of 5-fluorouracil was equally severe when the dose
was reduced by 25%.
The results obtained with the Oxoid diet indicate that these
feeding regimes do not maintain the normal growth of rats. It is •
clear that this approach has weaknesses and therefore it was not
pursued further in favour of the approach of variation of the drug
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administration time.
Variation of drug? administration time
The alternative of varying the time of 5-fluorouracil administrat¬
ion has proved to be the most promising approach to the problem of
redaction.of the toxicity of this drug. The results in Figs. 11.6 and
11.7 show clearly that the intestinal toxicity of 5-fluorouracil varies
markedly with the time of administration of the drug. Least toxicity,
estimated both by the effects on intestinal water absorption in vitro'
and by the incidence of diarhhoea in vivo, is observed in rats which
have been injected with the antimetabolite at 02:00 (Figs. 11.6 and
11.7 and Plate 11.l). The duration of intestinal toxicity is, however,
independent of the injection time (Fig. 11.3). Also, although the
time of injection did not affect the food intakes of the rats, the
reduction in body weight by the fifth day was less after injection at
02:00 (Figs. 11.8 and 11.10).
Absorption rates were significantly greater (PcO.Ol) by a factor
of 3 after administration at 02:00 than after administration at 01:00.
Since both of these estimates were made on the third day after
5-fluoroura.cil administration, it is clear that the diurnal variation
is not the result of estimation of absorption rates at varying times
between 3 and 4 days after 5-fluorouracil administration. Also, since
the minimum toxicity was observed in rats injected just after the peak
of feeding activity (19:00 - 22:00), the diurnal variation in toxicity
cannot be the result of drug administration on a body weight basis.
Furthermore, apart from the rise on the first day after administration
of 5-fluorouracil at 15:00, the injection time associated with maximal
intestinal toxicity, absorption rates were consistently higher after
administration at 02:00 than after administration at 15:00 on each of
the first 5 days after administration of 5-fluorouracil (Fig. II.9).
Although absorption rates were not significantly increased on the first
day after administration at 10:00 (Chapter 8), Gardner et al (1978)
demonstrated a significant increase at this time. It is possible that
there is a transient increase in absorption rates on the first day
after injection of the drug and that this was not observed after
administration at 02:00, since the first measurements of absorption
were not made until 32 hours after drug administration.
The plasma pharmacokinetics of 5-flnorouracil were similar after
intraperitoneal administration at 10:00 and at 02:00 (Fig. 11.12) and
this suggests that the differential toxicity of 5-fluorouracil after
administration at various times is not due to a major difference in
absorption and metabolism of the drug at these times.
In these experiments, 5-flnorouracil was administered via the
intraperitoneal route and the observations on plasma pharmacokinetics,
discussed in Chapter 9» indicate that plasma levels of the drug remain
elevated for at least 3 to 4 hours - see also Fig. 11.12. Thus a single
intraperitoneal injection at 02:00 is equivalent to an intra-arterial
infusion sustained over the period 02:00 to 06:00 (Fig. 11.12). This
raises the possibility that the toxicity might be decreased even
further by administration via a single bolus intra-arterial or intra¬
venous injection - a possibility which merits further attention.
There is a diurnal variation in intestinal cell proliferation and
in the number of villus cells (Al-Dewachi et al, 1976; Stevenson et al,
1979)- Al-Dewachi et. al (1976) showed that in the rat jejunum the
mitotic index was minimal at 02:00 and maximal at 15:00, and this is
consistent with the observation of a diurnal variation in the mucosal
DNA content which is maximal-^between 03:00 and 04:00 and minimal around
15:00 (Fig 11.13). Hence the optimum time for 5-flnorouracil
administration may coincide with the maximum number of cells in the
post mitotic resting (G]_) phase or simply with the maximum number of
intestinal cells.
Halberg (1977) demonstrated that cytosine arabinoside, when
injected on a sinusoidal schedule, is less toxic to host tissue in
mice when the largest portion of the total 24 hour dose is given around
the mid-point of the light span. This is consistent with the results
of this study, since the diurnal rhythm of proliferative activity in
the mouse small intestine is 12 hours out of phase with that of the rat
(Sigdestad and Lesher, 1970).
The substantial diurnal variation in mucosal DMA content (Fig.
11.3) corresponds approximately to the diurnal variation in glucose
and water absorption already observed (Fisher and Gardner, 197&).
This suggests that the increase in absorption rates at night could be
due to an increase in the number of absorbing cells. However, it must
be noted that the mucosal DHA content includes cells from the crypts
and from the lamina propria as well as those of the villus and there¬
fore is not a specific index of the number of absorbing cells.
Stevenson et. al (1979) showed that there is a diurnal variation in both
the villus height and the number of villus cells and that both are
maximal around the time of feeding. Their results lend support to the
above suggestion.
Diurnal variations in various intestinal absorptive and enzymic
activities and in the proliferative state of the epithelium have been
shown to he related to the feeding time in rats (fisher and Gardner,
1976; Stevenson et al, 1975? Stevenson and Fierstein, 1976). There¬
fore an attempt was made to relate the optimal injection time to the
feeding habits of the rats.
Two markedly different feeding patterns were observed depending
on both the diet and the number of rats in each cage. When rats were
caged in groups of 4 and fed on the Oxoid diet, there was a peak; of
food intake during the period 19:00 - 22:00, and a small but sustained
food intake throughout the rest of the 24 hours (Fig. 11.14b); a
pattern similar to that observed elsewhere (Kimura et al, 1970; Yonk
et al, 1978)* Administration of 5-fluorouracil at 02:00 was associated
with a reduction in the intestinal toxicity of the drug only when a
major portion of the daily food intake occurred in the period 19:00 -
22:00 (Figs. 11.14 and 11.15). This pattern was observed either (a)
when rats were caged in groups of 4 and had free access to the Oxoid
diet or (b) when access to the 'elemental' diet, Diet B, was restricted
to the period 19:00 - 22:00 daily (Fig. 11.14). In contrast, when rats
had free access to Diet B or when they were caged individually with free
access to the Oxoid diet, there was no peak of food intake and no
benefit was apparent from administration of 5-fluorouracil at 02:00
(Figs. 11.14 and 11.15). Although a reduction in the intestinal
toxicity of 5-fluorouracil was not observed after administration at
02:00 to rats that had been fed on the Oxoid diet only between 19:00
and 22:00 each day it should be noted that the growth rate of rats on
this dietary regime was relatively low (Table 11.3 and Fig. 11.6).
This was discussed earlier and these observations lend further support
to the conclusion that the restricted feeding regimes with the Oxoid
diet do not support the normal growth rate of rats, whereas those with
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the 'elemental' diet are comparable to ad lib regimes.
Thus, the intestinal toxicity of 5-fl'uorouracil does depend on the
injection time and the optimal injection time appears to be influenced
by the feeding time, although it cannot be concluded unequivocally
that the two are directly related.
Exploitation of these observations is clearly of potential value
to enhance the therapeutic value of 5-fluorouracil and, possibly, of
other cytotoxic agents and of irradiation provided that tumour tissue
does not exhibit the same diurnal rhythm in sensitivity. Further
studies on the relationship between the optimal injection time and the
feeding time and on cell kinetics should be useful in predicting and
manipulating the optimum time for 5~fl'uo:rouracil administration to
humans. Even if target and host cells do exhibit a similar rhythm in
toxicity, such studies might well provide a rational basis for
dissociating the rhythms so as to obtain maximum effect on a tumour
while minimising the host side effects, especially gastrointestinal
ones. Certainly if an optimal time for 5-fl'uorouracil administration
to humans was established and confirmed, the exploitation of this




The aims of this study have, on the whole, been achieved. The
results extend previous studies of the effects of 5~fluorouraci1 on
the small intestine (Gardner et al, 1978? Levin, 1968; Roche jet al,
1970) and now demonstrate clearly the dissociation of the effects of
5-fluorouracil on the small intestine from those simply consequent to
a reduced food intake. Although Bounous et al (l971a and b) claimed
that an 'elemental' diet could reduce the systemic toxicity of
5-fluorouracil, the results of this study do not support this claim.
On the contrary, the results suggest that these diets might even
increase the systemic toxicity of the drug. However, the most
rewarding part of this work was the identification of a possible
means of reducing the intestinal toxicity of 5~£.luorouracil, namely
selection of an "optimal" time of day for 5-fluorouracil injection.
The results have been discussed in detail in each chapter and
only the main points will be discussed in this final chapter.
The methods
Tne results, in retrospect, confirm that the methods chosen for
the study of intestinal absorption, cytoplasmic peptide hydrolase
activities and mucosal MA contents, were sound. All three methods
gave consistent and reproducible results throughout this work and
the values obtained compare well with those reported in the literature.
In Chapter 3 it was stressed that one of the major problems
associated with the development of intestinal preparations in vitro
was that of supplying sufficient oxygen to the mucosal cells. A
possible result of neglect of this factor is shown clearly in Chapter
6. The amount of peptide hydrolase activities released from the small
intestine during perfusion in vitro of intestines removed, after
establishment of perfusion, from anaesthetized rats is normally small
and very similar to that observed with perfusion in vivo (fig. 6.6).
However, if the animal is killed immediately prior to the establish¬
ment of luminal perfusion, a dramatic increase in the amount of
peptide hydrolase activity released is observed (fig. 6.6), Further¬
more, Gardner (1978) showed that this also results in a 50% reduction'
in the water absorption rate. Although it cannot be concluded that
these changes are a direct result of temporary anoxia, it must be
stressed that intestines removed from freshly killed animals are
frequently used for other intestinal preparations in vitro such as
everted sacs (e.g. Wilson and Wiseman, 1954 ) and tissue rings (e.g.
Agar et al, 1956). These observations seriously question the use of
these preparations for the study of intestinal absorption. This
applies especially to studies on peptide absorption and on peptide
hormones since these prpparations may release considerable amounts
of peptidase activities into the incubation medium.
These observations show the advantages of the method of fisher
and Gardner ("1974)5 chosen for the measurement of water absorption in
this work, provided that their precautions to avoid temporary hypoxia
are observed. They also show, for the first time, that observations
such as those of Silk and Kim (1976) on enzyme release from intestinal
preparations in vitro are strictly dependent on details of experi¬
mental technique, a point which is regrettably neglected in many
laboratories.
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The intestinal toxicity, of 5-fluorouracil
Gardner et al (1978) concluded that malabsorption may account
for some of the undesirable side effects associated with the adminis¬
tration of 5-fluorouracil. The results of this study agree with
their conclusion although, of course, no consideration has been
given to the effect on colonic function which is likely to be
involved in the pathogenesis of diarrhoea.
Intestinal absorption rates were unaffected 24 hours after drug
administration but were decreased to only 26% of control rates by the
third day. A similar decrease was observed on the fourth day but by
the fifth day after drug administration absorption rates had recovered
to about 70% of control rates (fig. 8.3). Since the turnover time of
the epithelium of the rat small intestine is between two and three
days (Eastwood, 1977) these changes in absorption rates could be
explained simply by an inhibition of crypt cell production by.
5-fluorouracil and a consequent loss of cells to replace the mature
enterocytes extruded from the tips of the villi. This theory is
supported by the observation that the marked decrease in the mucosal
DNA content 24 hours after drug administration (l'ig. 8.10) does not
result in an immediate reduction in water absorption rates.
The results presented in Chapter 8 are entirely consistent with
the theory that the impairment of intestinal absorption observed
after 5-fluorouracil administration is the result of a decrease in
the number of absorbing cells, as suggested by Levin (19S8), rather
than a decrease in the absorptive capacity of individual absorbing
cells. However, this question cannot be resolved conclusively,
since there is no method available to determine the number of
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absorbing cells in the intestinal mucosa. Whilst the mucosal DNA '
content is a useful j.ndex of the total number of mucosal cells and
of the proliferative state of the intestinal epithelium, it does
not distinguish between different cell types and is therefore not
a specific .index of absorbing cells as implied by Batt and Peters
(1976) .Furthermore, the results shown in Figs. 8.11 and 8.12
demonstrate the importance of the choice of reference system for
the expression of absorption rates, especially when studying the
effects of an antimetabolite on an heterogeneous population of cells
such as the intestinal mucosa. It is concluded that absorption
rates should be expressed per whole small intestine whenever
possible especially since these estimates are associated with the
least variance of the four reference systems used; they should
reflect the overall consequences for the animal.
While there is a dramatic decrease in the intestinal water
absorption rate and mucosal BNA content after 5-Pl'U-orouracil
administration the consequent reduced food intake alone results in
a much smaller decrease (Figs. 8.11 and 8.12). It is clear, there¬
fore, that the effects of 5-fluorouracil on the small intestine
cannot wholly be attributed to a reduction in food intake. This
conclusion is further supported by the observation that the Tris
and sodium salts of 5-fluorouracil have markedly different effects
on the food intake of rats (Fig. 8.1) but have very similar effects
on the small intestine (Figs. 8.3 and 8.4).
The Tris and sodium salts of 3-fIuorouracil
The introduction of the sodium salt of 5-fluorouracil was
fortuitous to the dissociation of the effects of 5-PBuorouracil per
se on the small intestine ffcom those of the reduced food intake.
However, the dramatic difference in the systemic toxicities of the
Tris and sodium salts of the drug was both unexpected and the cause
of some concern. A 1.6% mortality was observed following administra¬
tion of the Tris salt of 5-fluorouracil and all of the rats injected
with this salt of the drug showed signs of severe systemic toxicity
within three to four hours after injection. In contrast, no such
toxicity and no deaths were recorded following administration of an
equimolar dose of the sodium salt of 5-fluorouracil. There is a
difference between the plasma pharmacokinetics of the two salt forms
but this is only apparent after intraperitoneal injection (see
Chapter 9)« Plasma 5-fTuorouracil concentrations rose to and were
sustained at a higher level after administration of the Tris salt
than after administration of the sodium salt of 5~fluorouracil.
This difference alone is not thought to be sufficient to explain .
the severe systemic toxicity associated only with administration of
the Tris salt of the drug but is thought to be indicative of a
difference in the properties of the two salt forms. It is therefore
suggested that it is a property of the Tris salt per se that is
responsible for the severe toxicity and mortality associated with
its use. Whether this difference in the properties of the two salt
forms of the drug is reflected in their ability to kill tumour cells
is not known. The plasma pharmacokinetic studies suggest that there
may be a difference in the bioavailability of the Tris and sodium
salts of 5-fluorouracil. However, it is difficult, in retrospect,
to determine whether tumour response to chemotherapy with
i
5-fluorouracil is affected by the salt form of the drug used or
indeed whether the toxicity differs since authors seldom state the
salt form of a drug used. A number of reports of cardiotoxicity
following 5-fluorouracil administration (see review by Villani et
al, 1979) were published during the period when the Tris salt was
available on the U.K. market and it would be interesting to know if
the incidence of adverse effects has decreased since the introduction
(November 1973) of the sodium salt, The records of adverse
reactions to drugs held by the Committee on Safety of Medicines
shed no light on this point (M.L.G. Gardner, Personal Communication).
It is unlikely that the difference in the systemic toxicities
of the two salt forms of 5-flnorouracil could be exploited in an
attempt to reduce the clinical toxicity of the drug since the
intestinal toxicity of the two salt forms is very similar and this
toxicity is one of the major causes of the termination of chemo¬
therapy with the drug. However, the difference between the Tris and
sodium salts of 5-fluorouracil clearly merits further attention and
reinforces the principle that seemingly minor changes in drug
formulation can have important biological consequences.
1 Elemental' diets
The rationale behind the claim by Bounous et al (1971a and b)
that an 'elemental' diet could reduce the systemic toxicity of
5-fluorouracil seemed reasonable and therefore this possibility was
investigated in detail. However, the results presented in Chapter
10 do not support "this claim. These diets do not maintain the normal
growth rate observed in rats fed on a standard unhydrolysed diet,
although the growth rates of rats fed on one particular 'elemental'
diet were increased to a rate comparable to that of animals fed on-
a nomal diet by the novel use of dietary flavouring (fable 10.7)-
Furthermore, the energy utilization from these diets is very
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inefficient and this suggests that these diets are not ideally suited
to the nutrition of rats. If this is true for humans then these diets
do not meet the stated requirement - "to reduce each substrate to the
most efficient unit for digestion, absorption, transport and
utilization" (Tweedle, 1976). These observations alone argae against
the use of 'elemental® diets in patients with malabsorption as a
consequence of tumour growth (Costa, 1977).
If body weight loss after 5-fluorouracil administration is
regarded as a criterion of toxicity then it must be concluded that
'Flexical' and 'Vivonex-HN' increase the systemic toxicity of
5-fluorouracil (Fig. 10.2). Furthermore, none of the 'elemental'
diets reduced the severe impairment of intestinal absorption observed
after 5-fluorouracil administration (Fig. 10.6). It is noteworthy
that the most recent reports from Bounous and associates (Bounous et
al, 1978a and b) and an independent group of workers (Stanford et_ al,
1977) have eventually reported that 'elemental' diets actually
increase the mortality observed after 5-fluorouracil administration;
this must argue against their use regardless of the earlier claims
of benefit to the intestine. As explained in Chapter 10, the only
evidence in support of their earlier claim, relating to the measure¬
ment of intestinal absorption, was provided by Mohiuddin and Kramer
(1978)5 and. this did not stand up to critical scrutiny.
The mucosal DNA content is decreased to a similar extent after
administration of 5-fluorouracil to rats fed on a standard diet and
to rats fed on an 'elemental' diet (Fig. 10.4). Since it is concluded
that the impairment of intestinal absorption is probably due to a
decrease in the number of absorbing cells, it is clear that
'elemental' diets do not have a prophylactic action and the results
of this study suggest that they do not and the recovery of the
intestine from the injury following 5-fluorouracil administration.
It must therefore "be concluded that 'elemental' diets do not reduce
the intestinal toxicity of 5-fluorouracil•
Time of drug administration
By far the most rewarding part of this study was the
observation that the intestinal toxicity of 5-H'U-°rouracil varies
with the time of drug administration. Least toxicity, estimated
both by the effects on water absorption in vitro and by the
incidence of diarrhoea in vivo, was observed following injection at
02:00 and maximum toxicity was observed following injection at
15s00 (Figs. 11.6 and II.9). These two times coincide with the
nadir and peak respectively of the diurnal rhythm of proliferative
activity in the rat small intestine (Al-Dewachi et al, 197°)- This
suggests that the intestinal toxicity of 5~fInorouraci1 is related
to the proliferative activity of the mucosa at the time of adminis¬
tration and this possibility is consistent with the observation
that the mucosal UNA content is maximal at around 03:00 and minimal
at around 15:00 (Fig. 11.13). Furthermore, it has already been
shown that 5-flnorouracil is more toxic to proliferating cells than
to non-proliferating cells (Bruce and Meeker, 1967).
These observations suggest a simple means of reducing the
intestinal toxicity of 5-flu.orouracil, i.e. by careful selection of
the time of drug administration. However, in order to apply this
method to the clinical use of 5-Hu-Orourac:il, the time of minimal
proliferative activity in the human small intestine must be
identified. Unfortunately little is known about the proliferative
activity of the human small intestine since ethical considerations
prevent the use of the most useful methods of cell kinetic analysis
such as the labelling index and metaphase arrest techniques (Aherne
et al, 1977, P- 68). However, it may be possible to identify the
time of minimal intestinal proliferative activity by counting villus
populations or by measuring villus height in biopsies taken from
the same region of the small intestine at various times of the day
and night. Certainly the benefits to be gained from a reduction in
the systemic toxicity of 5~flnorouracil and of other chemotherapeutic
agents justifies further investigation of this 1chronopharmacological'
approach! it has much to recommend it, especially its simplicity
and lack of extra expense (c.f. the use of 'Vivonex-HN' is estimated
at £16.60 per patient per day by Eaton Laboratories Ltd). It may be
necessary and possible to synchronise or cue the timing of the cell
cycle (e.g by dietary manipulation); this might make it possible
to predict accurately the optimal time for 5-flnorouracil injection
in humans and to schedule this for a 'convenient' time.
A major shortcoming of this work is that haematological toxicity
has not been considered. Ibis exclusion is justified, in part, since
the gastrointestinal toxicity of 5-fluorouracil precedes the haemato¬
logical toxicity (Calabresi and Parks, 1975) by about four days and
therefore the same animals could not he used for both studies.
However, Halherg et al (l973) showed that there is a diurnal variation
in the proliferative activity of the hone marrow of rats and that the
activity is minimal at around 00:00. Thus it is possible that the
optimum time of injection in order to minimise the gastrointestinal
toxicity of 5-flnorouracil may well coincide with that producing
minimal haematological toxicity.
The plasma pharmacokinetics of 5-fkuorouracil showed (Fig. 9.5)
that an intraperitoneal injection^equivalent to an intravenous
infusion sustained over a three to four hour period? this raises
the possibility that even less intestinal toxicity might be observed
if the drug were administered at the optimum time as a single bolus
intravenous injection. This merits urgent consideration.
Thus the work reported in this thesis suggests that practical
improvements in chemotherapy may be simply achieved. More work is
clearly required and it is greatly hoped that the present findings
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The scries resistance determined in this manner
is higher than the usually measured resistance of
the bathing solution before mounting the tissue.
This is probably due to the contribution of the
resistance of the subepithelial tissue layers to R,.
Therefore the true epithelial resistance is lower than
that measured with the conventional method
(table).
The short circuit current increases because of the
decrease in RM. Consequently, as was shown in
rabbit ileum, the sodium net transfer rises from
5.74 ± 0.75 (SEM. n = 17. R3 measured conventio¬
nally) to 8.62 ± 0.92 (SEIVf, n = 17, R, measured
with the new method).
Vascular perfusion of tho rat small intestine.
T. J. Nicholls and H. f. LRF.se (Department of
Biology, Uttiversity of Yoik, York Y01 5DD.
U. K.).
A vascularly perfused preparation of the rat small
intestine, based on the method of Hanson and Par¬
sons (1), will be described. In this preparation, the
lumen of the jejunum is cannulated and perfused
with Krcbs-Hcnsclcit bicarbonate medium. The llow
of luminal perfusate is interrupted with bubbles of
95 p. 100 O., 5 p. 100 CO., (segmented circulation)
which gives increased stirring in the lumen and
improved oxygenation of the epithelial tissues. The
vascular system serving the jejunum is also perfused
with Krebs-Henseleit buffer, supplemented with
2.5 p. 100 bovine scrum albumin and washed red
cells at an hematocrit of 25 p. 100, which is intro¬
duced via the superior mesenteric artery and col¬
lected from a cannula inserted into the hepatic por¬
tal vein.
This method offers considerable advantages over
more conventional in vitro preparations such as iso¬
lated loops, gut rings or everted sacs, since the
tissue oxygenation is improved, the vascular flow
prevents the accumulation of substances taken up
from the lumen to unphysiologically high concen¬
trations in the epithelial cells and the metabolism of
nutrients can be studied as well as their transport.
Thus, the vascularly perfused preparation comes
close to duplicating the in vivo situation while still
retaining much of the versatility of measurement
afforded by other in vitro systems.
Measurements of various parameters of the pre¬
paration such as sugar uptake and lactate output
will be presented, together with a consideration of
the problems and technical details encountered in
setting up such a system.
1. Hanson PJ. Parsons DS : / Physiol (Lond), 1976,
255, 775.
The physiological viability of isolated intestine pre¬
pared from dead animals. J. A. Plumb and
M. L. G. Gardner (Department of Biochemistry,
University of Edinburgh Medical School. Tcviot
Place, Edinburgh ElIS 9A CI, U. K.).
Many intestinal preparations arc set up after the
animal is killed and the intestine removed. However
even if this is rapidly performed damage may occur.
Glucose and water absorption in perfused small
intestine arc halved if the intestine is rapidly
removed from a dead rat instead of being connected
to the apparatus while the animal is under anxsthe-
sia (2). Also, rales of leakage of amino acids and
cytoplasmic dipeptide hydrolases from the intestine
into the luminal perfusate arc substantially higher
when the rats arc killed by ether than when the
animals are kept alive under ether anxsthesia until
after the flow of oxygenated perfusate has been
established through the lumen (fig.).
□ In vitro (from an*r*!lM>ucr<t rata)
















Fici. — Rates of release
against gly-L-mct, L-lcu-gly and L-val-I.-leu
into (a) serosal secretion and (b) luminal effluent
during luminal perfusion in vitro and in vivo.
These findings suggest that the precautions of
Fisher and Gardner (1, 2) to avoid temporary
hypoxia should be adopted whenever possible.
Neglect of this may (a) decrease absorption,
(b) increase experimental variability and (c) permit
peptide hydrolysis in vitro at an unphysioiogical
site (3).
1. Fisher RB. Gardner MLG : J Physiol (Loud),
1974, 241. 211.
2. Gardner MLG : Q J E.xp Physiol. 1978. 63. 95.
3. Silk DBA, Kim YS : / Physiol (Lond). 1976, 258.
489.
Kinetic study of D-galactose and D-mannitol fluxes
across a doubly-perfused intestinal segment,
in vitro. J. BaTaille, (Lahoratoire de Physiologic
Comparic. Orsay, France).
In order to study the transmucosal fluxes of sugars
across the intestinal wall, an isolated segment of
guinea-pig jejunum was perfused on serosal and
mucosal sides (1.5 ml/min). After 30 rnin cquilibra-
Gastroenterol. Clin. Biol., (l98l) (in press)
The intestinal toxicity of an antimetabolite depends upon the hour
of injection
J.A. PLUMB and M.L.G. GARDNER
Department of Biochemistry, The University of Edinburgh,
Medical School, Teviot Place, Edinburgh EH8 9AG, U.K.
Although antimetabolites are widely used in chemotherapy their
side effects, especially intestinal ones, can be severe. The thera¬
peutic use of antimetabolites could be extended if this toxicity
were reduced. We have previously shown direct impairment of
intestinal absorption by 5-fTuorouracil (5MJ)(l) and have now
attempted to minimise this by (a) manipulating the time of injection
of 5FU and (b) feeding 'elemental' diets as suggested by Bounous et_
al (2).
Rats were injected i.p. with 5MU at various times. Subsequently
water absorption rates were measured in vitro in the perfused small
intestine (3), The incidence of diarrhoea was recorded.
Water absorption rates varied with the hour of injection: the
highest rates were observed in rats injected at 3 a.m. The least
incidence of diarrhoea also occurred after injection at 3 and 4 a.m.
The 'elemental' diet "Vivonex" or diets based on hydrolysed
lactalbumin or casein do not reduce the intestinal toxicity(4). We
have now shown that the 'elemental' diet "Flexical" and a diet based
on casein hydrolysate, sucrose and oil as used by Bounous et al (2)
also fail to protect intestinal absorption from toxicity.
We conclude that: (a) Manipulation of drug injection time
offers a potential means of increasing the therapeutic value of 5FU
and (b) 'Elemental' diets do not provide direct protection of the
intestine from 5FU toxicity.
(1) Gardner, MLG, Samson, RR, Heading, RC: Clin.Sci., 1978, 34,
411.
(2) Bounous G, Gentile, JM, Hugon, J: Can.J.Sur., 1971, 14, 298
(3) Fisher, RB, Gardner, MLG: J. Physiol (Lond)., 1974, 241, 211.
(4) Gardner, MLG, Heading, RC: Clin.Sci., 1971, ^6, 243-
Clinical Science (1981) ( in press)
SHORT COMMUHICATION
DIFFERENTIAL TOXICITY AND PHARMACOKINETICS CF SODIUM AND TRIS
SALTS OF 5-F'LUOROURACIL ITT THE RAT
JANE A. PLUMB*AND M.L.G. GARDNER
I
Department of Biochemistry, The University of Edinburgh Medical
School, Edinburgh, Scotland, U.K.
Present address: Department of Histopathology, Royal Postgraduate
Medical School, Ducane Road, London W12 OHS.
1
Summary
1. Rats injected intraperitoneally (i.p.) with the Tris salt
of 5-fluoro'uracil (1.44 mmol/kg) showed severe toxic symptoms
and a 15 a- mortality. No mortality and no obvious toxicity, apart
from intestinal toxicity, resulted after injection of the sodium
salt at equimolar dosage.
2. The plasma pharmacokinetics of the two salts of 5-fluorouracil
(1.44 mmol/kg) were different after i.p. injection: higher plasma
levels were achieved and were sustained for longer after the Tris
salt than after the sodium salt.
3. No differences in plasma pharmacokinetics were observed after
intra-arterial (i.a.) injection of the two salts of S-fluorouracil
(0.576 mmol/kg).
4. Thus there are fundamental (and potentially important)
differences betx^een the biological properties of the sodium and
Tris salts of 5-fluorouracil. These cannot be explained at
present. "
Key words: 5-f'luorouracil, pharmacokinetics.
. Correspondence: Dr M.L.G. Gardner, Department of Biochemistry,
The University of Edinburgh Medical School, Hugh Robson Building,
George Square, Edinburgh EH8 9XD, Scotland, U.K.
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Introduction
In the course of our investigations into the effects of
5-fluorouracil on intestinal absorption (Gardner, Samson &
Heading, 1978; Gardner & Heading, 1979; Gardner & Plumb, 1981)
we consistently observed toxic symptoms and an appreciable
mortality when rats were injected with a high dose (l.44 mmol/kg)
of the Tris salt of 5-fluorouracil but not after an equimolar
dose of the sodium salt. Prom analysis of animals' food intakes,
growth rates, mortality and signs of gross pancreatic lesions it
was clear that the effects of the two salts of the drug were highly
significantly different, although their direct effects on
intestinal absorption were closely similar (Gardner & Plumb,198l).
Since there was no obvious reason for this difference we have now
measured the plasma pharmacokinetics of the two salts of





Male and female Wistar rats of a local strain, weighing
160-200 g, were allowed free access to Oxoid 'Diet 86' (Oxoid
Ltd, Basingstoke, Hants, U.K.) and water. They were injected i.p.
with a sterile aqueous solution of 5-fluorouracil (l.44 mmol/kg)
as either the Tris salt (384 pmol/ml) or the sodium salt
(192 p.mol/ml) while temporarily tinder light ether anaesthesia.
The 5-fluorouracil solutions and a matched Tris placebo were
kindly provided by Roche Products Ltd, Welwyn Garden City, Herts.
U.K. All injections were given between 10:00 and 10:30 hours.
Measurement of plasma pharmacokinetics
Female Wistar rats of our local strain, weighing 195-205 g,
were used. They had free access to Oxoid 'Diet 86* and water
until the time of the experiment. Carotid arterial blood
(0.3 ml per sa.mple) was withdrawn via an indwelling cannula in
urethane-anaesthetized rats (a) over the first 240 min after i.p.
injection of 5-fluorouracil, sodium or Tris salt (l.44 mmol/kg as
in the other experiments described above) through a cannula
inserted through a laparotomy so that variability in the exact
site of injection could be minimized, and (b) over the first 60
min after intra-carotid arterial injection of 5-fluorouracil,
sodium or Tris salt (0.576 mmol/kg). The Tris salt as provided by
Roche Products Ltd was diluted 1:1 with the matched Tris placebo
for these experiments on pharmacokinetics so that both salts were
given at the same concentration, 192 pmol/ml. Fifteen rats were
4
injected with each salt "by the i.p. route; 3 with sodium salt
and 4 with Tris salt hy the i.a. route.
5-Fluorouracil was determined hy the absorbance at 267 nm
after ultrafiltration of the plasma, diluted 10-fold with
potassium phosphate buffer (0.1 mol/l, pH 7»0), throxxgh an
'Ultrafree' filter (Millipore (U.K.) Ltd, London). Control plasma
treated in this way showed no absorbance at 267 nm; the recovery
of 5-fluorouracil added to control plasma was 101 i 3.3$ (n=5 )
in the range 50 - 250 ng/ml. Nevertheless it should be noted
that this assay is not specific for 5-fluorouracil, and that
metabolites of the drug probably also contribute to the absorbsn.ee.




Within about 3-6 h after i.p. injection of the Tris salt of
5-fluorouracil all rats became cold, and very lethargic T^ith
obvious respiratory distress. In some cases death resulted,
although we do not know the actual cause of death. Severe
macroscopic haemorrhagic lesions on the surface of the pancreas
were noted. After injecting 319 rats with the Tris salt we have
observed a 15$ mortality; 27 out of 142 males and 21 out of 177
females died. The food intake of some of these animals was reported
by Gardner & Plumb (1981); it was negligible during the first 48 h
after 5-fluorouracil injection, and then it progressively
returned to normal over the following 7 days.
In contrast, after injecting 449 rats (436 males and 13
females) with the sodium salt at the same molar dosage we have
not recorded any deaths; furthermore we have never observed any
signs, apart from diarrhoea and impaired intestinal absorption,
of the systemic toxicity that was observed after injection of the
Tris salt. Also,the food intake, reported by Gardner & Plumb
(1981), over the first 48 h after injection with the sodium salt
was decreased to only 50$ of "the pre-injection intake; it
continued to decrease over the next few days before increasing
towards normal, a pattern which markedly differed from that after
administration of the Tris salt (Gardner & Plumb, 1981).
The toxicity and mortality associated with the Tris salt
were not reduced when the 5-fluorouracil was diluted lsl with
water or with Tris placebo so that the concentration and
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osmolarity, respectively, of the two salt preparations were the
same.
No toxicity or reduced food intake was observed when control
rats were injected with the matched Tris placebo.
Plasma pharmacokinetics
Pig. 1A shows that the plasma pharmacokinetics were different
after i.p. injection of the two salts; slightly higher plasma
levels of the Tris salt were achieved and maintained for longer
than those of the sodium salt. This difference was observed at
each point in time (Fig. lA). Therefore the probability of
difference at each point itfas assessed by a t_-test, and these
probabilities were combined as described by Fisher (1967).' The
difference between the two curves was significant (P<0.02).
In contrast, no difference was seen after i.a. injection (Fig. IB).




Sodium salt concentration = (l5b - 8.4) e-(0.0107 ± 0.0022)t
+ (1582 ± 8.4) e~(0±0. 111 )t




The differences between the toxic effects of the two salts of
5-fluorouracil are dramatic, although our previous experiments
showed that both salts caused diarrhoea and impairment of
intestinal absorption (Gardner & Plumb, I981). The significant
difference between the plasma pharmacokinetics of the two salts
after i.p. dosing suggests a possible explanation, and certainly
reinforces our conclusion that the biological properties of the
two salts are different.
Since different pharmacokinetics were observed after i.p.
injection (Fig. 1A) but not after i.a. injection (Fig. IB) it
is plausable that the difference in Fig. 1A may have been due to
more rapid uptake of the Tris salt from the peritoneal cavity,
rather than to slower clearance from the blood. Although we
cannot offer a definite explanation-for this, it may be relevant
that Tris base is a weaker base (pK = 8.1 at 25°C, Dawson,
ct
Elliott, Elliott & Jones, 19^9) "than sodium hydroxide. Hence, the
Tris salt of 5-fluorouracil is likely to be less dissociated than
the sodium salt, and thus may permeate some membranes more rapidly.
Although the higher plasma levels of the Tris salt than the
sodium salt after i.p. injection might themselves account for the
toxicity of the Tris salt, indirect evidence suggests that this
is unlikely: the Tris salt, i.p., at a lower dosage (l.08 mmol/kg)
was also associated with similar toxicity to that reported here.
Although the rate constants for the overall removal of both salts
from the plasma after i.a. injection were similar, it does not
follow that the rate of uptake by every organ was necessarily
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the same for both salts. Especially in the light of the apparently
greater rate of uptake from the peritoneal cavity, it seems
likely that some organs may accumulate the Tris salt faster than
the sodium salt.
We do not know whether cardiotoxicity contributed to the
mortality in out experiments; however, many authors have
referred to acute cardiotoxicity apparently associated with
5-fluorouracil chemotherapy (Levillain, Ramona & Cluzan, 1974,
Dent & McColl, 1975? Roth, Kolaric & Popovic, 1975; Lang-Stevenson,
Mikhailidis & Gillet, 1977; Mikhailidis, Gillet & Lang-Stevenson,
1978; Pottage, Holt, Ludgate & Langlands, 1978; Soukop, McVie &
Caiman, 1978; Villani, Guindani & Pagnoni, 1979) although none
stated which salt form was administered. We suggest that users
of 5-fluorouracil might study their records retrospectively in
order to see whether the incidence of adverse side effects,
including cardiac ones, has changed since November 1978 when the
sodium salt replaced the Tris salt on the U.K. market. It might
then be possible to assess whether our observations at high dosage
in rats are relevant to the clinical application of 5-fluorouracil.
Finally, our results emphasize the need to note full
details about drug formulations in publications and, preferably,
in clinical records.
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Legend
Pig. 1. Plasma levels of 5-fluorouracil after (a)
intra-peritoneal (i.p.) or (b) intra-arterial (i.a. ) injection
of either the sodium salt (•) or the Tris salt (o) in
anaesthetized female rats. Values are means i s.e.m. and (a)
the number of observations (n) is shown adjacent to each point,
(b) each point is the mean of three or four observations after
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